{
  "name" : "zero.sci-hub.se_5083_65e54a177b981b144080f43bb02154d5_parani2016.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Engineered Nanomaterials for Infection Control and Healing Acute and Chronic Wounds",
    "authors" : [ "Madasamy Parani", "Giriraj Lokhande", "Ankur Singh", "Akhilesh K Gaharwar" ],
    "emails" : [ "parani.m@ktr.srmuniv.ac.in", "gaharwar@tamu.edu" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Subscriber access provided by NORTHERN KENTUCKY UNIV STEELY\nACS Applied Materials & Interfaces is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.\nReview"
    }, {
      "heading" : "Engineered Nanomaterials for Infection Control and Healing Acute and Chronic Wounds",
      "text" : ""
    }, {
      "heading" : "Madasamy Parani, Giriraj Lokhande, Ankur Singh, and Akhilesh K Gaharwar",
      "text" : "ACS Appl. Mater. Interfaces, Just Accepted Manuscript • DOI: 10.1021/acsami.6b00291 • Publication Date (Web): 04 Apr 2016\nDownloaded from http://pubs.acs.org on April 5, 2016"
    }, {
      "heading" : "Just Accepted",
      "text" : "“Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.\n1\nEngineered Nanomaterials for Infection Control and\nHealing Acute and Chronic Wounds\nMadasamy Parani 1,2 , Giriraj Lokhande 2 , Ankur Singh 3 , Akhilesh K Gaharwar 2,4,5, *\n1Genomics Laboratory, Department of Genetic Engineering, SRM University, Chennai, Tamil\nNadu- 603 203, India\n2Department of Biomedical Engineering, Texas A&M University, College Station, TX 77843,"
    }, {
      "heading" : "USA",
      "text" : "3Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, NY 14853"
    }, {
      "heading" : "USA",
      "text" : "4Department of Materials Science and Engineering, Texas A&M University, College Station, TX"
    }, {
      "heading" : "77843 USA",
      "text" : "5Center for Remote Health Technologies and Systems, Texas A&M University, College Station,\nTX 77843, USA\nCorresponding author: parani.m@ktr.srmuniv.ac.in (MP); gaharwar@tamu.edu (AKG)\nKEYWORDS: Engineered Nanomaterials, Nanoparticles, Nanocomposites, Wound Healing,\nInfection Control, Antimicrobial\nPage 1 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n2\nABSTRACT: Nanoengineered biomaterials has dramatically expanded the range of tools used\nfor infection control and to accelerate wound healing. This review thoroughly describes the\ndevelopments that are shaping this emerging field, and evaluates the potential wound healing\napplications of recently developed engineered nanomaterials for both acute and chronic wounds.\nSpecifically, we will assess the unique characteristics of engineered nanomaterials that render\ntheir applicable for wound healing and infection control. A range of engineered nanomaterials\nincluding polymeric-, metallic- and ceramic-based nanomaterials that could be used as\ntherapeutic delivery agents to accelerate regeneration of damaged dermal and epidermal tissues\nare also detailed. Finally, we will detail the current state of engineered nanomaterial for wound\nregeneration and will identify promising new research directions in infection control.\nPage 2 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n3"
    }, {
      "heading" : "1. INTRODUCTION",
      "text" : "Wounds affect over 6 million people in the US at an annual cost of $25 billion.1-3 This high\nhealth and cost burden underlines the importance of research in this field. Wounds are classified\nas either acute or chronic. Acute wounds heal within a predictable time period (1 to 12 weeks\ndepending on the nature of the wound); however, accelerated wound healing is desirable for recovery, overall health, and cost.4 Chronic wounds do not heal in a predicted time period, are more susceptible to infection, and are considerably more difficult to manage.5\nChronic wounds include pressure ulcers, diabetic ulcers, and vascular ulcers (including venous\nand arterial ulcers). Age, peripheral neuropathy, peripheral arterial diseases, immuno-\ncompromised status, and venous insufficiency are some of the risk factors of chronic wounds. In\naddition, diabetes is also one of the major risk indicators for chronic wounds, and lifetime risk of developing a foot ulcer in a diabetes patient is estimated to be 25%.6 The most dreaded\nconsequence of unhealed diabetic foot ulcer is limb amputation due to infection, which occurs in 2.1 to 13.7 per 1000 diabetic patients;6 this incidence increases to as high as 80% mortality at five years post-amputation according to long-term studies.7 Therefore, there are multi-faceted\nresearch efforts to develop improved clinically-relevant therapeutic approaches aimed at both\ninfection control and achieving faster healing of acute and chronic wounds.\nThe ability of a range of biomaterials to accelerate wound healing and to control infection has been proposed and tested.8-9 Both synthetic and natural polymers could act as therapeutic agents\nto accelerate regeneration of damaged dermal and epidermal tissues. Most of these polymeric\nbiomaterials are able to mimic some of the physical and biological characteristics of native\ntissues due to high water content, biocompatibility, and biodegradable nature. Natural polymers\ninvestigated for wound healing applications include polysaccharides (chitosan, chitin, dextran,\nPage 3 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n4\nalginates, chondroitin, and heparin), proteoglycans, and proteins (collagen, gelatin, fibrin, silk fibroin, and keratin).10-14 A range of synthetic polymers are also investigated for their ability to\nfacilitate re-epithelialization. Some of the synthetic polymers investigated for wound healing\nincludes poly(glycolic acid)(PGA), poly-D, L-lactide-co-glycolide (PLGA), poly(vinyl\nalcohol)(PVA), poly(lactic acid)(PLA), poly(acrylic acid)(PAA), poly(ɛ-caprolactone) (PCL),\npoly(ethylene glycol)(PEG), and poly(vinyl pyrrolidone)(PVP). However, most these polymers\nlack bioactivity and the ability to accelerate the wound healing process; thus, several\nnanomaterials are incorporated within the polymeric network. Engineered nanomaterials are used\nto obtain sustain and control release of therapeutics to accelerates the healing process and\nprovides bioactive characteristics.\nA range of engineered nanomaterials are investigated for biomedical applications including\ntissue engineering, stem cell therapeutics, biosensing, immunomodulation and drug/gene delivery due to their unique physical, chemical and biological characteristics.15-21 By combining\nengineered nanomaterials with synthetic or natural polymers, nanocomposite biomaterials with desired characteristic can be designed.22-26 Recently, engineered nanomaterials have found more\nacceptance in wound healing applications as evident by the increase in publications (Fig. 1). A\nrange of polymeric, metallic and ceramic nanomaterials are investigated for wound healing applications.27-29 Some of the most common nanostructures include nanoparticles, nanofibers, nanocomposite, nanoengineered hydrogels and self-assembled nanostructures.30 These newly\ndeveloped nanomaterials are extensively used as tissue adhesive, hemostats, antimicrobial\nagents, and drug/therapeutics/cell delivery agents.\nMost nanomaterials are used for topical administration to minimize the perceived risks\nassociated with internal use. For example, topically applied antimicrobials are more effective\nPage 4 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n5\nthan systemically administrated antimicrobials in reducing the infections in granulating wounds.31 Additionally, exposure of nanoparticles in external wounds is more localized and thereby highly controlled.32 Undesirable effects, if any, can be easily detected and controlled due\nto the accessibility of the target area. The external nature of the whole system permit applied\ntreatments to focus on both faster wound closure and more aesthetic remodeling.\nRecently, development of effective antimicrobial wound dressings that utilize silver\nnanoparticles triggered expanded research on the use of nanoparticles and their composites for enhanced wound healing.32-35 While the impact of said nanoparticles will enable faster healing of acute accidental and surgical wounds,36-37 the true benefits of nanomaterials are seen in the\ndramatically improved healing times in cases of recalcitrant chronic wounds. The healing\npotential of nanoparticles combined with robust and flexible polymer systems will lead to ideal nanocomposite systems for wound healing and tissue regeneration.38-40\nIn this review, we will focus on a range of engineered nanomaterials (size<500 nm) that are\ncurrently used for infection control and wound healing applications. First, we will provide brief\noverview of biological aspect of wound healing process. Then we will critically evaluate various\nengineered nanomaterials including polymeric-, metallic- and ceramic-based nanomaterials that\ncurrently investigated for wound healing and infection control. Specifically, we will highlight\nnew developments that are shaping this emerging field, and evaluate the potential applications of\nthese engineered nanomaterials. We will review the unique characteristics of engineered\nnanoparticles that render them applicable for wound healing and infection control. Finally, we\nwill detail the current state of engineered nanomaterial for wound regeneration and will identify\npromising new research directions in infection control.\nPage 5 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n6"
    }, {
      "heading" : "2. ACUTE AND CHRONIC WOUND HEALING PROCESS",
      "text" : "Wound healing is a complex and well-orchestrated process, which is initiated immediately\nafter injury. This process follows a cascade of events involving different cell types, growth\nfactors, and cytokines, which act through distinct, but overlapping, sequential phases of (a)\nhemostasis and tissue inflammation, (b) cellular proliferation and new tissue formation, and (c) tissue remodeling (Fig. 2).4 Pathogenic infection of the wounds can extend the healing process,\nand may result in life threatening conditions. Recent reports indicate that stem cells and\nprogenitor cells are involved in the wound healing process, indicating that it is a systemic response rather than a local response to injury.41\nBreakage of blood vessels during injury results in bleeding; therefore, the first protective step\nis to achieve hemostasis though vascular constriction, platelet aggregation, and coagulation. The\nfibrin clots that form during this process have three major tasks: 1) plug the broken blood\ncapillaries to stop bleeding, 2) limit the pathogen entry into the blood stream, and 3) act as\nprovisional extracellular matrix (ECM) for migration and proliferation of the cells involved in\nwound healing. Simultaneously, the activated platelets off-load growth factors such as vascular\nendothelium growth factors (VEGFs), platelet-derived growth factors (PDGFs), transforming\ngrowth factors (TGFs), fibroblast growth factors (FGFs), and epidermal growth factors (EGFs).\nThe growth factors attract the pro-inflammatory neutrophils, monocytes, and lymphocytes, and initiate inflammation.42 Neutrophils are the first to clean up the wound bed from invading microbes and dead cells of the host.43 Monocytes divide and differentiate into macrophages,\nwhich in turn secrete cytokines that mount strong secondary inflammatory responses by\nrecruiting additional pro-inflammatory cells. Ultimately, the macrophages induce apoptosis of\nPage 6 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n7\ninflammatory cells, and clean up any dead cells; this action reduces inflammation and initiates\nthe cell proliferation.\nDuring the proliferation phase, fibroblasts secrete type III collagen to replace the damaged\nECM. Endothelial cells proliferate on the ECM and form new blood vessels (angiogenesis),\nwhich supply oxygen, nutrients, and growth factors to facilitate tissue growth. The wound is\nfilled with granulation tissue made of new connective tissue and blood vessels. This phase ends with wound closure, which is accomplished via traction forces generated by the fibroblasts.44\nRemodeling is the longest phase in wound healing, and begins when TGF-β and cytokines\nreleased from the platelets and activated macrophages induce the fibroblasts to differentiate into\ncontracting myofibroblasts. Minor superficial injuries do not need extensive remodeling; they\nheal without scarring by keratinocyte regeneration and minimal ECM production. Major injuries\nundergo extensive remodeling over a long period, in some cases as long as two years. The wound\ncontracts approximately 10 to 20 µm per day, and a large amount of ECM is produced and crosslinked during this time.45 The cells in granulation tissue undergo apoptosis, and the cell-rich granulation tissue results in formation of scar tissue.46 The density of the blood vessels in the granulation tissue reduces, and the wound becomes pale in color due to reduced blood flow.47 This results in formation of striated scar tissue consisting of collagen fibers and myofibroblasts.48\nThe strength of the skin over the scar gradually increases but it never surpasses 80% of the strength of unwounded tissue.49\nDue to infection or impaired wound healing, the above-mentioned cascade of events is absent\nor derailed in chronic wounds. Excessive neutrophil infiltration and/or an abundance of pro-\ninflammatory cytokines, reactive oxygen species, and wound proteases can stall the healing\nprocess at the inflammation phase. The wound proteases cause deficiencies in growth factors and\nPage 7 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n8\nECM proteins, which are central to the process of wound healing.50-51 Recruitment, survival, and proliferation of progenitor cells are also often defective in chronic wounds.52 The net result is\nthat the wound does not close for want of granulation tissue, which may be aggravated further by\nrepeated infections. External supply of the growth factors can reverse some of the deficits in\nimpaired wound healing. Recombinant PDGF-BB was approved by FDA as early as in 1998 as a topical application to improve healing of chronic wounds in diabetic patients.53-54 However,\ndespite best wound management, only 59% of diabetic foot ulcers were healed without amputation,55 which highlights the need for a more practical, safe, and effective therapy for non-\nhealing chronic wounds."
    }, {
      "heading" : "3. POLYMERIC NANOMATERIALS",
      "text" : "Macromolecular bulk polymers are used as nanoparticle carriers for controlled and sustained\nrelease of encapsulated or entrapped therapeutics. The molecular weight of the polymeric\nnanoparticles is tunable, and a range of characteristics—such as size, shape and hydrophilicity—\ncan be modulated. Nanomaterials derived from natural and synthetic polymers are investigated\nfor infection control and wound healing applications due to there unique physiochemical and\nbiological characteristics (Table I). Polymeric nanoparticles are normally bigger than metallic or\nceramics nanoparticles; those that are 500 nm or less in size are described in this review."
    }, {
      "heading" : "3.1 Natural polymers",
      "text" : ""
    }, {
      "heading" : "3.1.1 Chitosan-based nanoengineered materials",
      "text" : "Chitosan is derived from partial deacetylation of chitin and consists of D-glucosamine and Nacetyl-D-glucosamine.56 The amino groups present on the chitin backbone offer many\nPage 8 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n9\nopportunities for functional modifications to modulate mechanical stiffness, physiological\nstability, and biochemical characteristics. Chitin is deacetylated and cleaved to obtain chitosan;\nthe level of deacetylation and final molecular weight may vary. Increasing the degree of\ndeacetylation and molecular weight of chitosan promotes the protein loading capacity but decreases the release rate of entrapped therapeutics from the nanoparticles.57 Chitosan has been\ninvestigated extensively for a range of biomedical applications including tissue engineering, infection control, wound healing, therapeutic delivery, and hemostatic applications.56, 58-60\nChitosan is bioactive and have inherent characteristics to facilitate wound healing. For\nexample, in vitro testing of chitosan nanoparticles showed significant induction of lymphocyte proliferation and nitric oxide production.61 Nitric oxide is involved in wound healing through\nangiogenesis, migration of epithelial cells, and proliferation of keratinocytes. In vivo testing of\nexcision wounds in Sprague-Dawley rats with chitosan nanoparticles showed enhanced production of nitric oxide; this supports the role for chitosan nanoparticles in wound healing.61\nBy combining chitosan (CS) with free fatty acids, such as oleate and linoleate, polymeric micelles CS:OA and CS:LA respectively can be obtained via ionic interaction.62-63 Both CS:OA\nand CS:LA were mucoadhesive and had positive effects on cell viability. Due to the amphiphilic\nnature of micelles, topical delivery of poorly soluble drugs for infection control and wound\nhealing applications were investigated. Sustained delivery of clarithromycin and silver\nsulfadiazine from chitosan nanoparticles was reported.\nThe hemostatic and wound healing properties of chitosan nanoparticles (CS-NPs) loaded with adenosine diphosphate (ADP) or fibrinogen (FN) were explored.64 ADP binds to the receptors on\nplatelets and facilitates the wound healing process. Fibrin derived from fibrinogen provides the\nphysical framework for physical stability and aids in hemostasis. Scanning electron microscopy\nPage 9 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n10\n(SEM) showed that the positively charged CS-NPs adhered to the negatively charged membranes\nof red blood cells (RBC). CS-NPs strongly interact with blood and accelerates clotting. The\nincorporation of ADP and FN to CS-NPs further facilitates the clotting process, with ADP being the most effective molecule.64 ADP/FN in CS-NPs interacts with blood-derived thrombin and\nresults in the formation of profuse fibrin networks. The combination effect of ADP and FN has\nnot been investigated to date, but synergistic effects on blood clotting are possible.\nIn another study, chitosan/sodium tripolyphosphate (CS-TPP) nanoparticles were investigated for therapeutic delivery.65 Administration of CS-TPP nanoparticles encapsulated with\nstandardized extract from the leaves of Arrabidaea chica showed a ~60% reduction in\nindomethacin-induced acute lesions on gastric mucosa in rats. A comparative study between free\nextract and encapsulated extract demonstrated a four-fold reduction in the amount of\nencapsulated extract needed to achieve the equivalent healing response of free extract for ulcerative gastrointestinal lesions in rats.65 In addition, the free extract was cytotoxic at higher\nconcentrations (250 and 500mg/L), but the encapsulated CS-TPP nanoparticles promoted cell\nproliferation. It is important to note that long-term efficacy of CS-TPP still needs to be\ninvestigated for in vivo delivery of therapeutics.\nIn a similar study, chitosan-fibrin (CS-FN) nanoparticles were synthesized and investigated for antibacterial and wound healing applications.66 The CS-FN nanoparticles completely inhibited\nthe growth of Escherichia coli and Staphylococcus, and were not toxic to fibroblast cells even at\nhigher concentration (100 µg/mL). For in vivo wound healing studies, open excision wounds\nwere made in male albino rats, and treated with saline or CS-FN nanoparticles every other day\nfor 10 days. CS-FN nanoparticles-treated wounds were completely healed on day 14, whereas it took significantly more time (22 days) for the saline-treated wounds to heal completely.66\nPage 10 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n11\nCS-NPs were also investigated for gene therapy applications. Genes for two growth factors,\nPDGF-BB and FGF-2, were cloned in an expression vector and loaded onto chitosan nanoparticles.67 Gene-loaded CS-NPs were delivered into mice through subcutaneous and\nintramuscular routes. Though recombinant PDGF-BB and FGF-2 proteins were expressed in the\nmice sera, antibodies against them were also produced due to immune response. The effect of\ngene delivery on wound healing was not investigated, and it took ~60 days after delivery for the\nrecombinant proteins to be expressed. The two month of lag time severely limits applications of\nthis material for accelerated wound healing.\nThe process of wound healing culminates in regeneration of the lost tissue, which includes cell\nproliferation followed by tissue remodeling. The ECM, in addition to several other molecules,\nprovides a scaffold made of geometrically arranged collagen nanofibers that guide the cells in\ntissue remodeling. ECM also provides highly defined microenvironment that is essential for the\nregeneration of damaged tissue. Although it is difficult to mimic the chemical and biological\ncharacteristics of ECM, physical and structural characteristics can be mimicked using electrospinning or self-assembled techniques.68 Chitosan alone cannot form electrospun\nscaffolds, but it is often blended or modified with different synthetic and/or natural polymers.\nFor example, by combining chitosan with collagen, mechanically stable electrospun scaffolds can be obtained.56 The addition of collagen also facilitates proliferation and migration of\nfibroblasts, which aids in the wound healing process. In another approach, a hydrophilic and\nporous three-dimensional nanofibrous network was fabricated using deacetylated chitosan (CSDD) with and without arginine-modified chitosan (CS-A).69 Male Wistar rats were wounded and\nmonitored for 14 days after injury; treatment with both CS-DD and CS-A showed faster wound\nclosure than the control group. However, after 21 days, rats treated with CS-A showed\nPage 11 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n12\nsignificantly higher wound closure than rats treated with CS-DD or the control group. Both of\nthese approaches indicate the utility of nanofibrous chitosan-based scaffolds for accelerated\nwound healing.\nIn another study, chitosan and poly(ethylene oxide) (PEO) blend loaded with VEGF were electrospun into CS/PEO nanofibrous scaffolds.36 Additionally, poly-lactic-co-glycolic acid\n(PLGA) nanoparticles loaded with platelet derived growth factor-BB (PDGF-BB) were dispersed\nin the nanofibers. In vitro release of the growth factors was biphasic, with burst release of VEGF\non day 1 and sustained release of PDGF-BB over a period of seven days. Enhanced proliferation\nof human dermal fibroblasts on CS/PEO scaffolds was observed when compared to tissue culture polystyrene (TCPS) controls.36 Plates containing CS/PEO scaffolds with PDGF-BB loaded\nnanoparticles exhibited significantly higher cell growth compared to TCPS and CS/PEO\nscaffolds without growth factors. The effect of CS/PEO nanofiber scaffolds with and without\nVEGF and PDGF-BB growth factor on wound healing was investigated on full-thickness skin\nwounds of Sprague–Dawley rats. Untreated wounds and the wounds treated with commercial\nHyrofera Blue were maintained as controls. Wound closure was significantly higher in the\nwounds treated with CS/PEO nanofiber scaffolds containing the growth factors than in other\ntreatments. Though all wounds were closed after four weeks of treatment, wounds treated with\nCS/PEO nanofiber scaffolds with growth factors showed the smallest scar formation and more hair coverage due to the faster healing process.36 This study demonstrates a promising approach\nfor enhanced wound healing by dual growth factor delivery.\n3.1.2 Fibrin-based Nanomaterials and Nanocomposites\nPage 12 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n13\nFibrin is a biopolymer of fibrinogen, which is formed by the action of thrombin.70 Fibrin,\ntogether with blood platelets, forms the hemostatic plug that stops bleeding at a wound site prior\nto the initiation of the healing process. Fibrin is preferred for the delivery of protein growth\nfactors, which can be denatured by the heat and organic solvents that are used for the preparation\nof certain other polymeric scaffolds. Degraded fibrin fragment E also increased cell adhesion, differentiation, and angiogenesis to promote wound healing.71 Enzymatically degradable fibrin\nnanoparticles and nanotubes were synthesized and tested for their ability to deliver VEGF, which\nis a potent activator of vasculogenesis and angiogenesis. Treatment of human umbilical vein\nendothelial cells with fibrin nanoparticles and nanotubes loaded with VEGF increased cell\nproliferation, migration, and patterned alignment; this increase is most likely due to the combined action of VEGF and the fibrin degradation products released within the system.72\nRecombinant human EGF (rhEGF), which stimulates cell proliferation and facilitates wound\nhealing, was encapsulated in chitosan nanoparticles. Nanoparticles loaded with rhEGF were\nadded to a fibrin gel made from thrombin and fibrinogen. Encapsulated rhEGF was found to be more stable than the free form in simulated wound environments.70 Incorporation of chitosan\nnanoparticles in a fibrin gel matrix was helpful in controlling the burst release of rhEGF. In vitro\nrelease kinetics showed a sustained release of 65% of rhEGF over a period of four days. The\nresults also indicated that a sustained release over a period of two weeks could be achieved by\nincreasing the concentration of fibrinogen and thrombin. The rhEGF released from the hybrid matrix was able to retain bioactivity and facilitate proliferation of fibroblast cells in vitro.70\nIn another study, fibrin nanoparticles loaded with ciprofloxacin (broad spectrum antibiotic) and\nfluconazole (FDA approved broad spectrum antifungal compound) were tested for their antimicrobial properties as a drug delivery system for healing infected wounds.73 Results showed\nPage 13 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n14\na pH-dependent release profile of the encapsulated drug and dose-dependent antimicrobial\nactivity against Escherichia coli, Staphylococcus aureus, and Candida albicans. These results highlighted the ability of the nanomaterials system to respond to pH change.73\nChitosan and fibrin bandages (CFB), consisting of fibrin nanoparticles impregnated in a\nchitosan hydrogels were fabricated, characterized, and tested for several parameters that promote wound healing (Fig. 3).74 The CFBs were found to be microporous, flexible, and biodegradable.\nCFBs showed high cell viability, cell adhesion, and enhanced blood clotting when compared to\nchitosan-only bandages and to Kaltostat® (a commercial calcium sodium alginate dressing). In\nmale Sprague-Dawley rats, partial thickness skin wounds treated with CFBs showed 98% wound\nclosure. However, the wounds treated with either chitosan-only or Kaltostat® bandages and the\ncontrols (bare wounds) showed only 70% wound closure. These results were supported by\nenhanced collagen deposition and formation of granulation tissue in the epidermis in the rats\ntreated with CFBs. Presence of fibrin nanoparticles, in conjunction with the biodegradation of chitosan matrix, might produce an additive effect on wound healing.74"
    }, {
      "heading" : "3.1.3 Hyaluronic acid",
      "text" : "Growth factors suffer from rapid degradation; thus, they are used in high dosages and for shorter periods, but with the risk of developing malignant tumors.75-77 Therefore, sustained\ndelivery of a physiological dosage is preferred in regenerative therapies, especially when dealing\nwith chronic wounds, which can take several months to heal. In a recent approach, fibrin\nnanoparticles loaded with VEGF were prepared and loaded into a chitosan and hyaluronic acid blend to prepare a nanocomposite sponge for wound dressing.78 Hyaluronic acid was included\ndue to its ability to promote cellular proliferation and secretion of collagen. In vitro release of\nPage 14 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n15\nVEGF showed an initial burst release followed by a sustained release profile for a week, making\nit a suitable biomaterial for wound dressing. The nanocomposite sponge showed a higher blood\nclotting ability compared to either Kaltostat® or the chitosan/hyaluronic acid sponge.\nAdditionally, the nanocomposite sponge showed enhanced angiogenesis as indicated by\ncapillary-like tube formation when tested in vitro using human dermal fibroblasts and human umbilical vein endothelial cells.78"
    }, {
      "heading" : "3.2 Synthetic Polymeric Nanomaterials",
      "text" : ""
    }, {
      "heading" : "3.2.1 Poly-D, L-lactide-co-glycolide (PLGA) nanoparticles",
      "text" : "Under in vivo conditions, PLGA releases lactate, which facilitates wound repair by reducing muscular atrophy and improving reperfusion in ischemic hind limb wounds.79 However, PLGA\nnanoparticles are usually used in combination with drugs or growth factors for wound healing\napplications. rhEGF is effective against non-healing diabetic foot ulcers, but its short half-life\nlimits its bioavailability. To circumvent this problem, rhEGF was loaded on PLGA nanoparticles and tested on the full-thickness diabetic wounds of rats.80 PLGA nanoparticles facilitated a slow\nand sustainable release of rhEGF over a period of 24 hours thereby maintaining its effective\nconcentration to promote wound healing. The wounds treated with the rhEGF loaded PLGA\nnanoparticles showed an accelerated healing rate compared with wounds treated with nanoparticles without growth factors or controls.80\nIn another study, poly(ether)urethane-polydimethylsiloxane/fibrin-based scaffolds loaded with PLGA nanoparticles were fabricated.81 The PLGA nanoparticles were loaded with VEGF and\nbasic fibroblast growth factor (bFGF) that were to undergo a controlled release. Resulting data\nrevealed that the full-thickness skin wounds in healing impaired diabetic mice (db/db) showed\nPage 15 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n16\nsignificant wound closure when treated with growth factor loaded scaffolds compared to control\nscaffolds without growth factors. However, the rate of wound closure was not significantly\ndifferent from wounds treated with scaffolds containing free VEGF and bFGF. Scaffolds in the\npresence of growth factors (free or encapsulated with PLGA) resulted in complete reepithelialization, enhanced granulation tissue formation/maturity, and collagen deposition.81\nRecently, curcumin, a plant-derived compound, has been shown to promote healing of acute and chronic wounds.82-83 However, therapeutic application of this compound is reduced due to its\nlimited hydrophilicity, stability, and photosensitivity. To overcome these challenges, curcumin was encapsulated in PLGA (PLGA-CC) nanoparticles.82 The release kinetics showed an initial\nburst release of 40% curcumin in the first 24 hours, followed by a sustained release from 40 % to\n75% over a period of 8 days. PLGA-CC nanoparticles at a concentration of 100 µg/mL did not\nshow significant cytotoxicity to keratinocyte as indicated by LDH and MTT assays. Under in\nvivo conditions, the wounds treated with PLGA-CC nanoparticles showed complete closure,\nwhereas the wound treated with free curcumin and PLGA nanoparticles alone showed only 75%\nrecovery. In histological observations, the wounds treated with PLGA-CC nanoparticles showed complete re-epithelialization and significantly increased deposition of connective tissue.82 This\napproach of sustained delivery of therapeutics can significantly enhance the efficacy of difficult-\nto-soluble drugs.\nThe importance of nitric oxide (NO) in wound healing is underscored by its reported role in\ninflammation, cellular proliferation, ECM matrix deposition, angiogenesis, and matrix remodeling.84 However, NO delivery using a conventional delivery platform is challenging due\nto its gaseous nature. Attempts to deliver NO using metallic nanoparticles, liposomes, and dendrimers resulted in a maximum delivery period of 24 hours85-86, which is not sufficient for\nPage 16 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n17\nwound healing. In a recent study, sustained and controlled release of NO for extended periods was achieved using PLGA-polyethylenimine (PEI) nanoparticles.87 PEI/diazenium-diolate\n(PEI/NONOate) reacting NO was first synthesized with the secondary amine groups of PEI, and\nthen incorporated into PLGA nanoparticles. A sustained release of NO from PEI/NONOate was\nobserved for 6 days without any burst release. The NO-releasing nanoparticles showed\nantibacterial activity against Methicillin-Resistant Staphylococcus aureus (MRSA) and\nPseudomonas aeruginosa, which are the two major infectious agents of open wounds.\nAccelerated wound healing and epithelialization was observed when MRSA-infected fullthickness wounds in mice were treated with NO-releasing nanoparticles.87\nBesides growth factors, certain secreted lipids and proteins also play a role in wound healing.\nRecently, annexin A1 (ANXA1), a protein secreted from neutrophils as a component of\nextracellular vesicles, was shown to stimulate intestinal mucosal wound repair in murine model of colitis.88 PLGA-PEG-maleimide nanoparticles were decorated with the KLWVLPK peptide of\ntype IV collagen for mucosa targeting and encapsulated with an ANXA1 mimetic peptide for wound repair.89 In vivo studies in annexin A1 knockout mice showed that a single administration\nof the nanoparticles by intraperitoneal injection and intramucosal injection was sufficient to\naccelerate the repair of acute epithelial injury and closure of intestinal mucosal biopsy-induced\nwounds, respectively.\nNanofiber scaffolds loaded with drugs and growth factors are useful as wound dressing\nmaterial due to compatible biophysical and structural characteristics. Collagen/PLGA nanofiber scaffolds conjugated with CD29 antibodies were investigated for wound healing.90 Full-thickness\nskin wounds were made in rats, and skin grafts made of nanofiber scaffolds decorated with bone-\nmarrow-derived mesenchymal stem cells (BM-MSCs) were sutured over the wounds. Compared\nPage 17 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n18\nwith untreated controls, all of the wounds treated with nanofiber scaffolds, with or without BM-\nMSCs, promoted wound healing. The wounds that were treated with nanofiber scaffolds\ncontaining BM-MSCs achieved complete wound closure in 10 days. Histological observations\nshowed the formation of thin epidermal layer with several skin appendages, including hair\nfollicles and sebaceous glands. Increased expression of collagen, and epidermal differentiation\nmarkers, keratin 10 (early), filaggrin (middle), and involucrin (terminal), were also observed.\nThe wounds treated with empty nanofiber scaffolds were closed in 15 days, whereas it took 18 days for the untreated wounds to close.90 This study clearly indicates that use of nanofibrous\nscaffolds accelerates the wound healing process."
    }, {
      "heading" : "3.2.2 Poly(L-lactide) (PLLA)",
      "text" : "Dual-layer nanofiber wound dressing mats loaded with Nitrofurazone® (antibiotics drug used\nfor treating infected wounds) in both layers were fabricated with poly(L-lactide) (PLLA) and sericin nanofiber blend as the first layer and pure PLLA nanofibers as the second layer.91 Sericin,\na protein that envelops silk fibers created by silkworms, was included to enhance the hydrophilic\nproperty that facilitates cellular proliferation. This in vitro study showed an initial burst release\nof nitrofurazone from the PLLA/sericin blend fiber layer followed by a sustained release profile\nfrom the PLLA layer. The release of the entrapped drug was further fine-tuned by varying the\ndrug concentration in the different layers. When used as dressing material for full-thickness\nwounds in rats, wound size reduction was 97% for the wounds dressed with the Nitrofurazone®loaded dual-layer nanofiber mats, but 84% for the commercial woven dressing.91\nPLLA film functionalized with type 1 collagen was used as a biomimetic controlled drug delivery system for wound healing.92 Indomethacin, an anti-inflammatory drug used for wound\nhealing, was encapsulated within PCL and polyesterurethane (PU) nanoparticles. While PU\nPage 18 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n19\nnanoparticles showed a 20% burst release at 2 hours followed by a sustained release over a\nperiod of 48 hours (91%), PCL nanoparticles released 60% and 92% of the drug in 2 and 24\nhours, respectively. The same trend was observed even after the encapsulated nanoparticles were\nloaded on PLLA film. As a result, PU nanoparticles were shown to be better carriers for drug\ndelivery. Interestingly, for unknown reasons, PLLA film loaded with indomethacin encapsulated\nPU nanoparticles showed significantly lower cell viability compared to the empty film\n(functionalized with collagen) and the film loaded with indomethacin encapsulated PCL nanoparticles.92\nIn another study, growth factors were encapsulated in dextran glassy nanoparticles (DGN)\nbefore electrospinning in PLLA to avoid loss of the bioactivity of the protein due to denaturation.\nWound dressing membranes were fabricated by electrospinning of PLLA, PLLA fibers loaded\nwith bFGF (bFGF-PLLA) and bEGF-encapsulated in DGN (bFGF/DGN-PLLA). The\nbFGF/DGN-PLLA membranes released double the quantity of active bEGF from bFGF-PLLA,\nindicating enhanced protection due to encapsulation in DGN; the release was sustained for 30\ndays. The cells seeded on the bFGF/DGN-PLLA membrane surface showed enhanced\nproliferation compared to the bFGF-PLLA membrane. The in vivo study showed significant\nwound healing, capillary vessel density, and collagen type I expression for the group treated with\nbFGF/DGN-PLLA membrane when compared with controls (PLLA or bFGF-PLLA) membranes.93"
    }, {
      "heading" : "3.2.3 Poly(ε-caprolactone) (PCL)",
      "text" : "PCL is a biocompatible, biodegradable, and FDA-approved polymer, which is extensively used\nin the blends and composites for biomedical applications. Radially aligned PCL nanofibers were\nprepared by using the conventional electrospinning setup except for the collector, which included\nPage 19 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n20\na ring electrode and a point electrode.94 Ex vivo grafting of these fibers into a piece of dura with a\ncircular hole at the center showed the movement of fibroblasts from the surrounding tissue to the\ncenter of the scaffold along the radially aligned nanofibers. On day 4, the migrated cells covered\nthe entire surface of the radially aligned scaffold, whereas a cell-free region was observed in the\nrandomly aligned scaffold. Coating the scaffold with fibronectin improved this process. Highly\norganized type I collagen was observed on the radially aligned scaffolds, and haphazard\narrangements were observed on randomly aligned scaffolds. These results provide data for\nmethods that might help to heal the wound more aesthetically with reduced scar tissue formation.94\nNanofiber mats, with or without antibacterial gatifloxacin hydrochloride (Gati), were\nelectrospun by blending PCL with thermoresponsive poly(N-isopropylacrylamide) (PNIPAM)\nand a collagen substitute, egg albumin (EA), to increase the wound healing efficiency through efficient tissue regeneration.95. Release kinetics of Gati in PBS showed an initial burst release for\n10 hours, followed by slow and controlled release for 29 days, which is a suitable system for\ndrug release over the long period that is typically required for wound healing. Circular discs of\nnanofiber mats inhibited the growth of Staphylococcus aureus as indicated by zones of inhibition\nthat measured up to 35 mm in 24 hours. Full-thickness wounds were made in rats, and infected\nwith S. aureus. The infected wounds were subjected to a one-time dressing using gauze or\nnanofiber mats loaded with 10% and 15% Gati. On day 21 post-dressing, wound healing was 85\nto 95% in the wounds dressed with nanofibers whereas it was only 45% in the wound dressed with gauze.95\nPhotodynamic therapy (PDT) can be used as an alternative to antibiotics in infection control\nfor wounds. In PDT, a photosensitizer is administered first and then activated by light only on\nPage 20 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n21\nthe required location to achieve precise targeting. The activated photosensitizer produces singlet\noxygen molecules that kill the microbes. Hypericin is a new generation photosensitizer from Hypericum perforatum (St. John’s Wort) with potential antimicrobial activity,96 but its lipophilic\nproperty limits its clinical applications. To circumvent this problem, hypericin was encapsulated\nin amphiphilic PCL-PEG. The hypericin encapsulated in PCL-PEG showed an initial burst\nrelease followed by a slow release over a period of 48 hours. Photoactivated nanoparticles\nproduced 100-fold higher amounts of reactive oxygen species than the hypericin in DMSO, and\nthey efficiently inhibited the in vitro biofilm formation by MRSA. Wound healing was studied in\nWistar rats by making two circular full-thickness skin wounds on the dorsum of the animals. The\nwounds were infected with S. aureus on day 1, and treated with hypericin-loaded PCL-PEG\nnanoparticles, PBS, and hypericin in DMSO. On day 10, the wounds treated with hypericin-\nloaded PCL-PEG nanoparticles showed the maximum closure with a few completely healed\nwounds, whereas some wounds treated with hypericin in DMSO developed abscess and edema.\nWhile the animals treated with hypericin-loaded PCL-PEG nanoparticles showed 100% survival\nduring the study period, only 50 and 75% of the animals treated with PBS and hypericin in DMSO, respectively, survived.97"
    }, {
      "heading" : "3.2.4 Other types of polymeric nanomaterials",
      "text" : "A biocompatible wound dressing material was synthesized based on thermoresponsive and\nthermoreversible triblock copolymer hydrogel with water soluble poly(2-(methacryloyloxy)ethyl\nphosphorylcholine) (PMPC) flanked by water insoluble poly(2-hydroxypropyl methacrylate) (PHPMA).98 Self-assembled copolymers formed gel networks of micelles with bridging chains\nbetween the micelles. In hydrated conditions at 20 and 60 °C, the hydrodynamic radii of\ncopolymer micelles were observed to be around 30 nm and 80 nm when PMPC degree of\nPage 21 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n22\npolymerization was 250-300 and 400, respectively. In gels containing up to 20% copolymers, the\ncell viability was 80% of the control (without copolymer) for 72 hours. Exposure of 3D tissue-\nengineered skin to 20% gel for four days did not cause any structural change to the skin and\nMTT assay did not indicate any significant reduction in cell proliferation. Therefore, these\nthermoresponsive and biodegradable copolymers may be useful in developing better wound dressing material loaded with drugs and growth factors.98\nIn other studies, PEG nanoparticles were used to increase the bioavailability of quercetin and curcumin for improved wound healing.83 Dermal drug delivery capacity was studied in vitro in\nthe skin of newborn pig using Franz vertical cells under non-occlusive conditions. As determined\nby high-performance liquid chromatography, transdermal delivery of quercetin and curcumin\nwas found to be the highest in the stratum corneum followed by epidermis, dermis, and receptor\nfluid. For in vivo studies, cutaneous inflammation and ulceration were induced by applying\nphorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) on the shaved skin in the back of\nmice. The inhibitory effect of PEG-Curcumin and PEG-Quercetin on inflammation and\nulceration was determined by edema formation and myeloperoxidase (MPO) activity,\nrespectively. Curcumin was more bioactive in encapsulated form than in freely dispersed form.\nPEG-Curcumin provided more inhibition of edema (91% versus 74%) and MPO activity (68%\nversus 40%) than PEG-Quercetin. Examination of the skin biopsies was obtained 72 hours after\ntreatment; both PEG-Curcumin and PEG-Quercetin treated skin showed extensive keratinized\nareas and a thin layer of migrating epithelium over the dermis, indicating the epidermis\nreformation. Leukocyte infiltration was less severe, especially in the dermis, and congestion of\nblood vessels was less evident. Skin treated with PEG-Curcumin showed extensive reepithelialization with multiple layers of thick epidermis.83\nPage 22 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n23"
    }, {
      "heading" : "4. METALLIC NANOMATERIALS",
      "text" : "Silver and gold are the two major noble-metal nanoparticles that are used in wound healing\napplications (Table II). Metal nanoparticles exhibit a range of properties such as enhancing\nmechanical strength, controlled release, and antibacterial activity against both bacteria and fungi,\nwhich make them excellent candidates for topical use in wound healing. Here we review the\npromising wound healing applications, and the mechanism of action of metallic nanoparticles,\nand their composites."
    }, {
      "heading" : "4.1 Silver nanoparticles (AgNPs)",
      "text" : "Silver has a long history as an antimicrobial agent for preventing infections during wound\nhealing. Silver treatments were initially with a 1% silver nitrate solution in the beginning of the 19th century, followed by silver sulfadiazine cream formulations in 1960s, and now silver is\nbeing used in the form of metallic silver nanoparticles (AgNPs). AgNPs were reported to be effective against bacteria, yeast and fungi;99-101 although AgNPs inhibited the growth of both Gram-negative and Gram-positive bacteria, they were more effective against the former.32, 99, 102\nWhen used in combination with antibiotics, AgNPs showed synergistic (ceftazidime), additive\n(ampiclox, kanamycin, streptomycin, polymyxin B), and antagonistic (chloramphenicol) effect against pathogens.32 Antibacterial activity of AgNPs increased with decreasing size of the nanoparticles.102 Size-dependent antimicrobial activity of AgNPs was also observed with Pseudomonas sp., Penicillium sp., and Aspergillus niger.101 The size-dependent microbial activity of AgNPs was in fact due to the size-dependent release of silver ions.103\nAgNPs unleash multiple strategies to be effective as a broad-spectrum antimicrobial agent.\nThey are oxidized in aqueous solutions in the presence of oxygen, resulting in the release of\nPage 23 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n24\nsilver ions under acidic conditions. It must be noted that it is not the AgNPs that are responsible for the antimicrobial action, it is the silver ions that they carry and release.103 Electrostatic\ninteraction between silver ions (positive) and cell membrane (negative) of microorganisms result\nin a fatal interaction. For example, a majority of AgNPs are localized on bacteria cell membranes\nand induce a massive loss of intracellular potassium, a decrease in cellular ATP levels, and a rapid breakdown of proton motive force resulting in cell lysis.104 In addition, silver ions\ninactivate enzymes of respiratory chain and TCA cycle by binding to the amino acids with thiol group, and induce hydroxyl radical formation resulting in bacterial cell death.105 AgNPs-\nmediated dephosphorylation of the tyrosine residues of bacterial proteins involved in the signal transduction pathway and in essential enzymes may also inhibit the growth of the organisms.106\nThe formation of free radicals and radical–induced membrane damage causes microbial cell death.99 It was thought that such a multifaceted mode of action would guard against the\ndevelopment of microbial resistance against AgNPs; however, there are reports suggesting that\naggressive clinical use of AgNPs must be done with caution. Survival fitness of E. coli was increased at sub-lethal concentrations of AgNPs,103 and microbial resistance to AgNPs was developed by de novo mutations in existing genes.107 These results clearly show that more\nresearch is warranted in this direction. In addition to preventing infections, AgNPs also aid in faster and aesthetic wound healing.108-110\nAntimicrobial wound dressing material was developed by self-assembling AgNPs on the\nsurface of bacterial cellulose and demonstrated to be effective in controlling the growth of E. coli, S. aureus and P. aeruginosa.111 Mussel-inspired poly(dopamine methacrylamide-co-methyl\nmethacrylate, MADO) nanofibers were surface functionalized with AgNPs in a one-step electrospinning process (Fig. 4).108 In this method, AgNPs were coated uniformly without any\nPage 24 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n25\naggregation on the polymer surface, and the catechol redox chemistry used for the synthesis\nrendered the AgNPs insensitive to oxygen, endowing them with long-term antimicrobial activity. Studies of the release kinetics of Ag+ from MADO-AgNPs showed 13% burst release on day 1,\nfollowed by a sustained release for 5 days in physiological conditions. MADO-AgNPs\nnanofibers effectively prevented the growth of Gram-negative E. coli as well as Gram-positive P.\naeruginosa and S. aureus. Fibroblast cells treated with MADO-AgNPs for 72 h showed 85%\nviability compared to the untreated control. For in vivo studies, partial thickness skin wounds\nwere made on the dorsal side of Wistar rats, and covered with MADO-AgNPs nanofibers.\nWounds covered with MADO nanofibers or cotton gauze were used as controls. After 15 days,\nthe wounds treated with MADO-AgNPs and MADO showed 92% and 65% healing,\nrespectively, which was significantly higher than the healing rate observed with the wounds\ntreated with cotton gauze (51%). These results show that ECM-like property of MADO and the\ninfection control properties of AgNPs contribute to faster wound healing.\nIn Sprague–Dawley rats, AgNPs showed a 17% improved healing rate compared to silver\nsulfadiazine at day 13; AgNP treatment accomplished complete wound healing 4 days before silver sulfadiazine.112 While treating second-degree, deep-dermal burn wounds in humans, AgNPs showed complete wound healing 10 to 14 days earlier than silver sulfadiazine.113 Apart\nfrom faster wound healing, thermal wounds in mice treated with AgNPs showed minimum hypertrophic scarring and normal hair growth.110 In acute burn and excision wound models, mice\ntreated with nanohybrid AgNPs/nanoscale silicate platelets (AgNP/NSP) showed superior wound healing compared to mice treated with polymer-dispersed AgNPs, AquacelTM (commercial wound dressing material with ionic silver), and silver sulfadiazine.40 This is a significant\nobservation given the fact that wound healing without scar formation is the most desirable\nPage 25 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n26\noutcome for patients. Currently, wound-dressing materials containing AgNPs are regularly used\nin clinical practice. Use of wound care products with AgNPs posing local or systemic toxicity due to silver ions is considered to be low or negligible;114 however, significant efforts have been\nmade to reduce the toxicity by improving the efficiency of nanoparticles so that the lowest\nconcentration can be used with a controlled release. Typical wound healing systems often consist\nof AgNPs and a polymer. A significant reduction in silver cytotoxicity was observed when AgNPs were combined with chitosan, which ensured a control over its exposure to cells.112\nCombinations of silver nanoparticles with PVA and chitosan provided improved wound healing and infection control.88 Uniform distribution and pH dependent release was observed when\nAgNPs were incorporated in the electrospun fibers made of partially carboxymethylated cellulose.35"
    }, {
      "heading" : "4.2 Gold nanoparticles (AuNPs)",
      "text" : "Gold nanoparticles (AuNPs) are desirable due to their stability, custom size, and ease of\nsurface functionalization. The light absorbing ability of the AuNPs was used for tissue welding to facilitate healing of cut wounds.115 Gold nanoshells with peak extinction (matching the near\ninfrared wavelength) were used as exogenous chromophores to absorb the near infrared energy while welding surgically cut wounds.115 Tensile strength of the welded site was equal to the\nuncut tissue, and histological examination showed good wound-healing response. Biologically\ninert AuNPs are normally functionalized before being used for wound healing. Antibiotics\nshowed enhanced activity when conjugated to AuNPs. Vancomycin conjugated to AuNPs could effectively inhibit the growth of vancomycin-resistant enterococci.116 AuNPs capped with p-\nmercaptobenzoic acid and conjugated with a particular thiol group showed 99.9% inhibition of\nPage 26 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n27\nmethicillin-susceptible S. aureus (MSSA) and MRSA.117 Similarly, inactive amino-substituted\npyrimidine (4,6-Diamino-2-pyrimidinethiol) conjugated to AuNPs showed antibacterial activities\nagainst E. coli and P. aeruginosa by severely affecting membrane potential, ATP level, and binding of ribosome to tRNAs.118-119 The role of surface chemistry in AuNP-mediated\nmicrobicidal activity was investigated in detail by synthesizing AuNPs carrying different\ncationic functionalities varying in chain length, nonaromatic, and aromatic characteristics. It was\nfound that AuNPs with cationic and hydrophobic functional groups (e.g. n-decane end group) were the most effective against Gram-negative and Gram-positive bacteria.120 These studies\nhighlight specifically how AuNPs can be useful in the treatment of infected wounds.\nAn AuNP-loaded polymeric network can further accelerate wound healing and assist with\ninfection control. Compared with pure chitosan, AuNP-Chitosan nanocomposite showed\nenhanced proliferation of human fibroblasts in vitro. In male Sprague–Dawley rats, it showed improved healing of surgical wounds when compared to TegadermTM (commercial wound\ndressing material containing chlorhexidine gluconate) and bare chitosan. Also, hemostasis (as\nobserved after 90 seconds) and wound epithelialization were more pronounced in the treatment with AuNP-Chitosan nanocomposite than pure chitosan.121\nIn another study, negatively charged AuNPs and positively charged gold nanorods (AuNRs)\nwere incorporated into decellularized porcine diaphragm to produce a biocompatible scaffold\nsuitable for wound healing. The diaphragm scaffolds incorporated with AuNPs and AuNRs\nshowed enhanced cell proliferation and free radical generation, which appeared to be dependent on shape and concentration of the nanomaterial use.122 The possibility of a novel application for\nAuNPs in wound healing was indicated by controlled behavior of fibroblast cell detachment,\npatterning, and regrowth on artificially engineered AuNP-based surfaces that were triggered by\nPage 27 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n28\nnon-thermal laser irradiation. AuNP-mediated cell detachment was evident because irradiation of\nfibroblasts on the control glass surface under the same conditions did not result in their detachment.123 The age of the cell, intensity and duration of laser power, and AuNP patterning\ncould be used for controlling the spatial organization of the cells for efficient wound healing.\nInappropriate inflammation due to oxidative stress is a primary reason for reduced wound\nhealing in diabetes patients. Delivery of epigallocatechin gallate (antioxidant) and alpha-lipoic\nacid (ROS scavenger) in combination with AuNPs was shown to facilitate wound healing in a\ndiabetic mouse model due to increased angiogenesis and reduced oxidations and inflammation.124-125 Further enhancement in wound healing was observed when the same\nmaterial was topically applied using a propulsion device. The enhanced result was possibly due\nto the deep cutaneous delivery, which might protect the compounds from the enzyme that are abundant in the wound surface.126 Liposome encapsulation of the Calendula officinalis extract showed significantly enhanced wound healing in vitro when it was combined with AuNPs.127\nDressing the wounds with plain or pharmaceutically functionalized hydrocolloid membranes\n(polyurethane membrane coated with hydrophilic polymeric colloids) provide accelerated\nhealing with reduced pain due to the membrane’s mechanical characteristics, biocompatibility, and physiological stability.128 The surface of a hydrocolloid membrane coated with AuNPs\nshowed significantly enhanced wound healing abilities in eight-week-old Sprague-Dawley rats (Fig. 5).128 For example, the wound closure rate was significantly enhanced in the treated group\n(membrane coated with AuNPs) versus the control group (gauze or uncoated membrane).\nSignificant increase in collagen, vascular endothelial growth factor, angiopoietins, and\nsuperoxide dismutase enzymes with a concomitant decrease in matrix metalloproteinase 1 and\nPage 28 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n29\nTGF-β1 was observed in the group treated with AuNP-coated membrane, indicating synergistic\nregulation of angiogenesis and connective tissue formation along with antioxidant effects.\nIn a recent study, AuNPs were immobilized and protected by polyvinylpyrrolidone on a large 500nm nanosilica, forming a gold–silica core–shell structure.39 The AuNPs were allowed to\ngrow as nanoshells on the surface of SiO2 until they were connected to each other. The wound\nhealing capacity of this nanocomposite was studied by topical application on full-thickness skin\nexcision wounds in adult male Sprague–Dawley rats with recombinant human bFGF as a\npositive control. The nanocomposite and bFGF-treated group had a similar wound closure rates\non day 7 and 14 post-wounding. On day 18 after injury, nanocomposite treatment produced complete healing, whereas the wounds of the rh-bFGF treatment had not completely healed.39\nGene therapy for wound healing was investigated by delivering anti-microRNA (miRNA)\noligonucleotides using AuNPs. Integrin beta-3 is an integral cell surface protein implicated in promoting cell migration and angiogenesis,129-130 and vimentin is a major intermediate filament of cytoskeletal system shown to be essential for wound healing.131 Genes of these two proteins\nare negatively regulated by miRNA 378a (miR-378a). NIH/3T3 cells transfected with anti-miR-\n378a showed accelerated fibroblast migration, differentiation, and tube formation, and transgenic mice expressing anti-miR-378a showed enhanced wound healing.132 Encouraged by these results,\nnanoparticle-based delivery of anti-miR-378a was attempted for enhanced wound healing in a\nmouse model. Thiol-modified anti-miR-378a fragments were conjugated to methoxy PEG thiol\nand coated on the surface of AuNPs. Punch wounds were made in wild type CD-1 mice on the\nbackside of the neck, and a single dose of nanoparticles was administered in the area adjacent to\nthe wound by intradermal injection. On day 4, wounds treated with AuNPs carrying anti-miR-\nPage 29 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n30\n378a showed better wound closure compared to the wounds treated with AuNPs carrying blank vector.132"
    }, {
      "heading" : "5. CERAMIC-BASED NANOMATERIALS",
      "text" : "A range of ceramic nanoparticles are investigated for wound healing and infection control\n(Table II). Ceramic nanoparticles are used for controlled delivery of thereputics due to high\nsurface-to-volume ration and charged surface. Some of ther ceramic nanomaterials include silica,\nsilicate clays, bioglass and zinc oxide nanoparticles. Due to semi-crystalline nature of these\nnanomaterials, ionic dissolution products of nanomaterials have also shown positive influence on\nangiogenesis and wound healing."
    }, {
      "heading" : "5.1 Silica nanoparticles:",
      "text" : "The mesoporous nature of silica nanoparticles was considered an ideal property for delivering\ngrowth factors to facilitate wound healing process. For example, in situ encapsulation of bFGF in mesoporous silica nanoparticles (MSNs) was done by the water-in-oil microemulsion method.133\nThe loading efficiency of bFGF in MSNs was 72%, and the release kinetics showed 50% release\non day 8 and about 75% on day 15. The bFGF-loaded MSNs were able to enter the human\numbilical vein endothelial cells and remained in the cytoplasm. Treating the cells with bFGF-\nloaded MSNs promoted cell proliferation, indicating that this is a promising system for wound healing.133\nIn another study, silica nanoparticles were used to release NO to facilitate wound healing\nprocess. Silica nanoparticles with a secondary amine functional group were synthesized from tetraethoxysilane or tetramethoxysilane by the sol–gel method.134 The secondary amino groups\nPage 30 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n31\nwere subsequently converted to NO releasing N-diazeniumdiolate groups by exposing the\nnanoparticles to elevated pressures of NO gas for three days. These particles were capable of\nreleasing NO when exposed to water. The structure and concentration of silane precursors and\nthe reaction conditions could be varied to obtain nanoparticles that differ in the quantity and duration of NO release.134 Further control over the NO release could be achieved by incorporating the NO-releasing silicate nanoparticles into electrospun polyurethane fibers.135 In\nanother study, PEG and chitosan were incorporated during the sol-gel process to obtain NOreleasing nanocomposites.136 Heating the nanocomposites facilitated the thermal reduction of\nnitrite due to the presence of glucose, resulting in formation of NO-releasing silica nanoparticles.\nThe trapped NO was released when exposed to water. NO-releasing silica nanoparticles\nincreased the fibroblast proliferation and migration in vitro by promoting collagen deposition and\nangiogenesis in the wound area. Wounds treated with NO-releasing silica nanoparticles showed\ncomplete closure within 12 days after surgery. In contrast, complete wound closure was\nsignificantly delayed in the wounds treated with empty nanoparticles or untreated wounds.\nWound closure percentage at day 7 relative to the initial wound size was significant in comparing the NO-treated group with the untreated group.137\nTissue adhesives are commonly used for efficient healing of cuts and surgical incisions.\nCurrently available tissue adhesives that rely on in situ polymerization are problematic to use in\nclinical practice and are limited by toxicity, lack of strength, and swelling complications.\nDevelopment of more efficacious tissue adhesives is further challenged by the fact that tissue\njoining should happen quickly and in the wet conditions of profuse bleeding. The tissue should\nalso stay intact after adhesion while withstanding a constant flow of body fluid and, in some\ncases, constant tissue movements, as in heart muscles. Recently, a simple aqueous silica\nPage 31 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n32\nnanoparticle solution was developed that can be conveniently and efficiently used as a tissue adhesive for joining natural calf tissue ex vivo (Fig. 6).138 The same group has further refined it\nas very interesting nanobrindging technology for rapid and strong closure and healing of deep wounds made in the skin and liver of rats.139 In this method, a droplet of nanoparticle solution is\nspread over the wound surface of a tissue and brought into contact by gentle manual pressure.\nThe nanoparticles are absorbed by the tissue to form numerous connectors and join the tissue\ntogether within an extraordinarily short period (about one minute or less). Silica nanoparticles\nwere synthesized by the Stöber method, and the tissue adhesion of nanoparticles was evaluated.\nThe nanoparticle solution was spread on one edge of the wound, and the two edges were brought\ntogether and pressed into contact manually for less than one minute to seal the wound. At day 7\nafter sealing, there was no evidence of wound reopening, pathological inflammation, or necrosis,\nindicating efficient healing. The scars formed after nanobridging were more aesthetic (less scar\nand more hair in the wounded area) in comparison with suturing or use of cyanoacrylate glue. In\naddition, the nanoparticle solution was also applied on the bleeding injured area. There was no\npost-surgery bleeding syndrome, and histopathology done at day 3 post-surgery showed that hemostasis, biliostasis, and wound closure were achieved without affecting the liver function.139\nExtremely fast release kinetics of the loaded drugs is a major limitation to the use of collagen\nin the fabrication of wound dressing material. To address this problem, drug was loaded in silica nanoparticles before incorporating them in collagen based nanocomposite hydrogel system.140\nWhile direct loading of the drug in collagen hydrogels showed complete release in 24 hours, the\nnanocomposite hydrogel system with the drug encapsulated in silica nanoparticles showed\nsustained release over a period of 7 days. Incorporation of silica nanoparticles also slowed the\nPage 32 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n33\nenzymatic degradation of collagen, which increases the durability of the dressing material by protecting the collagen from the metalloproteases that are abundant in the wound site. 140\nWound healing is greatly influenced by the chemotactic movement of different cell types\ntowards the wound site. Microtubules are the part of the intracellular cytoskeleton, and their\ndepolymerization enhances cell motility. It was recently discovered that Fidgetin-like 2 gene in\nhumans encodes a microtubule depolymerizing enzyme that affects cellular movement by\nsevering the microtubules. Further, it was hypothesized that a small interfering RNA (siRNA)\ncan mediate down-regulation of Fidgetin-like 2, and this action should improve cell movement, and thereby, wound healing.141 Hydrogel/glass composites were made using\ntetramethylorthosilicate, chitosan and PEG, which contained silicate nanoparticles of 10 nm in size.136, 142 These silicate nanoparticles were encapsulated with the siRNAs targeted to the\nFidgetin-like 2 gene (NPsiRNA-FL2). Full-thickness wounds and thermal burn wounds in mice\nwere topically treated with single doses of NPsiRNA-FL2 suspension immediately after injury at\nday 0 or days 0 and 2. Significant decrease in the expression of Fidgetin-like 2 gene in the\nwounds treated with NPsiRNA-FL2 indicated successful functional delivery of siRNA from the\nnanoparticles to the cells in the wounded tissue. Treatment of the wounds with NPsiRNA-FL2\naccelerated wound closure in vivo, and the second treatment at day 2 after injury further\naccelerated the resolution of the excisional wound. Histopathology showed that the wounds were\ncompletely re-epithelialized by day 7, and hair follicles were clearly visible by day 10 in the\nNPsiRNA-FL2-treated wounds but absent in untreated wounds and wounds that were treated\nwith non-targeted NPsiRNA.\n5.2 Synthetic silicate clay\nPage 33 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n34\nNanosilicates clays are ultra-thin nanoparticles consisting of silicates, magnesium, lithium and sodium.22-24 They have been used in biomedical applications including regenerative medicine,\ntherapeutic delivery, would healing and bone tissue engineering. Considering the blood clotting\nability of aluminosilicate clay such as montmorillonite (MMT), MMT nanoparticles functionalized with EGF (MMT-EGF) were evaluated for epithelial wound healing in vitro.38\nThe role of EGF is implicated in cell proliferation and migration during wound healing process.\nIncorporation of 0.3% for EGF was estimated to displace only few cationic site on MMT surfacace, thus leaving enough Na+ ions to carry out cationic activation required for blood\nclotting. They shown that treating the human spontaneously transformed keratinocyte cell line\n(HaCaT) with MMT-EGF nanocomposite, activation of EGFR along the cell membrane was\nobserved. Activated EGFR promote cell growth and migration. Western blot analysis indicated\nthe activation phosphoinositide 3-kinase (PI3K)/AKT pathway and mitogen-activated protein\nkinase (MAPK) pathways in MMT-EGF-treated HaCaT cells. The gene expression of VEGF,\nand thrombospondin indicated that MMT-EGF activates the normal proliferation and migration\nsignals in HaCaT cells. In vitro wound scratch assays showed that MMT-EGF treatment induced cell migration resulting in complete wound closure.38\nNanosilicates, such as Laponite are also explored for growth factor delivery to enhance angiogenesis.143-144 Due to the presence of both positive and negative charges on nanosilicates surface, they strongly interact with proteins such as VEGF (Fig. 7).144 In addition, nanosilicate\naddition to collagen, stabilize the nanocomposite network due to strong physical interactions.\nThe nanocomposite hydrogels were also shown to promote the tubule formation of cultured\nendothelial cells. The presence of strong ionic interactions between Laponite and protein, no\nchemical conjugation is needed. Incorporation of VEGF within Laponite/collagen gel enhances\nPage 34 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n35\nangiogenesis in vivo. The ability of nanocomposite gel to enhance angiogenesis can be used to promote wound healing.144 In another study, nanosilicates have used to release growth factor-rich stem cell secretome.145 They fabricated nanocomposite hydrogels using photocrosslinking\nnanosilicates and gelatin methacrylate (GelMA). They showed that nanoclay can modulate the\nrelease of secretome and can induce angiogenesis. Although the current study showed\napplication of nanosilicates based hydrogel for cardiac tissue engineering, it can be readily\napplied for wound healing applications.\nNanosilicates based hydrogels are also explored for traumatic injuries requiring accelerated hemostasis.146 Penetrating injuries results in loss of blood and depending on the body parts\ninvolved, damage can happen to internal organs and presents a risk of shock and infection.\nInjectable nanocomposite hydrogels may be introduced into a wound site, forming a\nphysiologically stable artificial matrix and promoting the natural clotting cascade. They showed\nthat injectable nanosilicates/gelatin hydrogels demonstrated to decrease in vitro blood clotting times by 77%, and shown to form stable clot-gel systems under in vivo conditions.146 The\nenhanced hemostatic ability of nanoengineered hydrogel was attributed to the ability of\nnanosilicates to attract plasma components, providing a mechanism for clotting enhancement. It\nis expected that after achieving hemostasis, this hydrogel may promote wound healing while\ndelivering therapeutic agents.\nAntimicrobial ciprofloxacin was intercalated in layered silicate, MMT nanoparticles, and\ngelled in biodegradable gelatin to prepare composite hydrogel material with controlled release property for wound dressings.147 Physical analysis showed that the interlayer space of MMT was\n0.74 nm and slightly larger ciprofloxacin molecules could be intercalated by electrostatic\ninteraction. Presence of MMT nanoparticles reduced the rate of biodegradation of the gelatin that\nPage 35 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n36\nwill enable the hydrogel to remain intact for a longer duration for drug release. The composite\nhydrogel will be useful for infection control in wound healing as it showed controlled release of\n43% ciprofloxacin over a period of 150 hours. In in vitro wound healing scratch assays,\napplication of the composite hydrogels to human alveolar basal epithelial cells showed increased proliferation and cell migration towards the wound area in 24 hours.147\nIn another study, mafenide (Maf) was intercalated between the nanosize layers of laponite\n(Lap) to be used as an antibiotic elution gel for the healing of burn wounds. This system was\nfurther modified by including Lap/Maf/Alg film. The film showed 211% water absorption\ncapacity in comparison to 186% for alginate alone. However, both the gel and the film would need further modifications to overcome the problem of burst release and cytotoxicity.148 The\nsame research group has functionalized Laponite by intercalation of arginine (Lap/Arg), glutamic acid (Lap/Glu), leucine (Lap/Leu), and lysine (Lap/Lys) amino acids.149 Over a period of 24 hours, release of amino acids and Mg2+ in simulated wound exudate fluid was found to be the\nmaximum in Lap/Lys and Lap/Glu gel, respectively. Extracts from all the four gels, except\nLap/Glu, were found to be biocompatible. This data suggests that cyclisation of glutamic acid to\npyroglutamic acid in the presence of minerals might result in cytotoxic behavior. In vitro scratch\nassays in the presence of these extracts did not show any improvement in wound closure over the controls.149 This is in contrast with an earlier report in which Laponite was shown to be nontoxic at concentrations below 1 mg/mL and increased the osteoblast growth in culture. 150\nBacterial cellulose and MMT were combined to develop nanocomposites that can be used to\nfabricate wound dressing materials with superior infection control properties. Strong mechanical\nproperties and a high water absorption capacity of the composite make it a desirable material for\nwound dressing. The cation exchange property of MMT was exploited to functionalize it with\nPage 36 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n37\nsodium, calcium, and copper ions. Bacterial cellulose sheets were completely impregnated with\nthe functionalized MMTs in such a way that almost all the pores were completely filled.\nBacterial cellulose impregnated with Cu-MMT was found to be the most efficient\nnanocomposite, showing a 80-85% reduction in colony forming units (CFUs) against Gramnegative E. coli and Gram-positive S. aureus.151"
    }, {
      "heading" : "5.3 Bioglass nanoparticles",
      "text" : "Bioactive glass nanoparticles are extensively investigated for biomedical applications including bone tissue engineering, angiogenesis, and wound healing applications.152-155 It is\nshown that ionic dissolution products of bioglass play major role in stimulating cell proliferation,\nangiogenesis and wound healing. However, the exact mechanism of interaction between the\ndissolved ionic and human cells are not fully understood. Recent studies have shown that\nbioactive glass nanoparticles can bind to soft tissue through apatite layers that are formed on their surface upon contact with cells.156-157 It is showed that bioglass stimulate the secretion of angiogenic growth factors from human stromal cells and facilitate angiogenesis.156 The 45S5\nBioglass (45% SiO2, 24.5% Na2O, 24.5% CaO and 6% P2O5) particles were shown to have the potential to increase angiogenesis in vitro and in vivo through their dissolution products.156-157\nSol-gel derived bioactive glass particles showed better bioactivity and biocompatibility than that of the melt-derived bioglass particles.158 Recent studies have investigated bioglass nanoparticles\nfor their ability to stimulate angiogenic growth in cultured human umbilical vein endothelial cells (HUVECs).159 HUVECs treated with bioglass nanoparticles showed increased expression of\npro-angiogenic genes. In vitro studies showed that bioglass nanoparticles also induces cell proliferation, angiogenic tube formation and wound closure.159 Recent study have shown\nstimulatory effects of bioactive microparticles on gap junction communication in HUVECs.\nPage 37 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n38\nThey also showed that application of the dry powder of bioglass to the full thickness wounds in\nrats showed significantly higher wound closure (P < 0.05) than the control without bioglass application.160"
    }, {
      "heading" : "5.4 Zinc oxide nanoparticles",
      "text" : "Similar to AgNPs, zinc oxide nanoparticles (ZnONPs) also have antimicrobial activities. The\nefficacy of ZnONPs activity strongly depends on the nanoparticle size and the release of free Zn2+ ions from ZnO colloidal solution.161 Based on in vitro and in vivo wound healing and\nangiogenesis assays, Barui et al. showed that zinc oxide nanoflowers plays a direct role in wound healing by promoting angiogenesis and chemotaxis of cells (Fig. 8).162 Wound dressing bandages\nfabricated from ZnONPs and chitosan/chitin showed enhanced blood clotting ability (in\ncomparison with Kaltostat® and blood alone) and antibacterial characteristics (in comparison\nwith chitosan/ or chitin). In vivo studies showed that nanocomposite bandages result in enhanced\nwound healing compared to bare wound and Kaltostat®, and facilitated collagen deposition and re-epithelialization.163-164 Other studies showed that ZnONPs enhance fibroblast cell proliferation and can be used for wound healing applications.165 As per the FDA, ZnO is a generally-regarded-\nas-safe (GRAS) substance, and it is used to treat open wounds and rashes. However, research on\nthe safety profile of ZnO when used with nanoparticles remains inconclusive with contradicting results.166"
    }, {
      "heading" : "6. EMERGING TRENDS AND FUTURE PROSPECTS",
      "text" : "A diverse range of new engineered nanomaterials have been developed and tested in the past\nfew years, revealing unique property combinations for biomedical applications. Carbon-based\nPage 38 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n39\nnanoparticles, such as graphene, have been extensively investigated for tissue engineering\napplications. Despite interesting characteristics and strong potential, only limited studies have\ninvestigated graphene for wound healing and infection control applications. Graphene has strong\npotential for wound healing as it has a large water absorption capacity, anntibacterial activity, and the capacity to add mechanical strength to the composites.167-168 Graphene oxide\nnanoparticles (GONPs) showed higher antibacterial activity against E. coli when compared with reduced graphene oxide, graphite, and graphite oxide.169 Extremely sharp edges of the graphene\noxide nanowalls deposited on stainless steel substrate could cause damage to the cell membrane\nby direct contact and bring down bacterial survival as much as 95% within an hour time in comparison with bare stainless steel substrate used as control.170 It was reported that graphene\nnanosheets might limit bacterial growth through enhanced lipid peroxidation under the influence of ROS.171 While the zero-dimensional fullerenes and one-dimensional carbon nanotubes enter\nthe cells by penetration or endocytosis, the two-dimensional graphene oxides cut through the cell membranes of E. coli causing lethal damage to cellular integrity.172 Additional damage is caused\nby the extraction of membrane lipids, which is facilitated by the unique two-dimensional\nstructure of graphene oxide with sp2 carbons. Such antimicrobial activity through physical\ndamage could help to avoid the development of microbial resistance to nanoparticles.\nIn addition, GONPs can be photothermally activated using near infrared (NIR) laser. Activated\nGONPs showed more pronounced inhibition of bacterial (S. aureus and P. aeruginosa), yeast\n(Saccharomyces cerevisiae strain 20207), and fungal (Candida utilis strain 20260) growth than\nGONPs. To study the effect of activated GONPs on infected injuries in vivo, wounds were made\non thoracic and lumbar regions of albino mice and infected with S. aureus. Treatments were\nstarted after the infection spread on the wound surface and continued every day. First, a\nPage 39 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n40\nsuspension of GONPs was applied, followed by Nd-YAG laser (NIR laser, 1064 nm) irradiation\nfor 180 seconds. On day 12, it was clear that the infected wounds treated with GONPs and laser\nshowed improved healing compared to the untreated wounds and the wounds treated with laser alone.173\nFurthermore, multi-component biomaterials can combine multiple characteristics that are\nrequired to facilitate wound healing and infection control. For example, multicomponent\nbiomaterials consisting of chitosan, gelatin, and fibrin nanoparticles were created; each of these\nindividual components has shown to facilitate wound healing, infection control, homeostasis, and\ntherapeutic delivery. In vivo data showed that burn wounds treated with multicomponent\nbandages showed faster healing and complete re-epithelialization compared to bandages made of\nchitosan, gelatin (Gelspon®, commercial gelatin sponge), and chitosan plus fibrin. This\nhighlights that multicomponent systems are superior compared to single or dual component\nsystems. It is expected that future studies will focus on multifunctional and multicomponent\nbiomaterials. All of these studies underscore the emergence and importance of new\nnanomaterials for wound healing applications.\nAdditive tissue manufacture is another emerging area that can be used for wound healing\napplications. One of the challenges in wound healing is vascularization, but appropriate\npatterning of the vascularized structure and accelerated wound healing can be achieved. 3D\nbioprinting technology can be used to print different types of cells in complex architecture.\nSpatiotemporal patterning of cells can significantly aid in cellular reorganization,\nvascularization, and re-epithelialization that are pre-requisite for complete wound healing.\nFinally, a very important aspect of wound healing is developing nanomaterial strategies that\ncould minimize the chances of sepsis, a potentially life-threatening complication of an infection.\nPage 40 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n41\nFor example, severe burn injury imposes a high risk for the development of sepsis and delayed wound healing, and increase mortality.174 Sepsis initiates a complex interplay of host pro-\ninflammatory and anti-inflammatory processes, and there are competing theories that define host immune response to sepsis.175 While designing new materials, care must be taken to determine\nwhether the material has immunomodulatory properties and whether patients have entered an\nimmunosuppressive phase of sepsis. Finally, it would be critical to make such assessment of\nengineered nanomaterial response at the human level because of the lack of similarity in the\nhuman and mouse genomic response to injury."
    }, {
      "heading" : "7. CONCLUSION",
      "text" : "A range of engineered nanomaterials has been developed to improve clinically relevant\ntherapeutic approaches for infection control and faster healing. Engineering nanomaterials such\nas nanofibrous and nanocomposite scaffolds loaded with drugs, growth factors, and/or cells are\nattractive materials, since they can accelerate wound healing and aid in infection control to\nachieve faster healing. As new bioactive nanomaterials including ceramics and metallic are\nemerging, it is possible to mimic some of the physical and chemical properties of native tissues.\nThese bioactive nanomaterials not only aid in wound healing but also play important roles in\ninfection control. In addition, advanced manufacture and development of multicomponent\nsystems are expected to aid in designing the next generation of wound healing nanomaterials.\nPage 41 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n42\nTable I. Polymeric nanomaterials for wound healing and infection control.\nPolymeric Nanomaterials\nRemarks (Type of nanomaterials, specific role in wound healing and infection control)\nChitosan Chitosan nanoparticles have anti-microbial properties and have been shown to facilitate\nwound healing due to inherent bioactivity. They are also used for the controlled release of therapeutics (drugs, complex extracts, growth factors, and gene) to aids in the wound healing process.\nFibrin Fibrin being a part of the provisional ECM that attracts and aids in proliferation of the cells\ninvolved in wound healing is preferred polymeric nanomaterial for wound healing. Fibrine based nanomaterials are used to deliver growth factors and antibiotics. Bandage made of fibrin nanoparticles impregnated in chitosan hydrogel have also showed acceraletd wound healing.\nHyaluronic acid Hyaluronic acid (HA) has the ability to promote cellular proliferation and secretion of\ncollagen that help in wound healing. HA-based nanocomposite sponge showed accelerated blood clotting and enhanced angiogenesis.\nPoly-D, Llactide-coglycolide (PLGA)\nLactate released from PLGA facilitates wound repair by reducing muscular atrophy and improving reperfusion. PLGA is usually used in combination with drugs or growth factors for wound healing applications Wound healing property of curcumin was enhances when PLGA was used as delivery vehicle. Sustained and controlled release of NO from PLGA nanoparticles was found to be useful in infection control, wound healing and epithelialization.\nPoly(L-lactide) (PLLA)\nPLLA nanoparticles are used for sustained drug delivery for wound healing. Nanofibrous electrospun PLLA scaffold have shown to enhance sustain and controlled delivery of therapeutics for wound healing.\nPoly(εcaprolactone) (PCL)\nPCL is a FDA-approved biocompatible and biodegradable polymer extensively used in the blends and composites for biomedical applications. PCL nanoparticles are used as drug carrier in wound healing. PCL-PEG was to used overcome the clinical limitations of lipophilic hypericin in photodynamic therapy (PDT), and enhanced infection control and wound healing was observed in comparison with hypericin in DMSO applications.\nPoly(ethylene glycol) (PEG)\nPEG based nanoparticles are used to increase the bioavailability of plant-derived compounds with proven wound healing properties. Therapeutic drugs loaded in PEG nanoparticles are shown to retain bioactivity compared and showed inhibitory effect on inflammation and ulceration. Extensive keratinization and epidermis reformation were also observed due to sustained and controlled release of therapeutics.\nPage 42 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n43\nTable II. Metallic and Ceramic Nanomaterials for wound healing and infection control.\nMetallic and Ceramic Nanomaterials\nRemarks (Type of nanomaterials, specific role in wound healing and infection control)\nSilver Nanoparticle (AgNPs)\nAgNPs are effective in controlling bacterial, fungal and yeast infection, and improving wound healing. Wound dressing materials containing AgNPs are in clinical use. Nanocomposite loaded with AgNPs are investigated for wound dressing and controlled release of therapeutics.\nGold Nanoparticle (AuNPs)\nBiologically inert AuNPs are functionalized with antibiotics, antioxidants, and ROS scavengers for improved wound healing. Direct use in tissue welding for healing of cut wounds was also demonstrated. AuNPs are also investigated for gene delivery.\nSilica nanoparticles\nMesoporous silica nanoparticles are considered ideal for delivering growth factors to facilitate wound healing due to high surface to volume ratio. NO- releasing silica nanoparticles showed increased fibroblast proliferation, collagen deposition and angiogenesis in the wound area. Tissue adhesive for joining cut wounds was also developed using silica nanoparticle solution.\nSynthetic silicate clay Nanosilicate clays are desired in wound healing application due to their sustained delivery characteristics. Layered silicate clays are able to induce blood clotting due to their charged\ninteractions with clotting factors and developed as hemostatic agents. Nanosilicates based hydrogels are explored for traumatic injuries requiring accelerated hemostasis.\nBioactive glass\nBioactive glass particles bind to soft tissue through apatite layers that are formed on their surface upon contact with cells, and were shown to increase angiogenesis due to release of ionic dissolution products.\nZinc Oxide Nanoparticle (ZnONPs)\nZnONPs mainly used for infection control in wound healing. ZnOPs nanoflowers are shown to plays a direct role in promoting angiogenesis, cell proliferation, and chemotaxis which can be exploited for wound healing applications.\nPage 43 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n44"
    }, {
      "heading" : "ASSOCIATED CONTENT",
      "text" : "Conflict of Interest: The authors declare no competing financial interest.\nAcknowledgment: M.P would acknowledge financial support from SRM University for Faculty\nAbroad Program (SRMU/IR/FAP/2015/001). A.K.G would like to acknowledge funding support\nfrom Texas Engineering Experiment Station and Texas A&M University Seed Grant.\nSupporting Information. This material is available free of charge via the Internet at\nhttp://pubs.acs.org.\nAUTHOR INFORMATION"
    }, {
      "heading" : "Corresponding Author",
      "text" : "*Address correspondence to Prof. A. K. Gaharwar (gaharwar@tamu.edu), Prof. M. Parani\n(parani.m@ktr.srmuniv.ac.in).\nAddress: 3120 TAMU, 5024 Emerging Technology Building, College Station, TX 77843-3120.\nTelephone: (979) 458-5540; Fax: (979) 845-4450;"
    }, {
      "heading" : "Author Contributions",
      "text" : "The manuscript was written through contributions of all authors. All authors have given approval\nto the final version of the manuscript.\nPage 44 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n45"
    }, {
      "heading" : "REFERENCES AND NOTES",
      "text" : "1. Boulton, A. J.; Vileikyte, L.; Ragnarson-Tennvall, G.; Apelqvist, J., The Global Burden Of Diabetic Foot Disease. Lancet 2005, 366 (9498), 1719-1724. 2. Sen, C. K.; Gordillo, G. M.; Roy, S.; Kirsner, R.; Lambert, L.; Hunt, T. K.; Gottrup, F.; Gurtner, G. C.; Longaker, M. T., Human Skin Wounds: A Major And Snowballing Threat To Public Health And The Economy. Wound Repair Regen. 2009, 17 (6), 763-771. 3. Markova, A.; Mostow, E. N., US Skin Disease Assessment: Ulcer And Wound Care. Dermatol. Clin. 2012, 30 (1), 107-111. 4. Gurtner, G. C.; Werner, S.; Barrandon, Y.; Longaker, M. T., Wound Repair And Regeneration. Nature 2008, 453 (7193), 314-321. 5. Harding, K.; Morris, H.; Patel, G., Science, Medicine, And The Future: Healing Chronic Wounds. Br. Med. J. 2002, 324 (7330), 160. 6. Singh, N.; Armstrong, D. G.; Lipsky, B. A., Preventing Foot Ulcers In Patients With Diabetes. JAMA 2005, 293 (2), 217-228. 7. Rayber, G., Epidemiology Of Foot Ulcers And Amputations In The Diabetic Foot. Bowker JH, Pfeifer, MA. The Diabetic Foot. 6th Edition St Louis, Missouri. Mosby Inc 2001, 13- 32. 8. Ghobril, C.; Grinstaff, M., The Chemistry And Engineering Of Polymeric Hydrogel Adhesives For Wound Closure: A Tutorial. Chem. Soc. Rev. 2015, 44 (7), 1820-1835. 9. Boateng, J. S.; Matthews, K. H.; Stevens, H. N.; Eccleston, G. M., Wound Healing Dressings And Drug Delivery Systems: A Review. J. Pharm. Sci. 2008, 97 (8), 2892-2923. 10. Jayakumar, R.; Prabaharan, M.; Kumar, P. S.; Nair, S.; Tamura, H., Biomaterials Based On Chitin And Chitosan In Wound Dressing Applications. Biotechnol. Adv. 2011, 29 (3), 322- 337. 11. Chattopadhyay, S.; Raines, R. T., Review Collagen‐Based Biomaterials For Wound Healing. Biopolymers 2014, 101 (8), 821-833. 12. Moura, L. I.; Dias, A. M.; Carvalho, E.; De Sousa, H. C., Recent Advances On The Development Of Wound Dressings For Diabetic Foot Ulcer Treatment—A Review. Acta Biomater. 2013, 9 (7), 7093-7114. 13. Hu, M. S.; Maan, Z. N.; Wu, J.-C.; Rennert, R. C.; Hong, W. X.; Lai, T. S.; Cheung, A. T.; Walmsley, G. G.; Chung, M. T.; Mcardle, A., Tissue Engineering And Regenerative Repair In Wound Healing. Ann. Biomed. Eng. 2014, 42 (7), 1494-1507. 14. Campoccia, D.; Montanaro, L.; Arciola, C. R., A Review Of The Biomaterials Technologies For Infection-Resistant Surfaces. Biomaterials 2013, 34 (34), 8533-8554. 15. Brannon-Peppas, L.; Blanchette, J. O., Nanoparticle And Targeted Systems For Cancer Therapy. Adv. Drug Delivery Rev. 2012, 64, 206-212. 16. Cha, C.; Shin, S. R.; Annabi, N.; Dokmeci, M. R.; Khademhosseini, A., Carbon-Based Nanomaterials: Multifunctional Materials For Biomedical Engineering. ACS Nano 2013, 7 (4), 2891-2897. 17. Ferreira, L.; Karp, J. M.; Nobre, L.; Langer, R., New Opportunities: The Use Of Nanotechnologies To Manipulate And Track Stem Cells. Cell Stem Cell 2008, 3. 18. Gaharwar, A. K.; Peppas, N. A.; Khademhosseini, A., Nanocomposite Hydrogels For Biomedical Applications. Biotechnol. Bioeng. 2014, 111 (3), 441-453. 19. Zhang, L.; Webster, T. J., Nanotechnology And Nanomaterials: Promises For Improved Tissue Regeneration. Nano Today 2009, 4 (1), 66-80.\nPage 45 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n46\n20. Singh, A.; Peppas, N. A., Hydrogels And Scaffolds For Immunomodulation. Adv. Mater. 2014, 26 (38), 6530-6541. 21. Purwada, A.; Roy, K.; Singh, A., Engineering Vaccines And Niches For Immune Modulation. Acta Biomater. 2014, 10 (4), 1728-1740. 22. Carrow, J. K.; Gaharwar, A. K., Bioinspired Polymeric Nanocomposites For Regenerative Medicine. Macromol. Chem. Phys. 2015, 216 (3), 248−264. 23. Chimene, D.; Alge, D. L.; Gaharwar, A. K., Two‐Dimensional Nanomaterials For Biomedical Applications: Emerging Trends And Future Prospects. Adv. Mater. 2015, 27 (45), 7261–7284. 24. Kerativitayanan, P.; Carrow, J. K.; Gaharwar, A. K., Nanomaterials For Engineering Stem Cell Responses. Adv. Healthcare Mater. 2015, 4 (11), 1600–1627. 25. Gaharwar, A. K.; Nikkhah, M.; Sant, S.; Khademhosseini, A., Anisotropic Poly (Glycerol Sebacate)-Poly (ϵ-Caprolactone) Electrospun Fibers Promote Endothelial Cell Guidance. Biofabrication 2015, 7 (1), 015001. 26. Paul, A.; Hasan, A.; Kindi, H. A.; Gaharwar, A. K.; Rao, V. T.; Nikkhah, M.; Shin, S. R.; Krafft, D.; Dokmeci, M. R.; Shum-Tim, D., Injectable Graphene Oxide/Hydrogel-Based Angiogenic Gene Delivery System For Vasculogenesis And Cardiac Repair. ACS Nano 2014, 8 (8), 8050-8062. 27. Rieger, K. A.; Birch, N. P.; Schiffman, J. D., Designing Electrospun Nanofiber Mats To Promote Wound Healing–A Review. J. Mater. Chem. B 2013, 1 (36), 4531-4541. 28. Balkawade, R. S.; Lvov, Y. M.; Mills, D. K., Bioactive Nanomaterials For Enhanced Wound Healing. FASEB J. 2012, 26 (1_Meetingabstracts), 198.4. 29. Kalashnikova, I.; Das, S.; Seal, S., Nanomaterials For Wound Healing: Scope And Advancement. Nanomedicine 2015, 10 (16), 2593-2612. 30. Whitmire, R. E.; Scott Wilson, D.; Singh, A.; Levenston, M. E.; Murthy, N.; García, A. J., Self-Assembling Nanoparticles For Intra-Articular Delivery Of Anti-Inflammatory Proteins. Biomaterials 2012. 31. Steed, D. L.; Attinger, C.; Colaizzi, T.; Crossland, M.; Franz, M.; Harkless, L.; Johnson, A.; Moosa, H.; Robson, M.; Serena, T., Guidelines For The Treatment Of Diabetic Ulcers. Wound Repair Regen. 2006, 14 (6), 680-692. 32. Jain, J.; Arora, S.; Rajwade, J. M.; Omray, P.; Khandelwal, S.; Paknikar, K. M., Silver Nanoparticles In Therapeutics: Development Of An Antimicrobial Gel Formulation For Topical Use. Mol. Pharm. 2009, 6 (5), 1388-1401. 33. Maneerung, T.; Tokura, S.; Rujiravanit, R., Impregnation Of Silver Nanoparticles Into Bacterial Cellulose For Antimicrobial Wound Dressing. Carbohydr. Polym. 2008, 72 (1), 43-51. 34. Chaloupka, K.; Malam, Y.; Seifalian, A. M., Nanosilver As A New Generation Of Nanoproduct In Biomedical Applications. Trends Biotechnol. 2010, 28 (11), 580-588. 35. Song, J.; Birbach, N. L.; Hinestroza, J. P., Deposition Of Silver Nanoparticles On Cellulosic Fibers Via Stabilization Of Carboxymethyl Groups. Cellulose 2012, 19 (2), 411-424. 36. Xie, Z.; Paras, C. B.; Weng, H.; Punnakitikashem, P.; Su, L.-C.; Vu, K.; Tang, L.; Yang, J.; Nguyen, K. T., Dual Growth Factor Releasing Multi-Functional Nanofibers For Wound Healing. Acta Biomater. 2013, 9 (12), 9351-9359. 37. Miller, C. N.; Newall, N.; Kapp, S. E.; Lewin, G.; Karimi, L.; Carville, K.; Gliddon, T.; Santamaria, N. M., A Randomized‐Controlled Trial Comparing Cadexomer Iodine And Nanocrystalline Silver On The Healing Of Leg Ulcers. Wound Repair Regen. 2010, 18 (4), 359- 367.\nPage 46 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n47\n38. Vaiana, C. A.; Leonard, M. K.; Drummy, L. F.; Singh, K. M.; Bubulya, A.; Vaia, R. A.; Naik, R. R.; Kadakia, M. P., Epidermal Growth Factor: Layered Silicate Nanocomposites For Tissue Regeneration. Biomacromolecules 2011, 12 (9), 3139-3146. 39. Li, X.; Wang, H.; Rong, H.; Li, W.; Luo, Y.; Tian, K.; Quan, D.; Wang, Y.; Jiang, L., Effect Of Composite Sio 2@ Aunps On Wound Healing: In Vitro And Vivo Studies. J. Colloid Interface Sci. 2015, 445, 312-319. 40. Chu, C.-Y.; Peng, F.-C.; Chiu, Y.-F.; Lee, H.-C.; Chen, C.-W.; Wei, J.-C.; Lin, J.-J., Nanohybrids Of Silver Particles Immobilized On Silicate Platelet For Infected Wound Healing. Plos One 2012, 7 (6), E38360. 41. Gurtner, G. C., Wound Healing: Normal And Abnormal. Grabb Plastic Surgery. 6th Ed. Philadelphia: Wolters Kluwer-Lippincot William And Wilkins 2007, 15-22. 42. Singer, A. J.; Dagum, A. B., Current Management Of Acute Cutaneous Wounds. N. Engl. J. Med. 2008, 359 (10), 1037-1046. 43. Simpson, D. M.; Ross, R., The Neutrophilic Leukocyte In Wound Repair: A Study With Antineutrophil Serum. J. Clin. Invest. 1972, 51 (8), 2009. 44. Ehrlich, H. P.; Rajaratnam, J. B., Cell Locomotion Forces Versus Cell Contraction Forces For Collagen Lattice Contraction: An In Vitro Model Of Wound Contraction. Tissue Cell 1990, 22 (4), 407-417. 45. Tomasek, J. J.; Gabbiani, G.; Hinz, B.; Chaponnier, C.; Brown, R. A., Myofibroblasts And Mechano-Regulation Of Connective Tissue Remodelling. Nat. Rev. Mol. Cell Biol. 2002, 3 (5), 349-363. 46. Desmouliere, A.; Redard, M.; Darby, I.; Gabbiani, G., Apoptosis Mediates The Decrease In Cellularity During The Transition Between Granulation Tissue And Scar. Am. J. Pathol. 1995, 146 (1), 56. 47. Fine, N. M., T Wound Healing. Lippincott Williams & Wilkins, Philadelphia, USA 2006. 48. Mehendale, F.; Martin, P., The Cellular And Molecular Events Of Wound Healing. Cutaneous Wound Healing 2001, 15-37. 49. Witte, M. B.; Barbul, A., General Principles Of Wound Healing. Surg. Clin. North Am. 1997, 77 (3), 509-528. 50. Wlaschek, M.; Peus, D.; Achterberg, V.; Meyer‐Ingold, W.; Scharffetter‐Kochanek, K., Protease Inhibitors Protect Growth Factor Activity In Chronic Wounds. Br. J. Dermatol. 1997, 137 (4), 646-663. 51. Nwomeh, B. C.; Liang, H.-X.; Cohen, I. K.; Yager, D. R., MMP-8 Is The Predominant Collagenase In Healing Wounds And Nonhealing Ulcers. J. Surg. Res. 1999, 81 (2), 189-195. 52. Albiero, M.; Menegazzo, L.; Boscaro, E.; Agostini, C.; Avogaro, A.; Fadini, G., Defective Recruitment, Survival And Proliferation Of Bone Marrow-Derived Progenitor Cells At Sites Of Delayed Diabetic Wound Healing In Mice. Diabetologia 2011, 54 (4), 945-953. 53. Wieman, T. J., Clinical Efficacy Of Becaplermin (Rhpdgf-BB) Gel. The American Journal Of Surgery 1998, 176 (2), 74S-79S. 54. Smiell, J. M.; Wieman, T. J.; Steed, D. L.; Perry, B. H.; Sampson, A. R.; Schwab, B. H., Efficacy And Safety Of Becaplermin (Recombinant Human Platelet‐Derived Growth Factor‐BB) In Patients With Nonhealing, Lower Extremity Diabetic Ulcers: A Combined Analysis Of Four Randomized Studies. Wound Repair Regen. 1999, 7 (5), 335-346. 55. Jeffcoate, W. J.; Chipchase, S. Y.; Ince, P.; Game, F. L., Assessing The Outcome Of The Management Of Diabetic Foot Ulcers Using Ulcer-Related And Person-Related Measures. Diabetes Care 2006, 29 (8), 1784-1787.\nPage 47 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n48\n56. Ueno, H.; Mori, T.; Fujinaga, T., Topical Formulations And Wound Healing Applications Of Chitosan. Adv. Drug Delivery Rev. 2001, 52 (2), 105-115. 57. Xu, Y.; Du, Y., Effect Of Molecular Structure Of Chitosan On Protein Delivery Properties Of Chitosan Nanoparticles. Int. J. Pharm. 2003, 250 (1), 215-226. 58. Azad, A. K.; Sermsintham, N.; Chandrkrachang, S.; Stevens, W. F., Chitosan Membrane As A Wound‐Healing Dressing: Characterization And Clinical Application. J. Biomed. Mater. Res., Part B 2004, 69 (2), 216-222. 59. Gaharwar, A. K.; Schexnailder, P. J.; Jin, Q.; Wu, C.-J.; Schmidt, G., Addition Of Chitosan To Silicate Cross-Linked PEO For Tuning Osteoblast Cell Adhesion And Mineralization. ACS Appl. Mater. Interfaces 2010, 2 (11), 3119-3127. 60. Anitha, A.; Rani, V. D.; Krishna, R.; Sreeja, V.; Selvamurugan, N.; Nair, S.; Tamura, H.; Jayakumar, R., Synthesis, Characterization, Cytotoxicity And Antibacterial Studies Of Chitosan, O-Carboxymethyl And N, O-Carboxymethyl Chitosan Nanoparticles. Carbohydr. Polym. 2009, 78 (4), 672-677. 61. Pattani, A.; Patravale, V. B.; Panicker, L.; Potdar, P. D., Immunological Effects And Membrane Interactions Of Chitosan Nanoparticles. Mol. Pharm. 2009, 6 (2), 345-352. 62. Bonferoni, M.; Sandri, G.; Dellera, E.; Rossi, S.; Ferrari, F.; Mori, M.; Caramella, C., Ionic Polymeric Micelles Based On Chitosan And Fatty Acids And Intended For Wound Healing. Comparison Of Linoleic And Oleic Acid. Eur. J. Pharm. Biopharm. 2014, 87 (1), 101- 106. 63. Dellera, E.; Bonferoni, M. C.; Sandri, G.; Rossi, S.; Ferrari, F.; Del Fante, C.; Perotti, C.; Grisoli, P.; Caramella, C., Development Of Chitosan Oleate Ionic Micelles Loaded With Silver Sulfadiazine To Be Associated With Platelet Lysate For Application In Wound Healing. Eur. J. Pharm. Biopharm. 2014, 88 (3), 643-650. 64. Chung, T.-W.; Lin, P.-Y.; Wang, S.-S.; Chen, Y.-F., Adenosine Diphosphate-Decorated Chitosan Nanoparticles Shorten Blood Clotting Times, Influencing The Structures And Varying The Mechanical Properties Of The Clots. Int. J. Nanomed. 2014, 9, 1655. 65. Servat-Medina, L.; González-Gómez, A.; Reyes-Ortega, F.; Sousa, I. M. O.; Queiroz, N. D. C. A.; Zago, P. M. W.; Jorge, M. P.; Monteiro, K. M.; De Carvalho, J. E.; San Román, J., Chitosan–Tripolyphosphate Nanoparticles As Arrabidaea Chica Standardized Extract Carrier: Synthesis, Characterization, Biocompatibility, And Antiulcerogenic Activity. Int. J. Nanomed. 2015, 10, 3897. 66. Vedakumari, W. S.; Prabu, P.; Sastry, T. P., Chitosan-Fibrin Nanocomposites As Drug Delivering And Wound Healing Materials. J. Biomed. Nanotechnol. 2015, 11 (4), 657-667. 67. Jean, M.; Smaoui, F.; Lavertu, M.; Methot, S.; Bouhdoud, L.; Buschmann, M.; Merzouki, A., Chitosan–Plasmid Nanoparticle Formulations For IM And SC Delivery Of Recombinant FGF-2 And PDGF-BB Or Generation Of Antibodies. Gene Ther. 2009, 16 (9), 1097-1110. 68. Suvannasara, P.; Praphairaksit, N.; Muangsin, N., Self-Assembly Of Mucoadhesive Nanofibers. RSC Adv. 2014, 4 (102), 58664-58673. 69. Antunes, B.; Moreira, A.; Gaspar, V.; Correia, I., Chitosan/Arginine–Chitosan Polymer Blends For Assembly Of Nanofibrous Membranes For Wound Regeneration. Carbohydr. Polym. 2015, 130, 104-112. 70. Zhou, W.; Zhao, M.; Zhao, Y.; Mou, Y., A Fibrin Gel Loaded With Chitosan Nanoparticles For Local Delivery Of Rhegf: Preparation And In Vitro Release Studies. J. Mater. Sci.: Mater. Med. 2011, 22 (5), 1221-1230.\nPage 48 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n49\n71. Caiado, F.; Carvalho, T.; Silva, F.; Castro, C.; Clode, N.; Dye, J. F.; Dias, S., The Role Of Fibrin E On The Modulation Of Endothelial Progenitors Adhesion, Differentiation And Angiogenic Growth Factor Production And The Promotion Of Wound Healing. Biomaterials 2011, 32 (29), 7096-7105. 72. Praveen, G.; Sreerekha, P.; Menon, D.; Nair, S. V.; Chennazhi, K. P., Fibrin Nanoconstructs: A Novel Processing Method And Their Use As Controlled Delivery Agents. Nanotechnology 2012, 23 (9), 095102. 73. Alphonsa, B. M.; Kumar, P. S.; Praveen, G.; Biswas, R.; Chennazhi, K.; Jayakumar, R., Antimicrobial Drugs Encapsulated In Fibrin Nanoparticles For Treating Microbial Infested Wounds. Pharm. Res. 2014, 31 (5), 1338-1351. 74. Kumar, P. S.; Raj, N. M.; Praveen, G.; Chennazhi, K. P.; Nair, S. V.; Jayakumar, R., In Vitro And In Vivo Evaluation Of Microporous Chitosan Hydrogel/Nanofibrin Composite Bandage For Skin Tissue Regeneration. Tissue Eng. Part A 2012, 19 (3-4), 380-392. 75. Cross, M.; Dexter, T. M., Growth Factors In Development, Transformation, And Tumorigenesis. Cell 1991, 64 (2), 271-280. 76. Bergers, G.; Benjamin, L. E., Tumorigenesis And The Angiogenic Switch. Nat. Rev. Cancer 2003, 3 (6), 401-410. 77. Yancopoulos, G. D.; Davis, S.; Gale, N. W.; Rudge, J. S.; Wiegand, S. J.; Holash, J., Vascular-Specific Growth Factors And Blood Vessel Formation. Nature 2000, 407 (6801), 242- 248. 78. Mohandas, A.; Anisha, B.; Chennazhi, K.; Jayakumar, R., Chitosan–Hyaluronic Acid/VEGF Loaded Fibrin Nanoparticles Composite Sponges For Enhancing Angiogenesis In Wounds. Colloids Surfaces B 2015, 127, 105-113. 79. Porporato, P. E.; Payen, V. L.; De Saedeleer, C. J.; Préat, V.; Thissen, J.-P.; Feron, O.; Sonveaux, P., Lactate Stimulates Angiogenesis And Accelerates The Healing Of Superficial And Ischemic Wounds In Mice. Angiogenesis 2012, 15 (4), 581-592. 80. Chu, Y.; Yu, D.; Wang, P.; Xu, J.; Li, D.; Ding, M., Nanotechnology Promotes The Full‐ Thickness Diabetic Wound Healing Effect Of Recombinant Human Epidermal Growth Factor In Diabetic Rats. Wound Repair Regen. 2010, 18 (5), 499-505. 81. Losi, P.; Briganti, E.; Errico, C.; Lisella, A.; Sanguinetti, E.; Chiellini, F.; Soldani, G., Fibrin-Based Scaffold Incorporating VEGF-And Bfgf-Loaded Nanoparticles Stimulates Wound Healing In Diabetic Mice. Acta Biomater. 2013, 9 (8), 7814-7821. 82. Chereddy, K. K.; Coco, R.; Memvanga, P. B.; Ucakar, B.; Des Rieux, A.; Vandermeulen, G.; Préat, V., Combined Effect Of PLGA And Curcumin On Wound Healing Activity. J. Controlled Release 2013, 171 (2), 208-215. 83. Castangia, I.; Nácher, A.; Caddeo, C.; Valenti, D.; Fadda, A. M.; Díez-Sales, O.; RuizSaurí, A.; Manconi, M., Fabrication Of Quercetin And Curcumin Bionanovesicles For The Prevention And Rapid Regeneration Of Full-Thickness Skin Defects On Mice. Acta Biomater. 2014, 10 (3), 1292-1300. 84. Luo, J.-D. C., Alex F, Nitric Oxide: A Newly Discovered Function On Wound Healing. Acta Pharmacol. Sin. 2005, 26 (3), 259-264. 85. Lu, Y.; Slomberg, D. L.; Shah, A.; Schoenfisch, M. H., Nitric Oxide-Releasing Amphiphilic Poly (Amidoamine)(PAMAM) Dendrimers As Antibacterial Agents. Biomacromolecules 2013, 14 (10), 3589-3598.\nPage 49 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n50\n86. Huang, S.-L.; Kee, P. H.; Kim, H.; Moody, M. R.; Chrzanowski, S. M.; Macdonald, R. C.; Mcpherson, D. D., Nitric Oxide-Loaded Echogenic Liposomes For Nitric Oxide Delivery And Inhibition Of Intimal Hyperplasia. J. Am. Coll. Cardiol. 2009, 54 (7), 652-659. 87. Nurhasni, H.; Cao, J.; Choi, M.; Kim, I.; Lee, B. L.; Jung, Y.; Yoo, J.-W., Nitric OxideReleasing Poly (Lactic-Co-Glycolic Acid)-Polyethylenimine Nanoparticles For Prolonged Nitric Oxide Release, Antibacterial Efficacy, And In Vivo Wound Healing Activity. Int. J. Nanomed. 2015, 10, 3065. 88. Li, C.; Fu, R.; Yu, C.; Li, Z.; Guan, H.; Hu, D.; Zhao, D.; Lu, L., Silver Nanoparticle/Chitosan Oligosaccharide/Poly (Vinyl Alcohol) Nanofibers As Wound Dressings: A Preclinical Study. Int. J. Nanomed. 2013, 8, 4131. 89. Leoni, G.; Neumann, P.-A.; Kamaly, N.; Quiros, M.; Nishio, H.; Jones, H. R.; Sumagin, R.; Hilgarth, R. S.; Alam, A.; Fredman, G., Annexin A1–Containing Extracellular Vesicles And Polymeric Nanoparticles Promote Epithelial Wound Repair. J. Clin. Invest. 2015, 125 (125 (3)), 1215-1227. 90. Ma, K.; Liao, S.; He, L.; Lu, J.; Ramakrishna, S.; Chan, C. K., Effects Of Nanofiber/Stem Cell Composite On Wound Healing In Acute Full-Thickness Skin Wounds. Tissue Eng. Part A 2011, 17 (9-10), 1413-1424. 91. Zhao, R.; Li, X.; Sun, B.; Tong, Y.; Jiang, Z.; Wang, C., Nitrofurazone-Loaded Electrospun PLLA/Sericin-Based Dual-Layer Fiber Mats For Wound Dressing Applications. RSC Adv. 2015, 5 (22), 16940-16949. 92. Ferreira, A. M.; Mattu, C.; Ranzato, E.; Ciardelli, G., Bioinspired Porous Membranes Containing Polymer Nanoparticles For Wound Healing. J. Biomed. Mater. Res., Part A 2014, 102 (12), 4394-4405. 93. Liu, S.; Qin, M.; Hu, C.; Wu, F.; Cui, W.; Jin, T.; Fan, C., Tendon Healing And AntiAdhesion Properties Of Electrospun Fibrous Membranes Containing Bfgf Loaded Nanoparticles. Biomaterials 2013, 34 (19), 4690-4701. 94. Xie, J.; Macewan, M. R.; Ray, W. Z.; Liu, W.; Siewe, D. Y.; Xia, Y., Radially Aligned, Electrospun Nanofibers As Dural Substitutes For Wound Closure And Tissue Regeneration Applications. ACS Nano 2010, 4 (9), 5027-5036. 95. Pawar, M. D.; Rathna, G.; Agrawal, S.; Kuchekar, B. S., Bioactive Thermoresponsive Polyblend Nanofiber Formulations For Wound Healing. Mater. Sci. Eng. C Mater. Biol. Appl. 2015, 48, 126-137. 96. Kadam, N.; Chaudhari, H.; Parikh, J.; Modi, V.; Kokil, S.; Balaramnavar, V., De Novo Combination Therapy In Retroviral Infection. Int. J. Virol. 2010, 6, 219-223. 97. Nafee, N.; Youssef, A.; El-Gowelli, H.; Asem, H.; Kandil, S., Antibiotic-Free Nanotherapeutics: Hypericin Nanoparticles Thereof For Improved In Vitro And In Vivo Antimicrobial Photodynamic Therapy And Wound Healing. Int. J. Pharm. 2013, 454 (1), 249- 258. 98. Madsen, J.; Armes, S. P.; Bertal, K.; Lomas, H.; Macneil, S.; Lewis, A. L., Biocompatible Wound Dressings Based On Chemically Degradable Triblock Copolymer Hydrogels. Biomacromolecules 2008, 9 (8), 2265-2275. 99. Kim, J. S.; Kuk, E.; Yu, K. N.; Kim, J.-H.; Park, S. J.; Lee, H. J.; Kim, S. H.; Park, Y. K.; Park, Y. H.; Hwang, C.-Y., Antimicrobial Effects Of Silver Nanoparticles. Nanomedicine 2007, 3 (1), 95-101.\nPage 50 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n51\n100. Guzman, M.; Dille, J.; Godet, S., Synthesis And Antibacterial Activity Of Silver Nanoparticles Against Gram-Positive And Gram-Negative Bacteria. Nanomedicine 2012, 8 (1), 37-45. 101. Ajitha, B.; Reddy, Y. A. K.; Reddy, P. S., Enhanced Antimicrobial Activity Of Silver Nanoparticles With Controlled Particle Size By Ph Variation. Powder Technol. 2015, 269, 110- 117. 102. Martinez-Castanon, G.; Nino-Martinez, N.; Martinez-Gutierrez, F.; Martinez-Mendoza, J.; Ruiz, F., Synthesis And Antibacterial Activity Of Silver Nanoparticles With Different Sizes. J. Nanopart. Res. 2008, 10 (8), 1343-1348. 103. Xiu, Z.-M.; Zhang, Q.-B.; Puppala, H. L.; Colvin, V. L.; Alvarez, P. J., Negligible Particle-Specific Antibacterial Activity Of Silver Nanoparticles. Nano Letters 2012, 12 (8), 4271-4275. 104. Lok, C.-N.; Ho, C.-M.; Chen, R.; He, Q.-Y.; Yu, W.-Y.; Sun, H.; Tam, P. K.-H.; Chiu, J.F.; Che, C.-M., Proteomic Analysis Of The Mode Of Antibacterial Action Of Silver Nanoparticles. J. Proteome Res. 2006, 5 (4), 916-924. 105. Gordon, O.; Slenters, T. V.; Brunetto, P. S.; Villaruz, A. E.; Sturdevant, D. E.; Otto, M.; Landmann, R.; Fromm, K. M., Silver Coordination Polymers For Prevention Of Implant Infection: Thiol Interaction, Impact On Respiratory Chain Enzymes, And Hydroxyl Radical Induction. Antimicrob. Agents Chemother. 2010, 54 (10), 4208-4218. 106. Shrivastava, S.; Bera, T.; Roy, A.; Singh, G.; Ramachandrarao, P.; Dash, D., Characterization Of Enhanced Antibacterial Effects Of Novel Silver Nanoparticles. Nanotechnology 2007, 18 (22), 225103. 107. Graves Jr, J. L.; Tajkarimi, M.; Cunningham, Q.; Campbell, A.; Nonga, H.; Harrison, S. H.; Barrick, J. E., Rapid Evolution Of Silver Nanoparticle Resistance In Escherichia Coli. Front. Genet. 2015, 6. 108. Ghavaminejad, A.; Rajan Unnithan, A.; Ramachandra Kurup Sasikala, A.; Samarikhalaj, M.; Thomas, R. G.; Jeong, Y. Y.; Nasseri, S.; Murugesan, P.; Wu, D.; Hee Park, C., MusselInspired Electrospun Nanofibers Functionalized With Size Controlled Silver Nanoparticles For Wound Dressing Application. ACS Appl. Mater. Interfaces 2015, 7 (22), 12176–12183. 109. Nadworny, P. L.; Wang, J.; Tredget, E. E.; Burrell, R. E., Anti-Inflammatory Activity Of Nanocrystalline Silver In A Porcine Contact Dermatitis Model. Nanomedicine 2008, 4 (3), 241- 251. 110. Tian, J.; Wong, K. K.; Ho, C. M.; Lok, C. N.; Yu, W. Y.; Che, C. M.; Chiu, J. F.; Tam, P. K., Topical Delivery Of Silver Nanoparticles Promotes Wound Healing. Chemmedchem 2007, 2 (1), 129-136. 111. Wu, J.; Zheng, Y.; Song, W.; Luan, J.; Wen, X.; Wu, Z.; Chen, X.; Wang, Q.; Guo, S., In Situ Synthesis Of Silver-Nanoparticles/Bacterial Cellulose Composites For Slow-Released Antimicrobial Wound Dressing. Carbohydr. Polym. 2014, 102, 762-771. 112. Lu, S.; Gao, W.; Gu, H. Y., Construction, Application And Biosafety Of Silver Nanocrystalline Chitosan Wound Dressing. Burns 2008, 34 (5), 623-628. 113. Adhya, A.; Bain, J.; Ray, O.; Hazra, A.; Adhikari, S.; Dutta, G.; Ray, S.; Majumdar, B. K., Healing Of Burn Wounds By Topical Treatment: A Randomized Controlled Comparison Between Silver Sulfadiazine And Nano-Crystalline Silver. J. Basic Clin. Pharm. 2014, 6 (1), 29. 114. Walker, M.; Parsons, D., The Biological Fate Of Silver Ions Following The Use Of Silver‐Containing Wound Care Products–A Review. Int. Wound J. 2014, 11 (5), 496-504.\nPage 51 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n52\n115. Gobin, A. M.; O'Neal, D. P.; Watkins, D. M.; Halas, N. J.; Drezek, R. A.; West, J. L., Near Infrared Laser‐Tissue Welding Using Nanoshells As An Exogenous Absorber. Lasers Surg. Med. 2005, 37 (2), 123-129. 116. Gu, H.; Ho, P.; Tong, E.; Wang, L.; Xu, B., Presenting Vancomycin On Nanoparticles To Enhance Antimicrobial Activities. Nano Letters 2003, 3 (9), 1261-1263. 117. Bresee, J.; Maier, K. E.; Boncella, A. E.; Melander, C.; Feldheim, D. L., Growth Inhibition Of Staphylococcus Aureus By Mixed Monolayer Gold Nanoparticles. Small 2011, 7 (14), 2027-2031. 118. Zhao, Y.; Tian, Y.; Cui, Y.; Liu, W.; Ma, W.; Jiang, X., Small Molecule-Capped Gold Nanoparticles As Potent Antibacterial Agents That Target Gram-Negative Bacteria. J. Am. Chem. Soc. 2010, 132 (35), 12349-12356. 119. Cui, Y.; Zhao, Y.; Tian, Y.; Zhang, W.; Lü, X.; Jiang, X., The Molecular Mechanism Of Action Of Bactericidal Gold Nanoparticles On Escherichia Coli. Biomaterials 2012, 33 (7), 2327-2333. 120. Li, X.; Robinson, S. M.; Gupta, A.; Saha, K.; Jiang, Z.; Moyano, D. F.; Sahar, A.; Riley, M. A.; Rotello, V. M., Functional Gold Nanoparticles As Potent Antimicrobial Agents Against Multi-Drug-Resistant Bacteria. ACS Nano 2014, 8 (10), 10682-10686. 121. Hsu, S.-H.; Chang, Y.-B.; Tsai, C.-L.; Fu, K.-Y.; Wang, S.-H.; Tseng, H.-J., Characterization And Biocompatibility Of Chitosan Nanocomposites. Colloids Surfaces B 2011, 85 (2), 198-206. 122. Cozad, M. J.; Bachman, S. L.; Grant, S. A., Assessment Of Decellularized Porcine Diaphragm Conjugated With Gold Nanomaterials As A Tissue Scaffold For Wound Healing. J. Biomed. Mater. Res., Part A 2011, 99 (3), 426-434. 123. Kolesnikova, T. A.; Kohler, D.; Skirtach, A. G.; MöHwald, H., Laser-Induced Cell Detachment, Patterning, And Regrowth On Gold Nanoparticle Functionalized Surfaces. ACS Nano 2012, 6 (11), 9585-9595. 124. Chen, S.-A.; Chen, H.-M.; Yao, Y.-D.; Hung, C.-F.; Tu, C.-S.; Liang, Y.-J., Topical Treatment With Anti-Oxidants And Au Nanoparticles Promote Healing Of Diabetic Wound Through Receptor For Advance Glycation End-Products. Eur. J. Pharm. Sci. 2012, 47 (5), 875- 883. 125. Leu, J.-G.; Chen, S.-A.; Chen, H.-M.; Wu, W.-M.; Hung, C.-F.; Yao, Y.-D.; Tu, C.-S.; Liang, Y.-J., The Effects Of Gold Nanoparticles In Wound Healing With Antioxidant Epigallocatechin Gallate And Α-Lipoic Acid. Nanomedicine 2012, 8 (5), 767-775. 126. Huang, Y.-H.; Chen, C.-Y.; Chen, P.-J.; Tan, S.-W.; Chen, C.-N.; Chen, H.-M.; Tu, C.S.; Liang, Y.-J., Gas-Injection Of Gold Nanoparticles And Anti-Oxidants Promotes Diabetic Wound Healing. RSC Adv. 2013, 4 (9), 4656-4662. 127. Demir, B.; Barlas, F. B.; Guler, E.; Gumus, P. Z.; Can, M.; Yavuz, M.; Coskunol, H.; Timur, S., Gold Nanoparticle Loaded Phytosomal Systems: Synthesis, Characterization And In Vitro Investigations. RSC Adv. 2014, 4 (65), 34687-34695. 128. Kim, J. E.; Lee, J.; Jang, M.; Kwak, M. H.; Go, J.; Kho, E. K.; Song, S. H.; Sung, J. E.; Lee, J.; Hwang, D. Y., Accelerated Healing Of Cutaneous Wounds Using Phytochemically Stabilized Gold Nanoparticle Deposited Hydrocolloid Membranes. Biomater. Sci. 2015, 3 (3), 509-519. 129. De, S.; Razorenova, O.; Mccabe, N. P.; O'Toole, T.; Qin, J.; Byzova, T. V., VEGF– Integrin Interplay Controls Tumor Growth And Vascularization. Proc. Natl. Acad. Sci. U.S.A. 2005, 102 (21), 7589-7594.\nPage 52 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n53\n130. Mahabeleshwar, G. H.; Chen, J.; Feng, W.; Somanath, P. R.; Razorenova, O. V.; Byzova, T. V., Integrin Affinity Modulation In Angiogenesis. Cell Cycle 2008, 7 (3), 335-347. 131. Eckes, B.; Colucci-Guyon, E.; Smola, H.; Nodder, S.; Babinet, C.; Krieg, T.; Martin, P., Impaired Wound Healing In Embryonic And Adult Mice Lacking Vimentin. J. Cell Sci. 2000, 113 (13), 2455-2462. 132. Gaharwar, A. K.; Mukundan, S.; Karaca, E.; Dolatshahi-Pirouz, A.; Patel, A.; Rangarajan, K.; Mihaila, S. M.; Iviglia, G.; Zhang, H.; Khademhosseini, A., Fabrication And Characterization Of Nanoclay-Enriched Poly(E-Caprolactone) Electrospun Scaffolds For Osteogenic Differentiation Of Human Mesenchymal Stem Cells. Tissue Eng. Pt. A 2014, 9 (S1). 133. Zhang, J.; Postovit, L.-M.; Wang, D.; Gardiner, R. B.; Harris, R.; Abdul, M. M.; Thomas, A. A., In Situ Loading Of Basic Fibroblast Growth Factor Within Porous Silica Nanoparticles For A Prolonged Release. Nanoscale Res. Lett. 2009, 4 (11), 1297-1302. 134. Shin, J. H.; Metzger, S. K.; Schoenfisch, M. H., Synthesis Of Nitric Oxide-Releasing Silica Nanoparticles. J. Am. Chem. Soc. 2007, 129 (15), 4612-4619. 135. Koh, A.; Carpenter, A. W.; Slomberg, D. L.; Schoenfisch, M. H., Nitric Oxide-Releasing Silica Nanoparticle-Doped Polyurethane Electrospun Fibers. ACS Appl. Mater. Interfaces 2013, 5 (16), 7956-7964. 136. Friedman, A. J.; Han, G.; Navati, M. S.; Chacko, M.; Gunther, L.; Alfieri, A.; Friedman, J. M., Sustained Release Nitric Oxide Releasing Nanoparticles: Characterization Of A Novel Delivery Platform Based On Nitrite Containing Hydrogel/Glass Composites. Nitric Oxide 2008, 19 (1), 12-20. 137. Han, G.; Nguyen, L. N.; Macherla, C.; Chi, Y.; Friedman, J. M.; Nosanchuk, J. D.; Martinez, L. R., Nitric Oxide–Releasing Nanoparticles Accelerate Wound Healing By Promoting Fibroblast Migration And Collagen Deposition. Am. J. Pathol. 2012, 180 (4), 1465-1473. 138. Rose, S.; Prevoteau, A.; Elzière, P.; Hourdet, D.; Marcellan, A.; Leibler, L., Nanoparticle Solutions As Adhesives For Gels And Biological Tissues. Nature 2014, 505 (7483), 382-385. 139. Meddahi‐Pellé, A.; Legrand, A.; Marcellan, A.; Louedec, L.; Letourneur, D.; Leibler, L., Organ Repair, Hemostasis, And In Vivo Bonding Of Medical Devices By Aqueous Solutions Of Nanoparticles. Angew. Chem. 2014, 126 (25), 6487-6491. 140. Alvarez, G. S.; Hélary, C.; Mebert, A. M.; Wang, X.; Coradin, T.; Desimone, M. F., Antibiotic-Loaded Silica Nanoparticle–Collagen Composite Hydrogels With Prolonged Antimicrobial Activity For Wound Infection Prevention. J. Mater. Chem. B 2014, 2 (29), 4660- 4670. 141. Charafeddine, R. A.; Makdisi, J.; Schairer, D.; O'Rourke, B. P.; Diaz-Valencia, J. D.; Chouake, J.; Kutner, A.; Krausz, A.; Adler, B.; Nacharaju, P., Fidgetin-Like 2: A MicrotubuleBased Regulator Of Wound Healing. J. Invest. Dermatol. 2015. 142. Cabrales, P.; Han, G.; Roche, C.; Nacharaju, P.; Friedman, A. J.; Friedman, J. M., Sustained Release Nitric Oxide From Long-Lived Circulating Nanoparticles. Free Radicals Biol. Med. 2010, 49 (4), 530-538. 143. Dawson, J. I.; Oreffo, R. O., Clay: New Opportunities For Tissue Regeneration And Biomaterial Design. Adv. Mater. 2013, 25 (30), 4069-4086. 144. Dawson, J. I.; Kanczler, J. M.; Yang, X. B.; Attard, G. S.; Oreffo, R. O., Clay Gels For The Delivery Of Regenerative Microenvironments. Adv. Mater. 2011, 23 (29), 3304-3308. 145. Waters, R.; Pacelli, S.; Maloney, R.; Medhi, I.; Ahmed, R. P.; Paul, A., Stem Cell Secretome-Rich Nanoclay Hydrogel: A Dual Action Therapy For Cardiovascular Regeneration. Nanoscale 2016, DOI: 10.1039/C5NR07806G.\nPage 53 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n54\n146. Gaharwar, A. K.; Avery, R. K.; Assmann, A.; Paul, A.; Mckinley, G. H.; Khademhosseini, A.; Olsen, B. D., Shear-Thinning Nanocomposite Hydrogels For The Treatment Of Hemorrhage. ACS Nano 2014, 8 (10), 9833-9842. 147. Kevadiya, B. D.; Rajkumar, S.; Bajaj, H. C.; Chettiar, S. S.; Gosai, K.; Brahmbhatt, H.; Bhatt, A. S.; Barvaliya, Y. K.; Dave, G. S.; Kothari, R. K., Biodegradable Gelatin– Ciprofloxacin–Montmorillonite Composite Hydrogels For Controlled Drug Release And Wound Dressing Application. Colloids Surfaces B 2014, 122, 175-183. 148. Ghadiri, M.; Chrzanowski, W.; Rohanizadeh, R., Antibiotic Eluting Clay Mineral (Laponite®) For Wound Healing Application: An In Vitro Study. J. Mater. Sci.: Mater. Med. 2014, 25 (11), 2513-2526. 149. Ghadiri, M.; Chrzanowski, W.; Lee, W.; Rohanizadeh, R., Layered Silicate Clay Functionalized With Amino Acids: Wound Healing Application. RSC Adv. 2014, 4 (67), 35332- 35343. 150. Gaharwar, A. K.; Mihaila, S. M.; Swami, A.; Patel, A.; Sant, S.; Reis, R. L.; Marques, A. P.; Gomes, M. E.; Khademhosseini, A., Bioactive Silicate Nanoplatelets For Osteogenic Differentiation Of Human Mesenchymal Stem Cells. Adv. Mater. 2013, 25 (24), 3329-3336. 151. Ul-Islam, M.; Khan, T.; Khattak, W. A.; Park, J. K., Bacterial Cellulose-Mmts Nanoreinforced Composite Films: Novel Wound Dressing Material With Antibacterial Properties. Cellulose 2013, 20 (2), 589-596. 152. Erol‐Taygun, M.; Zheng, K.; Boccaccini, A. R., Nanoscale Bioactive Glasses In Medical Applications. Int. J. Appl. Glass Sci. 2013, 4 (2), 136-148. 153. Izquierdo-Barba, I.; Colilla, M.; Vallet-Regí, M., Zwitterionic Ceramics For Biomedical Applications. Acta Biomater. 2016. 154. Colilla, M.; Martínez-Carmona, M.; Sánchez-Salcedo, S.; Ruiz-González, M. L.; González-Calbet, J. M.; Vallet-Regí, M., A Novel Zwitterionic Bioceramic With Dual Antibacterial Capability. J. Mater. Chem. B 2014, 2 (34), 5639-5651. 155. Vallet‐Regí, M.; Balas, F.; Arcos, D., Mesoporous Materials For Drug Delivery. Angew. Chem., Int. Ed. 2007, 46 (40), 7548-7558. 156. Day, R. M., Bioactive Glass Stimulates The Secretion Of Angiogenic Growth Factors And Angiogenesis In Vitro. Tissue Eng. 2005, 11 (5-6), 768-777. 157. Leu, A.; Leach, J. K., Proangiogenic Potential Of A Collagen/Bioactive Glass Substrate. Pharm. Res. 2008, 25 (5), 1222-1229. 158. Chen, X.; Lei, B.; Wang, Y.; Zhao, N., Morphological Control And In Vitro Bioactivity Of Nanoscale Bioactive Glasses. J. Non-Cryst. Solids 2009, 355 (13), 791-796. 159. Mao, C.; Chen, X.; Miao, G.; Lin, C., Angiogenesis Stimulated By Novel Nanoscale Bioactive Glasses. Biomed. Mater. 2015, 10 (2), 025005. 160. Li, H.; He, J.; Yu, H.; Green, C. R.; Chang, J., Bioglass Promotes Wound Healing By Affecting Gap Junction Connexin 43 Mediated Endothelial Cell Behavior. Biomaterials 2016. 161. Raghupathi, K. R.; Koodali, R. T.; Manna, A. C., Size-Dependent Bacterial Growth Inhibition And Mechanism Of Antibacterial Activity Of Zinc Oxide Nanoparticles. Langmuir 2011, 27 (7), 4020-4028. 162. Barui, A. K.; Veeriah, V.; Mukherjee, S.; Manna, J.; Patel, A. K.; Patra, S.; Pal, K.; Murali, S.; Rana, R. K.; Chatterjee, S., Zinc Oxide Nanoflowers Make New Blood Vessels. Nanoscale 2012, 4 (24), 7861-7869. 163. Sudheesh Kumar, P.; Lakshmanan, V.-K.; Anilkumar, T.; Ramya, C.; Reshmi, P.; Unnikrishnan, A.; Nair, S. V.; Jayakumar, R., Flexible And Microporous Chitosan\nPage 54 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n55\nHydrogel/Nano Zno Composite Bandages For Wound Dressing: In Vitro And In Vivo Evaluation. ACS Appl. Mater. Interfaces 2012, 4 (5), 2618-2629. 164. Kumar, S.; Lakshmanan, V.-K.; Raj, M.; Biswas, R.; Hiroshi, T.; Nair, S. V.; Jayakumar, R., Evaluation Of Wound Healing Potential Of Β-Chitin Hydrogel/Nano Zinc Oxide Composite Bandage. Pharm. Res. 2013, 30 (2), 523-537. 165. Augustine, R.; Malik, H. N.; Singhal, D. K.; Mukherjee, A.; Malakar, D.; Kalarikkal, N.; Thomas, S., Electrospun Polycaprolactone/Zno Nanocomposite Membranes As Biomaterials With Antibacterial And Cell Adhesion Properties. J. Polym. Res. 2014, 21 (3), 1-17. 166. Soenen, S. J.; Parak, W. J.; Rejman, J.; Manshian, B., (Intra) Cellular Stability Of Inorganic Nanoparticles: Effects On Cytotoxicity, Particle Functionality, And Biomedical Applications. Chem. Rev. 2015, 115 (5), 2109-2135. 167. Lu, B.; Li, T.; Zhao, H.; Li, X.; Gao, C.; Zhang, S.; Xie, E., Graphene-Based Composite Materials Beneficial To Wound Healing. Nanoscale 2012, 4 (9), 2978-2982. 168. Fan, Z.; Liu, B.; Wang, J.; Zhang, S.; Lin, Q.; Gong, P.; Ma, L.; Yang, S., A Novel Wound Dressing Based On Ag/Graphene Polymer Hydrogel: Effectively Kill Bacteria And Accelerate Wound Healing. Adv. Funct. Mater. 2014, 24 (25), 3933-3943. 169. Liu, S.; Zeng, T. H.; Hofmann, M.; Burcombe, E.; Wei, J.; Jiang, R.; Kong, J.; Chen, Y., Antibacterial Activity Of Graphite, Graphite Oxide, Graphene Oxide, And Reduced Graphene Oxide: Membrane And Oxidative Stress. ACS Nano 2011, 5 (9), 6971-6980. 170. Akhavan, O.; Ghaderi, E., Toxicity Of Graphene And Graphene Oxide Nanowalls Against Bacteria. ACS Nano 2010, 4 (10), 5731-5736. 171. Krishnamoorthy, K.; Veerapandian, M.; Zhang, L.-H.; Yun, K.; Kim, S. J., Antibacterial Efficiency Of Graphene Nanosheets Against Pathogenic Bacteria Via Lipid Peroxidation. J. Phys. Chem. C 2012, 116 (32), 17280-17287. 172. Tu, Y.; Lv, M.; Xiu, P.; Huynh, T.; Zhang, M.; Castelli, M.; Liu, Z.; Huang, Q.; Fan, C.; Fang, H., Destructive Extraction Of Phospholipids From Escherichia Coli Membranes By Graphene Nanosheets. Nat. Nanotechnol. 2013, 8 (8), 594-601. 173. Khan, M. S.; Abdelhamid, H. N.; Wu, H.-F., Near Infrared (Nir) Laser Mediated Surface Activation Of Graphene Oxide Nanoflakes For Efficient Antibacterial, Antifungal And Wound Healing Treatment. Colloids Surfaces B 2015, 127, 281-291. 174. Toliver-Kinsky, T. E.; Cui, W.; Murphey, E. D.; Lin, C.; Sherwood, E. R., Enhancement Of Dendritic Cell Production By Fms-Like Tyrosine Kinase-3 Ligand Increases The Resistance Of Mice To A Burn Wound Infection. Journal Of Immunology 2005, 174 (1), 404-10. 175. Hotchkiss, R. S.; Monneret, G.; Payen, D., Sepsis-Induced Immunosuppression: From Cellular Dysfunctions To Immunotherapy. Nature Reviews. Immunology 2013, 13 (12), 862-74.\nPage 55 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\n56\nPage 56 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nTable of Content: Nanotechnology has stimulated the development of multifunctional biomaterials for infection control and wound healing. This review focuses on the recent developments that are shaping this emerging field, and\nevaluates the applications of engineered nanomaterials for both acute and chronic wounds. The scope of this paper is to capture the synergistic interactions between nanomaterials and cell that are used to address some of the daunting challenges in wound healing, such as angiogenesis, infection control, and immune reactions. Additionally, recent developments in antimicrobial nanoengineered wound dressings are also\nevaluated and promising research directions in the field are identify. 140x78mm (300 x 300 DPI)\nPage 57 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nFigure 1. Number of publications in “wound healing” and “nano*” according to Web of Science. (a) Application of nanoengineered materials in wound healing. (b) A steady increase in the number of publications and citations indicate a growing interest nanomaterials applications for wound healing. (c) and (d) Types of nanomaterials investigated for wound healing applications. (Data obtained from ISI Web of Science, March 2016) 207x212mm (300 x 300 DPI)\nPage 58 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nFigure 2. Stages of wound healing include (a) hemostasis and tissue inflammation, (b) cellular proliferation and new tissue formation, and (c) tissue remodeling. Adapted and reprinted with permission.4 Copyright 2008, Macmillan Publishers Ltd: Nature. 87x183mm (300 x 300 DPI)\nPage 59 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nFigure 3. Chitosan-nanofibrin composite for accelerated wound healing. (a) SEM image showing nanofibrin combined with chitosan results in formation of porous mat. (b) Application of chitosan/fibrin nanocomposite significantly enhances wound healing ability and (c) re-epithelialization of wounded tissue. Adapted and reprinted with permission.74 Copyright 2012, Mary Ann Liebert, Inc. 261x166mm (300 x 300 DPI)\nPage 60 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nFigure 4. Mussel-Inspired electrospun nanofibers loaded with silver nanoparticles (AgNPs) for wound dressing application. (a) SEM and TEM images of electrospun scaffold made from poly(methyl methacrylateco-dopamine methacrylamide) (MADO) and AgNPs. (b) XPS showing presence of AgNPs as evident by the Ag related peaks. (c) Wound appearance at 0, 5, 10, and 15 days after grafting with MADO-AgNPs nanofiber, and control. Adapted and reproduced with permission.108 Copyright 2015, American Chemical Society. 174x181mm (300 x 300 DPI)\nPage 61 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nFigure 5. Gold nanoparticles (AuNPs) coated on a hydrocolloid membrane (HCM) for curing cutaneous wounds. (a) Schematic showing fabrication of nanocomposite wound healing patch from AuNPs and HCM. (b) Wound area and (c) wound size significantly decreases when treated with AuNP-HCM. Adapted and reproduced with permission.128 Copyright 2015, Royal Society of Chemistry. 163x173mm (300 x 300 DPI)\nPage 62 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nFigure 6. Silica nanoparticles for tissue adhesive. (a) Silica nanoparticles act as connectors between gel surfaces. Adsorbed polymer chains act as bridges between nanoparticles. (b) hydrogel and calf liver glued together by spreading silica nanoparticle solution. (c) TEM image of silica nanoparticles (~50 nm). The concept of nanobridging for wound closure. A droplet of nanoparticle solution spread over the wound surface form numerous connectors to link the wound edges together. (d) Wound healing ability of silica nanoparticles (SiO2NP), non-resorbable suture (Ethicon) and 2-octyl cyano-acrylate (Dermabond). (a) and (b) adapted and reproduced with permission.138 Copyright 2014, Macmillan Publishers Limited; and (c) and (d) adapted and reproduced with permission.139 Copyright 2014, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. 264x193mm (300 x 300 DPI)\nPage 63 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nFigure 7. Nanosilicate for growth factor delivery to promote angiogenesis. (a) Schematic showing loading of VEGF on silicate nanoparticles (Laponite) in collagen gel. (b) Laponite/collagen gels support network organization of endothelial cells in vitro (scale bars 100 µm). (c) VEGF loaded Laponite/Collagen gels induces angiogenic in a murine femoral defect. (d) The sustain release of VEGF from Laponite significantly increases in vessel volume and vessel number. Adapted and reproduced with permission.144 Copyright 2011, Wiley-VCH Verlag GmbH & Co. 246x186mm (300 x 300 DPI)\nPage 64 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nFigure 8. ZnO nanoflowers for wound healing applications. (a) SEM image of ZnO nanoflowers and cellular internalization of ZnO. (b) XRD data showing diffraction pattern of ZnO. (c) Effect of ZnO concentration on stimulating cell proliferation and cell cycle. (d) Effect of ZnO nanoflower on in vitro wound healing characteristics compared to VEGF. Adapted and reproduced with permission.162 Copyright 2012, Royal Society of Chemistry. 181x152mm (300 x 300 DPI)\nPage 65 of 65\nACS Paragon Plus Environment\nACS Applied Materials & Interfaces\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60"
    } ],
    "references" : [ {
      "title" : "The Global Burden Of Diabetic Foot Disease",
      "author" : [ "A.J. Boulton", "L. Vileikyte", "G. Ragnarson-Tennvall", "J. Apelqvist" ],
      "venue" : null,
      "citeRegEx" : "1",
      "shortCiteRegEx" : "1",
      "year" : 2005
    }, {
      "title" : "Human Skin Wounds: A Major And Snowballing Threat To Public Health And The Economy",
      "author" : [ "C.K. Sen", "G.M. Gordillo", "S. Roy", "R. Kirsner", "L. Lambert", "T.K. Hunt", "F. Gottrup", "G.C. Gurtner", "M.T. Longaker" ],
      "venue" : "Wound Repair Regen. 2009,",
      "citeRegEx" : "2",
      "shortCiteRegEx" : "2",
      "year" : 2009
    }, {
      "title" : "US Skin Disease Assessment: Ulcer",
      "author" : [ "A. Markova", "E.N. Mostow" ],
      "venue" : "And Wound Care. Dermatol. Clin. 2012,",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2012
    }, {
      "title" : "Wound Repair And Regeneration",
      "author" : [ "G.C. Gurtner", "S. Werner", "Y. Barrandon", "M.T. Longaker" ],
      "venue" : "Nature",
      "citeRegEx" : "4",
      "shortCiteRegEx" : "4",
      "year" : 2008
    }, {
      "title" : "Science, Medicine, And The Future: Healing Chronic Wounds",
      "author" : [ "K. Harding", "H. Morris", "G. Patel" ],
      "venue" : "Br. Med. J. 2002,",
      "citeRegEx" : "5",
      "shortCiteRegEx" : "5",
      "year" : 2002
    }, {
      "title" : "Preventing Foot Ulcers In Patients With Diabetes",
      "author" : [ "N. Singh", "D.G. Armstrong", "B.A. Lipsky" ],
      "venue" : "JAMA 2005,",
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 2005
    }, {
      "title" : "Epidemiology Of Foot Ulcers And Amputations In The Diabetic Foot",
      "author" : [ "G. Rayber" ],
      "venue" : "Bowker JH, Pfeifer, MA. The Diabetic Foot. 6th Edition St Louis, Missouri. Mosby Inc",
      "citeRegEx" : "7",
      "shortCiteRegEx" : "7",
      "year" : 2001
    }, {
      "title" : "The Chemistry And Engineering Of Polymeric Hydrogel Adhesives For Wound Closure: A Tutorial",
      "author" : [ "C. Ghobril", "M. Grinstaff" ],
      "venue" : "Chem. Soc. Rev. 2015,",
      "citeRegEx" : "8",
      "shortCiteRegEx" : "8",
      "year" : 2015
    }, {
      "title" : "Wound Healing Dressings And Drug Delivery Systems: A Review",
      "author" : [ "J.S. Boateng", "K.H. Matthews", "H.N. Stevens", "G.M. Eccleston" ],
      "venue" : "J. Pharm. Sci. 2008,",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 2008
    }, {
      "title" : "Biomaterials Based On Chitin And Chitosan",
      "author" : [ "R. Jayakumar", "M. Prabaharan", "P.S. Kumar", "S. Nair", "H. Tamura" ],
      "venue" : "In Wound Dressing Applications. Biotechnol. Adv. 2011,",
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2011
    }, {
      "title" : "Review Collagen‐Based Biomaterials For Wound Healing",
      "author" : [ "S. Chattopadhyay", "R.T. Raines" ],
      "venue" : "Biopolymers 2014,",
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2014
    }, {
      "title" : "Recent Advances On The Development Of Wound Dressings For Diabetic Foot Ulcer Treatment—A Review",
      "author" : [ "L.I. Moura", "A.M. Dias", "E. Carvalho", "H.C. De Sousa" ],
      "venue" : "Acta Biomater. 2013,",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2013
    }, {
      "title" : "Tissue Engineering And Regenerative Repair",
      "author" : [ "M.S. Hu", "Z.N. Maan", "J.-C. Wu", "R.C. Rennert", "W.X. Hong", "T.S. Lai", "A.T. Cheung", "G.G. Walmsley", "M.T. Chung", "A. Mcardle" ],
      "venue" : "In Wound Healing. Ann. Biomed. Eng. 2014,",
      "citeRegEx" : "13",
      "shortCiteRegEx" : "13",
      "year" : 2014
    }, {
      "title" : "A Review Of The Biomaterials Technologies For Infection-Resistant Surfaces",
      "author" : [ "D. Campoccia", "L. Montanaro", "C.R. Arciola" ],
      "venue" : "Biomaterials 2013,",
      "citeRegEx" : "14",
      "shortCiteRegEx" : "14",
      "year" : 2013
    }, {
      "title" : "Nanoparticle And Targeted Systems For Cancer Therapy",
      "author" : [ "L. Brannon-Peppas", "J.O. Blanchette" ],
      "venue" : "Adv. Drug Delivery Rev. 2012,",
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2012
    }, {
      "title" : "Carbon-Based Nanomaterials: Multifunctional Materials For Biomedical Engineering",
      "author" : [ "C. Cha", "S.R. Shin", "N. Annabi", "M.R. Dokmeci", "A. Khademhosseini" ],
      "venue" : "ACS Nano 2013,",
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2013
    }, {
      "title" : "New Opportunities: The Use Of Nanotechnologies To Manipulate And Track Stem Cells",
      "author" : [ "L. Ferreira", "J.M. Karp", "L. Nobre", "R. Langer" ],
      "venue" : "Cell Stem Cell 2008,",
      "citeRegEx" : "17",
      "shortCiteRegEx" : "17",
      "year" : 2008
    }, {
      "title" : "Nanocomposite Hydrogels",
      "author" : [ "A.K. Gaharwar", "N.A. Peppas", "A. Khademhosseini" ],
      "venue" : "For Biomedical Applications. Biotechnol. Bioeng. 2014,",
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 2014
    }, {
      "title" : "Nanotechnology And Nanomaterials: Promises For Improved Tissue Regeneration",
      "author" : [ "L. Zhang", "T.J. Webster" ],
      "venue" : "Nano Today",
      "citeRegEx" : "19",
      "shortCiteRegEx" : "19",
      "year" : 2009
    }, {
      "title" : "Hydrogels And Scaffolds For Immunomodulation",
      "author" : [ "A. Singh", "N.A. Peppas" ],
      "venue" : "Adv. Mater. 2014,",
      "citeRegEx" : "20",
      "shortCiteRegEx" : "20",
      "year" : 2014
    }, {
      "title" : "Engineering Vaccines And Niches For Immune Modulation",
      "author" : [ "A. Purwada", "K. Roy", "A. Singh" ],
      "venue" : "Acta Biomater. 2014,",
      "citeRegEx" : "21",
      "shortCiteRegEx" : "21",
      "year" : 2014
    }, {
      "title" : "Bioinspired Polymeric Nanocomposites For Regenerative Medicine",
      "author" : [ "J.K. Carrow", "A.K. Gaharwar" ],
      "venue" : "Macromol. Chem. Phys. 2015,",
      "citeRegEx" : "22",
      "shortCiteRegEx" : "22",
      "year" : 2015
    }, {
      "title" : "Two‐Dimensional Nanomaterials For Biomedical Applications: Emerging Trends And Future Prospects",
      "author" : [ "D. Chimene", "D.L. Alge", "A.K. Gaharwar" ],
      "venue" : "Adv. Mater. 2015,",
      "citeRegEx" : "23",
      "shortCiteRegEx" : "23",
      "year" : 2015
    }, {
      "title" : "Nanomaterials For Engineering Stem Cell Responses",
      "author" : [ "P. Kerativitayanan", "J.K. Carrow", "A.K. Gaharwar" ],
      "venue" : "Adv. Healthcare Mater. 2015,",
      "citeRegEx" : "24",
      "shortCiteRegEx" : "24",
      "year" : 2015
    }, {
      "title" : "Anisotropic Poly (Glycerol Sebacate)-Poly (ε-Caprolactone) Electrospun Fibers Promote Endothelial Cell Guidance",
      "author" : [ "A.K. Gaharwar", "M. Nikkhah", "S. Sant", "A. Khademhosseini" ],
      "venue" : "Biofabrication 2015,",
      "citeRegEx" : "25",
      "shortCiteRegEx" : "25",
      "year" : 2015
    }, {
      "title" : "Injectable Graphene Oxide/Hydrogel-Based Angiogenic Gene Delivery System For Vasculogenesis And Cardiac Repair",
      "author" : [ "A. Paul", "A. Hasan", "H.A. Kindi", "A.K. Gaharwar", "V.T. Rao", "M. Nikkhah", "S.R. Shin", "D. Krafft", "M.R. Dokmeci", "D. Shum-Tim" ],
      "venue" : "ACS Nano 2014,",
      "citeRegEx" : "26",
      "shortCiteRegEx" : "26",
      "year" : 2014
    }, {
      "title" : "Designing Electrospun Nanofiber Mats To Promote Wound Healing–A Review",
      "author" : [ "K.A. Rieger", "N.P. Birch", "J.D. Schiffman" ],
      "venue" : "J. Mater. Chem. B 2013,",
      "citeRegEx" : "27",
      "shortCiteRegEx" : "27",
      "year" : 2013
    }, {
      "title" : "Nanomaterials For Wound Healing: Scope And Advancement",
      "author" : [ "I. Kalashnikova", "S. Das", "S. Seal" ],
      "venue" : "Nanomedicine 2015,",
      "citeRegEx" : "29",
      "shortCiteRegEx" : "29",
      "year" : 2015
    }, {
      "title" : "Self-Assembling Nanoparticles For Intra-Articular Delivery Of Anti-Inflammatory Proteins",
      "author" : [ "R.E. Whitmire", "D. Scott Wilson", "A. Singh", "M.E. Levenston", "N. Murthy", "A.J. García" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "30",
      "shortCiteRegEx" : "30",
      "year" : 2012
    }, {
      "title" : "Guidelines For The Treatment Of Diabetic Ulcers",
      "author" : [ "D.L. Steed", "C. Attinger", "T. Colaizzi", "M. Crossland", "M. Franz", "L. Harkless", "A. Johnson", "H. Moosa", "M. Robson", "T. Serena" ],
      "venue" : "Wound Repair Regen. 2006,",
      "citeRegEx" : "31",
      "shortCiteRegEx" : "31",
      "year" : 2006
    }, {
      "title" : "Silver Nanoparticles In Therapeutics: Development Of An Antimicrobial Gel Formulation For Topical Use",
      "author" : [ "J. Jain", "S. Arora", "J.M. Rajwade", "P. Omray", "S. Khandelwal", "K.M. Paknikar" ],
      "venue" : "Mol. Pharm. 2009,",
      "citeRegEx" : "32",
      "shortCiteRegEx" : "32",
      "year" : 2009
    }, {
      "title" : "Impregnation Of Silver Nanoparticles Into Bacterial Cellulose For Antimicrobial Wound Dressing",
      "author" : [ "T. Maneerung", "S. Tokura", "R. Rujiravanit" ],
      "venue" : "Carbohydr. Polym. 2008,",
      "citeRegEx" : "33",
      "shortCiteRegEx" : "33",
      "year" : 2008
    }, {
      "title" : "Nanosilver As A New Generation Of Nanoproduct",
      "author" : [ "K. Chaloupka", "Y. Malam", "A.M. Seifalian" ],
      "venue" : "In Biomedical Applications. Trends Biotechnol. 2010,",
      "citeRegEx" : "34",
      "shortCiteRegEx" : "34",
      "year" : 2010
    }, {
      "title" : "Deposition Of Silver Nanoparticles On Cellulosic Fibers Via Stabilization Of Carboxymethyl Groups",
      "author" : [ "J. Song", "N.L. Birbach", "J.P. Hinestroza" ],
      "venue" : "Cellulose 2012,",
      "citeRegEx" : "35",
      "shortCiteRegEx" : "35",
      "year" : 2012
    }, {
      "title" : "Dual Growth Factor Releasing Multi-Functional Nanofibers For Wound Healing",
      "author" : [ "Z. Xie", "C.B. Paras", "H. Weng", "P. Punnakitikashem", "L.-C. Su", "K. Vu", "L. Tang", "J. Yang", "K.T. Nguyen" ],
      "venue" : "Acta Biomater. 2013,",
      "citeRegEx" : "36",
      "shortCiteRegEx" : "36",
      "year" : 2013
    }, {
      "title" : "Epidermal Growth Factor: Layered Silicate Nanocomposites For Tissue Regeneration",
      "author" : [ "C.A. Vaiana", "M.K. Leonard", "L.F. Drummy", "K.M. Singh", "A. Bubulya", "R.A. Vaia", "R.R. Naik", "M.P. Kadakia" ],
      "venue" : "Biomacromolecules 2011,",
      "citeRegEx" : "38",
      "shortCiteRegEx" : "38",
      "year" : 2011
    }, {
      "title" : "Effect Of Composite Sio 2@ Aunps On Wound Healing: In Vitro",
      "author" : [ "X. Li", "H. Wang", "H. Rong", "W. Li", "Y. Luo", "K. Tian", "D. Quan", "Y. Wang", "L. Jiang" ],
      "venue" : "And Vivo Studies. J. Colloid Interface Sci",
      "citeRegEx" : "39",
      "shortCiteRegEx" : "39",
      "year" : 2015
    }, {
      "title" : "Nanohybrids Of Silver Particles Immobilized On Silicate Platelet For Infected Wound Healing",
      "author" : [ "C.-Y. Chu", "F.-C. Peng", "Y.-F. Chiu", "H.-C. Lee", "C.-W. Chen", "J.-C. Wei", "J.-J. Lin" ],
      "venue" : "Plos One 2012,",
      "citeRegEx" : "40",
      "shortCiteRegEx" : "40",
      "year" : 2012
    }, {
      "title" : "Wound Healing: Normal And Abnormal",
      "author" : [ "G.C. Gurtner" ],
      "venue" : "Grabb Plastic Surgery. 6th Ed. Philadelphia: Wolters Kluwer-Lippincot William And Wilkins",
      "citeRegEx" : "41",
      "shortCiteRegEx" : "41",
      "year" : 2007
    }, {
      "title" : "Current Management Of Acute Cutaneous Wounds",
      "author" : [ "A.J. Singer", "A.B. Dagum" ],
      "venue" : "N. Engl. J. Med. 2008,",
      "citeRegEx" : "42",
      "shortCiteRegEx" : "42",
      "year" : 2008
    }, {
      "title" : "The Neutrophilic Leukocyte In Wound Repair: A Study With Antineutrophil Serum",
      "author" : [ "D.M. Simpson", "R. Ross" ],
      "venue" : "J. Clin. Invest. 1972,",
      "citeRegEx" : "43",
      "shortCiteRegEx" : "43",
      "year" : 2009
    }, {
      "title" : "Cell Locomotion Forces Versus Cell Contraction Forces For Collagen Lattice Contraction: An In Vitro Model Of Wound Contraction",
      "author" : [ "H.P. Ehrlich", "J.B. Rajaratnam" ],
      "venue" : "Tissue Cell 1990,",
      "citeRegEx" : "44",
      "shortCiteRegEx" : "44",
      "year" : 1990
    }, {
      "title" : "Myofibroblasts And Mechano-Regulation Of Connective Tissue Remodelling",
      "author" : [ "J.J. Tomasek", "G. Gabbiani", "B. Hinz", "C. Chaponnier", "R.A. Brown" ],
      "venue" : "Nat. Rev. Mol. Cell Biol",
      "citeRegEx" : "45",
      "shortCiteRegEx" : "45",
      "year" : 2002
    }, {
      "title" : "Apoptosis Mediates The Decrease In Cellularity During The Transition Between Granulation Tissue And Scar",
      "author" : [ "A. Desmouliere", "M. Redard", "I. Darby", "G. Gabbiani" ],
      "venue" : "Am. J. Pathol",
      "citeRegEx" : "46",
      "shortCiteRegEx" : "46",
      "year" : 1995
    }, {
      "title" : "Wound Healing",
      "author" : [ "N.M. Fine" ],
      "venue" : null,
      "citeRegEx" : "47",
      "shortCiteRegEx" : "47",
      "year" : 2006
    }, {
      "title" : "The Cellular And Molecular Events Of Wound Healing. Cutaneous Wound Healing",
      "author" : [ "F. Mehendale", "P. Martin" ],
      "venue" : null,
      "citeRegEx" : "48",
      "shortCiteRegEx" : "48",
      "year" : 2001
    }, {
      "title" : "General Principles Of Wound Healing",
      "author" : [ "M.B. Witte", "A. Barbul" ],
      "venue" : "Surg. Clin. North Am. 1997,",
      "citeRegEx" : "49",
      "shortCiteRegEx" : "49",
      "year" : 1997
    }, {
      "title" : "Protease Inhibitors Protect Growth Factor Activity In Chronic Wounds",
      "author" : [ "M. Wlaschek", "D. Peus", "V. Achterberg", "W. Meyer‐Ingold", "K. Scharffetter‐Kochanek" ],
      "venue" : "Br. J. Dermatol",
      "citeRegEx" : "50",
      "shortCiteRegEx" : "50",
      "year" : 1997
    }, {
      "title" : "MMP-8 Is The Predominant Collagenase In Healing Wounds And Nonhealing Ulcers",
      "author" : [ "B.C. Nwomeh", "H.-X. Liang", "I.K. Cohen", "D.R. Yager" ],
      "venue" : "J. Surg. Res",
      "citeRegEx" : "51",
      "shortCiteRegEx" : "51",
      "year" : 1999
    }, {
      "title" : "Defective Recruitment, Survival And Proliferation Of Bone Marrow-Derived Progenitor Cells At Sites Of Delayed Diabetic Wound Healing In Mice",
      "author" : [ "M. Albiero", "L. Menegazzo", "E. Boscaro", "C. Agostini", "A. Avogaro", "G. Fadini" ],
      "venue" : "Diabetologia 2011,",
      "citeRegEx" : "52",
      "shortCiteRegEx" : "52",
      "year" : 2011
    }, {
      "title" : "Clinical Efficacy Of Becaplermin (Rhpdgf-BB) Gel",
      "author" : [ "T.J. Wieman" ],
      "venue" : "The American Journal Of Surgery 1998,",
      "citeRegEx" : "53",
      "shortCiteRegEx" : "53",
      "year" : 1998
    }, {
      "title" : "Efficacy And Safety Of Becaplermin (Recombinant Human Platelet‐Derived Growth Factor‐BB) In Patients With Nonhealing, Lower Extremity Diabetic Ulcers: A Combined Analysis Of Four Randomized Studies",
      "author" : [ "J.M. Smiell", "T.J. Wieman", "D.L. Steed", "B.H. Perry", "A.R. Sampson", "B.H. Schwab" ],
      "venue" : "Wound Repair Regen. 1999,",
      "citeRegEx" : "54",
      "shortCiteRegEx" : "54",
      "year" : 1999
    }, {
      "title" : "Topical Formulations And Wound Healing Applications Of Chitosan",
      "author" : [ "H. Ueno", "T. Mori", "T. Fujinaga" ],
      "venue" : "Adv. Drug Delivery Rev. 2001,",
      "citeRegEx" : "56",
      "shortCiteRegEx" : "56",
      "year" : 2001
    }, {
      "title" : "Effect Of Molecular Structure Of Chitosan On Protein Delivery Properties Of Chitosan Nanoparticles",
      "author" : [ "Y. Xu", "Y. Du" ],
      "venue" : "Int. J. Pharm. 2003,",
      "citeRegEx" : "57",
      "shortCiteRegEx" : "57",
      "year" : 2003
    }, {
      "title" : "Chitosan Membrane As A Wound‐Healing Dressing: Characterization And Clinical Application",
      "author" : [ "A.K. Azad", "N. Sermsintham", "S. Chandrkrachang", "W.F. Stevens" ],
      "venue" : "J. Biomed. Mater. Res., Part B 2004,",
      "citeRegEx" : "58",
      "shortCiteRegEx" : "58",
      "year" : 2004
    }, {
      "title" : "Addition Of Chitosan To Silicate Cross-Linked PEO For Tuning Osteoblast Cell Adhesion And Mineralization",
      "author" : [ "A.K. Gaharwar", "P.J. Schexnailder", "Q. Jin", "C.-J. Wu", "G. Schmidt" ],
      "venue" : "ACS Appl. Mater. Interfaces 2010,",
      "citeRegEx" : "59",
      "shortCiteRegEx" : "59",
      "year" : 2010
    }, {
      "title" : "Synthesis, Characterization, Cytotoxicity And Antibacterial Studies Of Chitosan, O-Carboxymethyl And N, O-Carboxymethyl Chitosan Nanoparticles",
      "author" : [ "A. Anitha", "V.D. Rani", "R. Krishna", "V. Sreeja", "N. Selvamurugan", "S. Nair", "H. Tamura", "R. Jayakumar" ],
      "venue" : "Carbohydr. Polym. 2009,",
      "citeRegEx" : "60",
      "shortCiteRegEx" : "60",
      "year" : 2009
    }, {
      "title" : "Immunological Effects And Membrane Interactions Of Chitosan Nanoparticles",
      "author" : [ "A. Pattani", "V.B. Patravale", "L. Panicker", "P.D. Potdar" ],
      "venue" : "Mol. Pharm. 2009,",
      "citeRegEx" : "61",
      "shortCiteRegEx" : "61",
      "year" : 2009
    }, {
      "title" : "Ionic Polymeric Micelles Based On Chitosan And Fatty Acids And Intended For Wound Healing",
      "author" : [ "M. Bonferoni", "G. Sandri", "E. Dellera", "S. Rossi", "F. Ferrari", "M. Mori", "C. Caramella" ],
      "venue" : "Comparison Of Linoleic And Oleic Acid. Eur. J. Pharm. Biopharm. 2014,",
      "citeRegEx" : "62",
      "shortCiteRegEx" : "62",
      "year" : 2014
    }, {
      "title" : "Development Of Chitosan Oleate Ionic Micelles Loaded With Silver Sulfadiazine To Be Associated With Platelet Lysate For Application In Wound Healing",
      "author" : [ "E. Dellera", "M.C. Bonferoni", "G. Sandri", "S. Rossi", "F. Ferrari", "C. Del Fante", "C. Perotti", "P. Grisoli", "C. Caramella" ],
      "venue" : "Eur. J. Pharm. Biopharm. 2014,",
      "citeRegEx" : "63",
      "shortCiteRegEx" : "63",
      "year" : 2014
    }, {
      "title" : "Adenosine Diphosphate-Decorated Chitosan Nanoparticles Shorten Blood Clotting Times, Influencing The Structures And Varying The Mechanical Properties Of The Clots",
      "author" : [ "T.-W. Chung", "P.-Y. Lin", "S.-S. Wang", "Y.-F. Chen" ],
      "venue" : "Int. J. Nanomed. 2014,",
      "citeRegEx" : "64",
      "shortCiteRegEx" : "64",
      "year" : 2014
    }, {
      "title" : "Chitosan–Tripolyphosphate Nanoparticles As Arrabidaea Chica Standardized Extract Carrier: Synthesis, Characterization, Biocompatibility",
      "author" : [ "L. Servat-Medina", "A. González-Gómez", "F. Reyes-Ortega", "I.M.O. Sousa", "N.D.C.A. Queiroz", "P.M.W. Zago", "M.P. Jorge", "K.M. Monteiro", "J.E. De Carvalho", "J. San Román" ],
      "venue" : "And Antiulcerogenic Activity. Int. J. Nanomed",
      "citeRegEx" : "65",
      "shortCiteRegEx" : "65",
      "year" : 2015
    }, {
      "title" : "Chitosan-Fibrin Nanocomposites As Drug Delivering And Wound Healing Materials",
      "author" : [ "W.S. Vedakumari", "P. Prabu", "T.P. Sastry" ],
      "venue" : "J. Biomed. Nanotechnol. 2015,",
      "citeRegEx" : "66",
      "shortCiteRegEx" : "66",
      "year" : 2015
    }, {
      "title" : "Chitosan–Plasmid Nanoparticle Formulations For IM And SC Delivery Of Recombinant FGF-2 And PDGF-BB Or Generation Of Antibodies",
      "author" : [ "M. Jean", "F. Smaoui", "M. Lavertu", "S. Methot", "L. Bouhdoud", "M. Buschmann", "A. Merzouki" ],
      "venue" : "Gene Ther. 2009,",
      "citeRegEx" : "67",
      "shortCiteRegEx" : "67",
      "year" : 2009
    }, {
      "title" : "Self-Assembly Of Mucoadhesive Nanofibers",
      "author" : [ "P. Suvannasara", "N. Praphairaksit", "N. Muangsin" ],
      "venue" : "RSC Adv. 2014,",
      "citeRegEx" : "68",
      "shortCiteRegEx" : "68",
      "year" : 2014
    }, {
      "title" : "Chitosan/Arginine–Chitosan Polymer Blends For Assembly Of Nanofibrous Membranes",
      "author" : [ "B. Antunes", "A. Moreira", "V. Gaspar", "I. Correia" ],
      "venue" : "For Wound Regeneration. Carbohydr. Polym",
      "citeRegEx" : "69",
      "shortCiteRegEx" : "69",
      "year" : 2015
    }, {
      "title" : "A Fibrin Gel Loaded With Chitosan Nanoparticles For Local Delivery Of Rhegf: Preparation And In Vitro Release Studies",
      "author" : [ "W. Zhou", "M. Zhao", "Y. Zhao", "Y. Mou" ],
      "venue" : "J. Mater. Sci.: Mater. Med",
      "citeRegEx" : "70",
      "shortCiteRegEx" : "70",
      "year" : 2011
    }, {
      "title" : "The Role Of Fibrin E On The Modulation Of Endothelial Progenitors Adhesion, Differentiation And Angiogenic Growth Factor Production And The Promotion Of Wound Healing",
      "author" : [ "F. Caiado", "T. Carvalho", "F. Silva", "C. Castro", "N. Clode", "J.F. Dye", "S. Dias" ],
      "venue" : "Biomaterials 2011,",
      "citeRegEx" : "71",
      "shortCiteRegEx" : "71",
      "year" : 2011
    }, {
      "title" : "Fibrin Nanoconstructs: A Novel Processing Method",
      "author" : [ "G. Praveen", "P. Sreerekha", "D. Menon", "S.V. Nair", "K.P. Chennazhi" ],
      "venue" : "And Their Use As Controlled Delivery Agents. Nanotechnology 2012,",
      "citeRegEx" : "72",
      "shortCiteRegEx" : "72",
      "year" : 2012
    }, {
      "title" : "Antimicrobial Drugs Encapsulated In Fibrin Nanoparticles For Treating Microbial Infested Wounds",
      "author" : [ "B.M. Alphonsa", "P.S. Kumar", "G. Praveen", "R. Biswas", "K. Chennazhi", "R. Jayakumar" ],
      "venue" : "Pharm. Res. 2014,",
      "citeRegEx" : "73",
      "shortCiteRegEx" : "73",
      "year" : 2014
    }, {
      "title" : "In Vitro And In Vivo Evaluation Of Microporous Chitosan Hydrogel/Nanofibrin Composite Bandage For Skin Tissue Regeneration",
      "author" : [ "P.S. Kumar", "N.M. Raj", "G. Praveen", "K.P. Chennazhi", "S.V. Nair", "R. Jayakumar" ],
      "venue" : "Tissue Eng. Part A 2012,",
      "citeRegEx" : "74",
      "shortCiteRegEx" : "74",
      "year" : 2012
    }, {
      "title" : "Growth Factors In Development, Transformation, And Tumorigenesis",
      "author" : [ "M. Cross", "T.M. Dexter" ],
      "venue" : "Cell 1991,",
      "citeRegEx" : "75",
      "shortCiteRegEx" : "75",
      "year" : 1991
    }, {
      "title" : "Tumorigenesis And The Angiogenic Switch",
      "author" : [ "G. Bergers", "L.E. Benjamin" ],
      "venue" : "Nat. Rev. Cancer 2003,",
      "citeRegEx" : "76",
      "shortCiteRegEx" : "76",
      "year" : 2003
    }, {
      "title" : "Vascular-Specific Growth Factors And Blood Vessel Formation",
      "author" : [ "G.D. Yancopoulos", "S. Davis", "N.W. Gale", "J.S. Rudge", "S.J. Wiegand", "J. Holash" ],
      "venue" : "Nature",
      "citeRegEx" : "77",
      "shortCiteRegEx" : "77",
      "year" : 2000
    }, {
      "title" : "Chitosan–Hyaluronic Acid/VEGF Loaded Fibrin Nanoparticles Composite Sponges For Enhancing Angiogenesis In Wounds",
      "author" : [ "A. Mohandas", "B. Anisha", "K. Chennazhi", "R. Jayakumar" ],
      "venue" : "Colloids Surfaces B",
      "citeRegEx" : "78",
      "shortCiteRegEx" : "78",
      "year" : 2015
    }, {
      "title" : "Lactate Stimulates Angiogenesis And Accelerates The Healing Of Superficial And Ischemic Wounds",
      "author" : [ "P.E. Porporato", "V.L. Payen", "C.J. De Saedeleer", "V. Préat", "J.-P. Thissen", "O. Feron", "P. Sonveaux" ],
      "venue" : "In Mice. Angiogenesis 2012,",
      "citeRegEx" : "79",
      "shortCiteRegEx" : "79",
      "year" : 2012
    }, {
      "title" : "Nanotechnology Promotes The Full‐ Thickness Diabetic Wound Healing Effect Of Recombinant Human Epidermal Growth Factor In Diabetic Rats",
      "author" : [ "Y. Chu", "D. Yu", "P. Wang", "J. Xu", "D. Li", "M. Ding" ],
      "venue" : "Wound Repair Regen. 2010,",
      "citeRegEx" : "80",
      "shortCiteRegEx" : "80",
      "year" : 2010
    }, {
      "title" : "Fibrin-Based Scaffold Incorporating VEGF-And Bfgf-Loaded Nanoparticles Stimulates Wound Healing In Diabetic Mice",
      "author" : [ "P. Losi", "E. Briganti", "C. Errico", "A. Lisella", "E. Sanguinetti", "F. Chiellini", "G. Soldani" ],
      "venue" : "Acta Biomater. 2013,",
      "citeRegEx" : "81",
      "shortCiteRegEx" : "81",
      "year" : 2013
    }, {
      "title" : "Combined Effect Of PLGA And Curcumin On Wound Healing Activity",
      "author" : [ "K.K. Chereddy", "R. Coco", "P.B. Memvanga", "B. Ucakar", "A. Des Rieux", "G. Vandermeulen", "V. Préat" ],
      "venue" : "J. Controlled Release 2013,",
      "citeRegEx" : "82",
      "shortCiteRegEx" : "82",
      "year" : 2013
    }, {
      "title" : "Fabrication Of Quercetin And Curcumin Bionanovesicles For The Prevention And Rapid Regeneration Of Full-Thickness Skin Defects On Mice",
      "author" : [ "I. Castangia", "A. Nácher", "C. Caddeo", "D. Valenti", "A.M. Fadda", "O. Díez-Sales", "A. RuizSaurí", "M. Manconi" ],
      "venue" : "Acta Biomater. 2014,",
      "citeRegEx" : "83",
      "shortCiteRegEx" : "83",
      "year" : 2014
    }, {
      "title" : "Nitric Oxide: A Newly Discovered Function On Wound Healing",
      "author" : [ "Luo", "C.J.-D", "F Alex" ],
      "venue" : "Acta Pharmacol. Sin. 2005,",
      "citeRegEx" : "84",
      "shortCiteRegEx" : "84",
      "year" : 2005
    }, {
      "title" : "Nitric Oxide-Releasing Amphiphilic Poly (Amidoamine)(PAMAM) Dendrimers As Antibacterial Agents. Biomacromolecules",
      "author" : [ "Y. Lu", "D.L. Slomberg", "A. Shah", "M.H. Schoenfisch" ],
      "venue" : "ACS Paragon Plus Environment ACS Applied Materials & Interfaces",
      "citeRegEx" : "85",
      "shortCiteRegEx" : "85",
      "year" : 2013
    }, {
      "title" : "Nitric Oxide-Loaded Echogenic Liposomes For Nitric Oxide Delivery And Inhibition Of Intimal Hyperplasia",
      "author" : [ "S.-L. Huang", "P.H. Kee", "H. Kim", "M.R. Moody", "S.M. Chrzanowski", "R.C. Macdonald", "D.D. Mcpherson" ],
      "venue" : "J. Am. Coll. Cardiol. 2009,",
      "citeRegEx" : "86",
      "shortCiteRegEx" : "86",
      "year" : 2009
    }, {
      "title" : "Nitric OxideReleasing Poly (Lactic-Co-Glycolic Acid)-Polyethylenimine Nanoparticles For Prolonged Nitric Oxide Release, Antibacterial Efficacy, And In Vivo Wound Healing Activity",
      "author" : [ "H. Nurhasni", "J. Cao", "M. Choi", "I. Kim", "B.L. Lee", "Y. Jung", "J.-W. Yoo" ],
      "venue" : "Int. J. Nanomed",
      "citeRegEx" : "87",
      "shortCiteRegEx" : "87",
      "year" : 2015
    }, {
      "title" : "Silver Nanoparticle/Chitosan Oligosaccharide/Poly (Vinyl Alcohol) Nanofibers As Wound Dressings: A Preclinical Study",
      "author" : [ "C. Li", "R. Fu", "C. Yu", "Z. Li", "H. Guan", "D. Hu", "D. Zhao", "L. Lu" ],
      "venue" : "Int. J. Nanomed",
      "citeRegEx" : "88",
      "shortCiteRegEx" : "88",
      "year" : 2013
    }, {
      "title" : "Annexin A1–Containing Extracellular Vesicles And Polymeric Nanoparticles Promote Epithelial Wound Repair",
      "author" : [ "G. Leoni", "P.-A. Neumann", "N. Kamaly", "M. Quiros", "H. Nishio", "H.R. Jones", "R. Sumagin", "R.S. Hilgarth", "A. Alam", "G. Fredman" ],
      "venue" : "J. Clin. Invest",
      "citeRegEx" : "89",
      "shortCiteRegEx" : "89",
      "year" : 2015
    }, {
      "title" : "Effects Of Nanofiber/Stem Cell Composite On Wound Healing In Acute Full-Thickness Skin Wounds",
      "author" : [ "K. Ma", "S. Liao", "L. He", "J. Lu", "S. Ramakrishna", "C.K. Chan" ],
      "venue" : "Tissue Eng. Part A 2011,",
      "citeRegEx" : "90",
      "shortCiteRegEx" : "90",
      "year" : 2011
    }, {
      "title" : "Nitrofurazone-Loaded Electrospun PLLA/Sericin-Based Dual-Layer Fiber Mats For Wound Dressing Applications",
      "author" : [ "R. Zhao", "X. Li", "B. Sun", "Y. Tong", "Z. Jiang", "C. Wang" ],
      "venue" : "RSC Adv. 2015,",
      "citeRegEx" : "91",
      "shortCiteRegEx" : "91",
      "year" : 2015
    }, {
      "title" : "Bioinspired Porous Membranes Containing Polymer Nanoparticles For Wound Healing",
      "author" : [ "A.M. Ferreira", "C. Mattu", "E. Ranzato", "G. Ciardelli" ],
      "venue" : "J. Biomed. Mater. Res., Part A 2014,",
      "citeRegEx" : "92",
      "shortCiteRegEx" : "92",
      "year" : 2014
    }, {
      "title" : "Tendon Healing And AntiAdhesion Properties Of Electrospun Fibrous Membranes Containing Bfgf Loaded Nanoparticles",
      "author" : [ "S. Liu", "M. Qin", "C. Hu", "F. Wu", "W. Cui", "T. Jin", "C. Fan" ],
      "venue" : "Biomaterials 2013,",
      "citeRegEx" : "93",
      "shortCiteRegEx" : "93",
      "year" : 2013
    }, {
      "title" : "Radially Aligned, Electrospun Nanofibers As Dural Substitutes For Wound Closure And Tissue Regeneration Applications",
      "author" : [ "J. Xie", "M.R. Macewan", "W.Z. Ray", "W. Liu", "D.Y. Siewe", "Y. Xia" ],
      "venue" : "ACS Nano 2010,",
      "citeRegEx" : "94",
      "shortCiteRegEx" : "94",
      "year" : 2010
    }, {
      "title" : "Bioactive Thermoresponsive Polyblend Nanofiber Formulations For Wound Healing",
      "author" : [ "M.D. Pawar", "G. Rathna", "S. Agrawal", "B.S. Kuchekar" ],
      "venue" : "Mater. Sci. Eng. C Mater. Biol. Appl. 2015,",
      "citeRegEx" : "95",
      "shortCiteRegEx" : "95",
      "year" : 2015
    }, {
      "title" : "Antibiotic-Free Nanotherapeutics: Hypericin Nanoparticles Thereof For Improved In Vitro And In Vivo Antimicrobial Photodynamic Therapy And Wound Healing",
      "author" : [ "N. Nafee", "A. Youssef", "H. El-Gowelli", "H. Asem", "S. Kandil" ],
      "venue" : "Int. J. Pharm. 2013,",
      "citeRegEx" : "97",
      "shortCiteRegEx" : "97",
      "year" : 2013
    }, {
      "title" : "Biocompatible Wound Dressings Based On Chemically Degradable Triblock Copolymer Hydrogels",
      "author" : [ "J. Madsen", "S.P. Armes", "K. Bertal", "H. Lomas", "S. Macneil", "A.L. Lewis" ],
      "venue" : "Biomacromolecules 2008,",
      "citeRegEx" : "98",
      "shortCiteRegEx" : "98",
      "year" : 2008
    }, {
      "title" : "Antimicrobial Effects Of Silver Nanoparticles",
      "author" : [ "J.S. Kim", "E. Kuk", "K.N. Yu", "J.-H. Kim", "S.J. Park", "H.J. Lee", "S.H. Kim", "Y.K. Park", "Y.H. Park", "C.-Y. Hwang" ],
      "venue" : "Nanomedicine",
      "citeRegEx" : "99",
      "shortCiteRegEx" : "99",
      "year" : 2007
    }, {
      "title" : "Synthesis And Antibacterial Activity Of Silver Nanoparticles Against Gram-Positive And Gram-Negative Bacteria",
      "author" : [ "M. Guzman", "J. Dille", "S. Godet" ],
      "venue" : "Nanomedicine 2012,",
      "citeRegEx" : "100",
      "shortCiteRegEx" : "100",
      "year" : 2012
    }, {
      "title" : "Enhanced Antimicrobial Activity Of Silver Nanoparticles With Controlled Particle Size By Ph Variation",
      "author" : [ "B. Ajitha", "Y.A.K. Reddy", "P.S. Reddy" ],
      "venue" : "Powder Technol",
      "citeRegEx" : "101",
      "shortCiteRegEx" : "101",
      "year" : 2015
    }, {
      "title" : "Synthesis And Antibacterial Activity Of Silver Nanoparticles With Different Sizes",
      "author" : [ "G. Martinez-Castanon", "N. Nino-Martinez", "F. Martinez-Gutierrez", "J. Martinez-Mendoza", "F. Ruiz" ],
      "venue" : "J. Nanopart. Res. 2008,",
      "citeRegEx" : "102",
      "shortCiteRegEx" : "102",
      "year" : 2008
    }, {
      "title" : "Negligible Particle-Specific Antibacterial Activity Of Silver Nanoparticles",
      "author" : [ "Z.-M. Xiu", "Q.-B. Zhang", "H.L. Puppala", "V.L. Colvin", "P.J. Alvarez" ],
      "venue" : "Nano Letters 2012,",
      "citeRegEx" : "103",
      "shortCiteRegEx" : "103",
      "year" : 2012
    }, {
      "title" : "Proteomic Analysis Of The Mode Of Antibacterial Action Of Silver Nanoparticles",
      "author" : [ "C.-N. Lok", "C.-M. Ho", "R. Chen", "Q.-Y. He", "W.-Y. Yu", "H. Sun", "P.K.-H. Tam", "J.F. Chiu", "C.-M. Che" ],
      "venue" : "J. Proteome Res",
      "citeRegEx" : "104",
      "shortCiteRegEx" : "104",
      "year" : 2006
    }, {
      "title" : "Silver Coordination Polymers For Prevention Of Implant Infection: Thiol Interaction, Impact On Respiratory Chain Enzymes, And Hydroxyl Radical Induction",
      "author" : [ "O. Gordon", "T.V. Slenters", "P.S. Brunetto", "A.E. Villaruz", "D.E. Sturdevant", "M. Otto", "R. Landmann", "K.M. Fromm" ],
      "venue" : "Antimicrob. Agents Chemother. 2010,",
      "citeRegEx" : "105",
      "shortCiteRegEx" : "105",
      "year" : 2010
    }, {
      "title" : "Characterization Of Enhanced Antibacterial Effects Of Novel Silver Nanoparticles",
      "author" : [ "S. Shrivastava", "T. Bera", "A. Roy", "G. Singh", "P. Ramachandrarao", "D. Dash" ],
      "venue" : "Nanotechnology 2007,",
      "citeRegEx" : "106",
      "shortCiteRegEx" : "106",
      "year" : 2007
    }, {
      "title" : "Rapid Evolution Of Silver Nanoparticle Resistance In Escherichia Coli",
      "author" : [ "J.L. Graves Jr.", "M. Tajkarimi", "Q. Cunningham", "A. Campbell", "H. Nonga", "S.H. Harrison", "J.E. Barrick" ],
      "venue" : null,
      "citeRegEx" : "107",
      "shortCiteRegEx" : "107",
      "year" : 2015
    }, {
      "title" : "MusselInspired Electrospun Nanofibers Functionalized With Size Controlled Silver Nanoparticles For Wound Dressing Application",
      "author" : [ "A. Ghavaminejad", "A. Rajan Unnithan", "A. Ramachandra Kurup Sasikala", "M. Samarikhalaj", "R.G. Thomas", "Y.Y. Jeong", "S. Nasseri", "P. Murugesan", "D. Wu", "C. Hee Park" ],
      "venue" : "ACS Appl. Mater. Interfaces 2015,",
      "citeRegEx" : "108",
      "shortCiteRegEx" : "108",
      "year" : 2015
    }, {
      "title" : "Anti-Inflammatory Activity Of Nanocrystalline Silver In A Porcine Contact Dermatitis",
      "author" : [ "P.L. Nadworny", "J. Wang", "E.E. Tredget", "R.E. Burrell" ],
      "venue" : "Model. Nanomedicine 2008,",
      "citeRegEx" : "109",
      "shortCiteRegEx" : "109",
      "year" : 2008
    }, {
      "title" : "Topical Delivery Of Silver Nanoparticles Promotes Wound Healing",
      "author" : [ "J. Tian", "K.K. Wong", "C.M. Ho", "C.N. Lok", "W.Y. Yu", "C.M. Che", "J.F. Chiu", "P.K. Tam" ],
      "venue" : "Chemmedchem 2007,",
      "citeRegEx" : "110",
      "shortCiteRegEx" : "110",
      "year" : 2007
    }, {
      "title" : "In Situ Synthesis Of Silver-Nanoparticles/Bacterial Cellulose Composites For Slow-Released Antimicrobial Wound Dressing",
      "author" : [ "J. Wu", "Y. Zheng", "W. Song", "J. Luan", "X. Wen", "Z. Wu", "X. Chen", "Q. Wang", "S. Guo" ],
      "venue" : "Carbohydr. Polym",
      "citeRegEx" : "111",
      "shortCiteRegEx" : "111",
      "year" : 2014
    }, {
      "title" : "Construction, Application And Biosafety Of Silver Nanocrystalline Chitosan Wound Dressing",
      "author" : [ "S. Lu", "W. Gao", "H.Y. Gu" ],
      "venue" : null,
      "citeRegEx" : "112",
      "shortCiteRegEx" : "112",
      "year" : 2008
    }, {
      "title" : "Healing Of Burn Wounds By Topical Treatment: A Randomized Controlled Comparison Between Silver Sulfadiazine And Nano-Crystalline Silver",
      "author" : [ "A. Adhya", "J. Bain", "O. Ray", "A. Hazra", "S. Adhikari", "G. Dutta", "S. Ray", "B.K. Majumdar" ],
      "venue" : "J. Basic Clin. Pharm. 2014,",
      "citeRegEx" : "113",
      "shortCiteRegEx" : "113",
      "year" : 2014
    }, {
      "title" : "The Biological Fate Of Silver Ions Following The Use Of Silver‐Containing Wound Care Products–A Review",
      "author" : [ "M. Walker", "D. Parsons" ],
      "venue" : "Int. Wound J. 2014,",
      "citeRegEx" : "114",
      "shortCiteRegEx" : "114",
      "year" : 2014
    }, {
      "title" : "Near Infrared Laser‐Tissue Welding Using Nanoshells As An Exogenous Absorber",
      "author" : [ "A.M. Gobin", "D.P. O'Neal", "D.M. Watkins", "N.J. Halas", "R.A. Drezek", "J.L. West" ],
      "venue" : "Lasers Surg. Med",
      "citeRegEx" : "115",
      "shortCiteRegEx" : "115",
      "year" : 2005
    }, {
      "title" : "Presenting Vancomycin On Nanoparticles To Enhance Antimicrobial Activities",
      "author" : [ "H. Gu", "P. Ho", "E. Tong", "L. Wang", "B. Xu" ],
      "venue" : "Nano Letters 2003,",
      "citeRegEx" : "116",
      "shortCiteRegEx" : "116",
      "year" : 2003
    }, {
      "title" : "Growth Inhibition Of Staphylococcus Aureus By Mixed Monolayer Gold Nanoparticles",
      "author" : [ "J. Bresee", "K.E. Maier", "A.E. Boncella", "C. Melander", "D.L. Feldheim" ],
      "venue" : "Small 2011,",
      "citeRegEx" : "117",
      "shortCiteRegEx" : "117",
      "year" : 2031
    }, {
      "title" : "Small Molecule-Capped Gold Nanoparticles As Potent Antibacterial Agents That Target Gram-Negative Bacteria",
      "author" : [ "Y. Zhao", "Y. Tian", "Y. Cui", "W. Liu", "W. Ma", "X. Jiang" ],
      "venue" : "J. Am. Chem. Soc. 2010,",
      "citeRegEx" : "118",
      "shortCiteRegEx" : "118",
      "year" : 2010
    }, {
      "title" : "The Molecular Mechanism Of Action Of Bactericidal Gold Nanoparticles On Escherichia Coli",
      "author" : [ "Y. Cui", "Y. Zhao", "Y. Tian", "W. Zhang", "X. Lü", "X. Jiang" ],
      "venue" : "Biomaterials 2012,",
      "citeRegEx" : "119",
      "shortCiteRegEx" : "119",
      "year" : 2012
    }, {
      "title" : "Functional Gold Nanoparticles As Potent Antimicrobial Agents Against Multi-Drug-Resistant Bacteria",
      "author" : [ "X. Li", "S.M. Robinson", "A. Gupta", "K. Saha", "Z. Jiang", "D.F. Moyano", "A. Sahar", "M.A. Riley", "V.M. Rotello" ],
      "venue" : "ACS Nano 2014,",
      "citeRegEx" : "120",
      "shortCiteRegEx" : "120",
      "year" : 2014
    }, {
      "title" : "Characterization And Biocompatibility Of Chitosan Nanocomposites",
      "author" : [ "S.-H. Hsu", "Y.-B. Chang", "C.-L. Tsai", "K.-Y. Fu", "S.-H. Wang", "H.-J. Tseng" ],
      "venue" : "Colloids Surfaces B 2011,",
      "citeRegEx" : "121",
      "shortCiteRegEx" : "121",
      "year" : 2011
    }, {
      "title" : "Assessment Of Decellularized Porcine Diaphragm Conjugated With Gold Nanomaterials As A Tissue Scaffold For Wound Healing",
      "author" : [ "M.J. Cozad", "S.L. Bachman", "S.A. Grant" ],
      "venue" : "J. Biomed. Mater. Res., Part A 2011,",
      "citeRegEx" : "122",
      "shortCiteRegEx" : "122",
      "year" : 2011
    }, {
      "title" : "Laser-Induced Cell Detachment, Patterning, And Regrowth On Gold Nanoparticle Functionalized Surfaces",
      "author" : [ "T.A. Kolesnikova", "D. Kohler", "A.G. Skirtach", "H. MöHwald" ],
      "venue" : "ACS Nano 2012,",
      "citeRegEx" : "123",
      "shortCiteRegEx" : "123",
      "year" : 2012
    }, {
      "title" : "Topical Treatment With Anti-Oxidants And Au Nanoparticles Promote Healing Of Diabetic Wound Through Receptor For Advance Glycation End-Products",
      "author" : [ "S.-A. Chen", "H.-M. Chen", "Y.-D. Yao", "C.-F. Hung", "C.-S. Tu", "Y.-J. Liang" ],
      "venue" : "Eur. J. Pharm. Sci. 2012,",
      "citeRegEx" : "124",
      "shortCiteRegEx" : "124",
      "year" : 2012
    }, {
      "title" : "The Effects Of Gold Nanoparticles In Wound Healing With Antioxidant Epigallocatechin Gallate And Α-Lipoic Acid",
      "author" : [ "J.-G. Leu", "S.-A. Chen", "H.-M. Chen", "W.-M. Wu", "C.-F. Hung", "Y.-D. Yao", "C.-S. Tu", "Y.-J. Liang" ],
      "venue" : "Nanomedicine 2012,",
      "citeRegEx" : "125",
      "shortCiteRegEx" : "125",
      "year" : 2012
    }, {
      "title" : "Gas-Injection Of Gold Nanoparticles And Anti-Oxidants Promotes Diabetic Wound Healing",
      "author" : [ "Y.-H. Huang", "C.-Y. Chen", "P.-J. Chen", "S.-W. Tan", "C.-N. Chen", "H.-M. Chen", "C.S. Tu", "Y.-J. Liang" ],
      "venue" : "RSC Adv. 2013,",
      "citeRegEx" : "126",
      "shortCiteRegEx" : "126",
      "year" : 2013
    }, {
      "title" : "Accelerated Healing Of Cutaneous Wounds Using Phytochemically Stabilized Gold Nanoparticle Deposited Hydrocolloid Membranes",
      "author" : [ "J.E. Kim", "J. Lee", "M. Jang", "M.H. Kwak", "J. Go", "E.K. Kho", "S.H. Song", "J.E. Sung", "D.Y. Hwang" ],
      "venue" : "Biomater. Sci. 2015,",
      "citeRegEx" : "128",
      "shortCiteRegEx" : "128",
      "year" : 2015
    }, {
      "title" : "VEGF– Integrin Interplay Controls Tumor Growth And Vascularization",
      "author" : [ "S. De", "O. Razorenova", "N.P. Mccabe", "T. O'Toole", "J. Qin", "T.V. Byzova" ],
      "venue" : "Proc. Natl. Acad. Sci. U.S.A",
      "citeRegEx" : "129",
      "shortCiteRegEx" : "129",
      "year" : 2005
    }, {
      "title" : "Integrin Affinity Modulation In Angiogenesis",
      "author" : [ "G.H. Mahabeleshwar", "J. Chen", "W. Feng", "P.R. Somanath", "O.V. Razorenova", "T.V. Byzova" ],
      "venue" : "Cell Cycle 2008,",
      "citeRegEx" : "130",
      "shortCiteRegEx" : "130",
      "year" : 2008
    }, {
      "title" : "Impaired Wound Healing In Embryonic And Adult Mice Lacking Vimentin",
      "author" : [ "B. Eckes", "E. Colucci-Guyon", "H. Smola", "S. Nodder", "C. Babinet", "T. Krieg", "P. Martin" ],
      "venue" : "J. Cell Sci",
      "citeRegEx" : "131",
      "shortCiteRegEx" : "131",
      "year" : 2000
    }, {
      "title" : "Fabrication And Characterization Of Nanoclay-Enriched Poly(E-Caprolactone) Electrospun Scaffolds For Osteogenic Differentiation Of Human Mesenchymal Stem Cells",
      "author" : [ "A.K. Gaharwar", "S. Mukundan", "E. Karaca", "A. Dolatshahi-Pirouz", "A. Patel", "K. Rangarajan", "S.M. Mihaila", "G. Iviglia", "H. Zhang", "A. Khademhosseini" ],
      "venue" : "Tissue Eng. Pt. A 2014,",
      "citeRegEx" : "132",
      "shortCiteRegEx" : "132",
      "year" : 2014
    }, {
      "title" : "In Situ Loading Of Basic Fibroblast Growth Factor Within Porous Silica Nanoparticles For A Prolonged Release",
      "author" : [ "J. Zhang", "L.-M. Postovit", "D. Wang", "R.B. Gardiner", "R. Harris", "M.M. Abdul", "A.A. Thomas" ],
      "venue" : "Nanoscale Res. Lett. 2009,",
      "citeRegEx" : "133",
      "shortCiteRegEx" : "133",
      "year" : 2009
    }, {
      "title" : "Synthesis Of Nitric Oxide-Releasing Silica Nanoparticles",
      "author" : [ "J.H. Shin", "S.K. Metzger", "M.H. Schoenfisch" ],
      "venue" : "J. Am. Chem. Soc. 2007,",
      "citeRegEx" : "134",
      "shortCiteRegEx" : "134",
      "year" : 2007
    }, {
      "title" : "Nitric Oxide-Releasing Silica Nanoparticle-Doped Polyurethane Electrospun Fibers",
      "author" : [ "A. Koh", "A.W. Carpenter", "D.L. Slomberg", "M.H. Schoenfisch" ],
      "venue" : "ACS Appl. Mater. Interfaces 2013,",
      "citeRegEx" : "135",
      "shortCiteRegEx" : "135",
      "year" : 2013
    }, {
      "title" : "Sustained Release Nitric Oxide Releasing Nanoparticles: Characterization Of A Novel Delivery Platform Based On Nitrite Containing Hydrogel/Glass Composites",
      "author" : [ "A.J. Friedman", "G. Han", "M.S. Navati", "M. Chacko", "L. Gunther", "A. Alfieri", "J.M. Friedman" ],
      "venue" : "Nitric Oxide 2008,",
      "citeRegEx" : "136",
      "shortCiteRegEx" : "136",
      "year" : 2008
    }, {
      "title" : "Nitric Oxide–Releasing Nanoparticles Accelerate Wound Healing By Promoting Fibroblast Migration And Collagen Deposition",
      "author" : [ "G. Han", "L.N. Nguyen", "C. Macherla", "Y. Chi", "J.M. Friedman", "J.D. Nosanchuk", "L.R. Martinez" ],
      "venue" : "Am. J. Pathol",
      "citeRegEx" : "137",
      "shortCiteRegEx" : "137",
      "year" : 2012
    }, {
      "title" : "Nanoparticle Solutions As Adhesives For Gels And Biological Tissues",
      "author" : [ "S. Rose", "A. Prevoteau", "P. Elzière", "D. Hourdet", "A. Marcellan", "L. Leibler" ],
      "venue" : "Nature",
      "citeRegEx" : "138",
      "shortCiteRegEx" : "138",
      "year" : 2014
    }, {
      "title" : "Organ Repair, Hemostasis, And In Vivo Bonding Of Medical Devices By Aqueous Solutions Of Nanoparticles",
      "author" : [ "A. Meddahi‐Pellé", "A. Legrand", "A. Marcellan", "L. Louedec", "D. Letourneur", "L. Leibler" ],
      "venue" : "Angew. Chem. 2014,",
      "citeRegEx" : "139",
      "shortCiteRegEx" : "139",
      "year" : 2014
    }, {
      "title" : "Antibiotic-Loaded Silica Nanoparticle–Collagen Composite Hydrogels With Prolonged Antimicrobial Activity For Wound Infection Prevention",
      "author" : [ "G.S. Alvarez", "C. Hélary", "A.M. Mebert", "X. Wang", "T. Coradin", "M.F. Desimone" ],
      "venue" : "J. Mater. Chem. B 2014,",
      "citeRegEx" : "140",
      "shortCiteRegEx" : "140",
      "year" : 2014
    }, {
      "title" : "Fidgetin-Like 2: A MicrotubuleBased Regulator Of Wound Healing",
      "author" : [ "R.A. Charafeddine", "J. Makdisi", "D. Schairer", "B.P. O'Rourke", "J.D. Diaz-Valencia", "J. Chouake", "A. Kutner", "A. Krausz", "B. Adler", "P. Nacharaju" ],
      "venue" : "J. Invest. Dermatol",
      "citeRegEx" : "141",
      "shortCiteRegEx" : "141",
      "year" : 2015
    }, {
      "title" : "Sustained Release Nitric Oxide From Long-Lived Circulating Nanoparticles",
      "author" : [ "P. Cabrales", "G. Han", "C. Roche", "P. Nacharaju", "A.J. Friedman", "J.M. Friedman" ],
      "venue" : "Free Radicals Biol. Med. 2010,",
      "citeRegEx" : "142",
      "shortCiteRegEx" : "142",
      "year" : 2010
    }, {
      "title" : "Clay: New Opportunities For Tissue Regeneration",
      "author" : [ "J.I. Dawson", "R.O. Oreffo" ],
      "venue" : "And Biomaterial Design. Adv. Mater. 2013,",
      "citeRegEx" : "143",
      "shortCiteRegEx" : "143",
      "year" : 2013
    }, {
      "title" : "Clay Gels For The Delivery Of Regenerative Microenvironments",
      "author" : [ "J.I. Dawson", "J.M. Kanczler", "X.B. Yang", "G.S. Attard", "R.O. Oreffo" ],
      "venue" : "Adv. Mater. 2011,",
      "citeRegEx" : "144",
      "shortCiteRegEx" : "144",
      "year" : 2011
    }, {
      "title" : "Shear-Thinning Nanocomposite Hydrogels For The Treatment Of Hemorrhage",
      "author" : [ "A.K. Gaharwar", "R.K. Avery", "A. Assmann", "A. Paul", "G.H. Mckinley", "A. Khademhosseini", "B.D. Olsen" ],
      "venue" : "ACS Nano 2014,",
      "citeRegEx" : "146",
      "shortCiteRegEx" : "146",
      "year" : 2014
    }, {
      "title" : "Biodegradable Gelatin– Ciprofloxacin–Montmorillonite Composite Hydrogels For Controlled Drug Release And Wound Dressing Application",
      "author" : [ "B.D. Kevadiya", "S. Rajkumar", "H.C. Bajaj", "S.S. Chettiar", "K. Gosai", "H. Brahmbhatt", "A.S. Bhatt", "Y.K. Barvaliya", "G.S. Dave", "R.K. Kothari" ],
      "venue" : "Colloids Surfaces B",
      "citeRegEx" : "147",
      "shortCiteRegEx" : "147",
      "year" : 2014
    }, {
      "title" : "Antibiotic Eluting Clay Mineral (Laponite®) For Wound Healing Application: An In Vitro Study",
      "author" : [ "M. Ghadiri", "W. Chrzanowski", "R. Rohanizadeh" ],
      "venue" : "J. Mater. Sci.: Mater. Med. 2014,",
      "citeRegEx" : "148",
      "shortCiteRegEx" : "148",
      "year" : 2014
    }, {
      "title" : "Layered Silicate Clay Functionalized With Amino Acids: Wound Healing Application",
      "author" : [ "M. Ghadiri", "W. Chrzanowski", "W. Lee", "R. Rohanizadeh" ],
      "venue" : "RSC Adv. 2014,",
      "citeRegEx" : "149",
      "shortCiteRegEx" : "149",
      "year" : 2014
    }, {
      "title" : "Bioactive Silicate Nanoplatelets For Osteogenic Differentiation Of Human Mesenchymal Stem Cells",
      "author" : [ "A.K. Gaharwar", "S.M. Mihaila", "A. Swami", "A. Patel", "S. Sant", "R.L. Reis", "A.P. Marques", "M.E. Gomes", "A. Khademhosseini" ],
      "venue" : "Adv. Mater. 2013,",
      "citeRegEx" : "150",
      "shortCiteRegEx" : "150",
      "year" : 2013
    }, {
      "title" : "Bacterial Cellulose-Mmts Nanoreinforced Composite Films: Novel Wound Dressing Material With Antibacterial Properties",
      "author" : [ "M. Ul-Islam", "T. Khan", "W.A. Khattak", "J.K. Park" ],
      "venue" : "Cellulose 2013,",
      "citeRegEx" : "151",
      "shortCiteRegEx" : "151",
      "year" : 2013
    }, {
      "title" : "Nanoscale Bioactive Glasses",
      "author" : [ "M. Erol‐Taygun", "K. Zheng", "A.R. Boccaccini" ],
      "venue" : "Medical Applications. Int. J. Appl. Glass Sci. 2013,",
      "citeRegEx" : "152",
      "shortCiteRegEx" : "152",
      "year" : 2013
    }, {
      "title" : "Zwitterionic Ceramics For Biomedical Applications",
      "author" : [ "I. Izquierdo-Barba", "M. Colilla", "M. Vallet-Regí" ],
      "venue" : "Acta Biomater",
      "citeRegEx" : "153",
      "shortCiteRegEx" : "153",
      "year" : 2016
    }, {
      "title" : "A Novel Zwitterionic Bioceramic With Dual Antibacterial Capability",
      "author" : [ "M. Colilla", "M. Martínez-Carmona", "S. Sánchez-Salcedo", "M.L. Ruiz-González", "J.M. González-Calbet", "M. Vallet-Regí" ],
      "venue" : "J. Mater. Chem. B 2014,",
      "citeRegEx" : "154",
      "shortCiteRegEx" : "154",
      "year" : 2014
    }, {
      "title" : "Mesoporous Materials For Drug Delivery",
      "author" : [ "M. Vallet‐Regí", "F. Balas", "D. Arcos" ],
      "venue" : "Angew. Chem., Int. Ed. 2007,",
      "citeRegEx" : "155",
      "shortCiteRegEx" : "155",
      "year" : 2007
    }, {
      "title" : "Bioactive Glass Stimulates The Secretion Of Angiogenic Growth Factors And Angiogenesis In Vitro",
      "author" : [ "R.M. Day" ],
      "venue" : "Tissue Eng. 2005,",
      "citeRegEx" : "156",
      "shortCiteRegEx" : "156",
      "year" : 2005
    }, {
      "title" : "Proangiogenic Potential Of A Collagen/Bioactive Glass Substrate",
      "author" : [ "A. Leu", "J.K. Leach" ],
      "venue" : "Pharm. Res. 2008,",
      "citeRegEx" : "157",
      "shortCiteRegEx" : "157",
      "year" : 2008
    }, {
      "title" : "Morphological Control And In Vitro Bioactivity Of Nanoscale Bioactive Glasses",
      "author" : [ "X. Chen", "B. Lei", "Y. Wang", "N. Zhao" ],
      "venue" : "J. Non-Cryst. Solids 2009,",
      "citeRegEx" : "158",
      "shortCiteRegEx" : "158",
      "year" : 2009
    }, {
      "title" : "Angiogenesis Stimulated By Novel Nanoscale Bioactive Glasses",
      "author" : [ "C. Mao", "X. Chen", "G. Miao", "C. Lin" ],
      "venue" : "Biomed. Mater. 2015,",
      "citeRegEx" : "159",
      "shortCiteRegEx" : "159",
      "year" : 2015
    }, {
      "title" : "Bioglass Promotes Wound Healing By Affecting Gap Junction Connexin 43 Mediated Endothelial Cell Behavior",
      "author" : [ "H. Li", "J. He", "H. Yu", "C.R. Green", "J. Chang" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "160",
      "shortCiteRegEx" : "160",
      "year" : 2016
    }, {
      "title" : "Size-Dependent Bacterial Growth Inhibition And Mechanism Of Antibacterial Activity Of Zinc Oxide Nanoparticles",
      "author" : [ "K.R. Raghupathi", "R.T. Koodali", "A.C. Manna" ],
      "venue" : "Langmuir 2011,",
      "citeRegEx" : "161",
      "shortCiteRegEx" : "161",
      "year" : 2011
    }, {
      "title" : "Zinc Oxide Nanoflowers Make New Blood Vessels",
      "author" : [ "A.K. Barui", "V. Veeriah", "S. Mukherjee", "J. Manna", "A.K. Patel", "S. Patra", "K. Pal", "S. Murali", "R.K. Rana", "S. Chatterjee" ],
      "venue" : "Nanoscale 2012,",
      "citeRegEx" : "162",
      "shortCiteRegEx" : "162",
      "year" : 2012
    }, {
      "title" : "Evaluation Of Wound Healing Potential Of Β-Chitin Hydrogel/Nano Zinc Oxide Composite Bandage",
      "author" : [ "S. Kumar", "V.-K. Lakshmanan", "M. Raj", "R. Biswas", "T. Hiroshi", "S.V. Nair", "R. Jayakumar" ],
      "venue" : "Pharm. Res. 2013,",
      "citeRegEx" : "164",
      "shortCiteRegEx" : "164",
      "year" : 2013
    }, {
      "title" : "Electrospun Polycaprolactone/Zno Nanocomposite Membranes As Biomaterials With Antibacterial And Cell Adhesion Properties",
      "author" : [ "R. Augustine", "H.N. Malik", "D.K. Singhal", "A. Mukherjee", "D. Malakar", "N. Kalarikkal", "S. Thomas" ],
      "venue" : "J. Polym. Res. 2014,",
      "citeRegEx" : "165",
      "shortCiteRegEx" : "165",
      "year" : 2014
    }, {
      "title" : "Intra) Cellular Stability Of Inorganic Nanoparticles: Effects On Cytotoxicity, Particle Functionality",
      "author" : [ "S.J. Soenen", "W.J. Parak", "J. Rejman", "B. Manshian" ],
      "venue" : "And Biomedical Applications. Chem. Rev. 2015,",
      "citeRegEx" : "166",
      "shortCiteRegEx" : "166",
      "year" : 2015
    }, {
      "title" : "Graphene-Based Composite Materials Beneficial To Wound Healing",
      "author" : [ "B. Lu", "T. Li", "H. Zhao", "X. Li", "C. Gao", "S. Zhang", "E. Xie" ],
      "venue" : "Nanoscale 2012,",
      "citeRegEx" : "167",
      "shortCiteRegEx" : "167",
      "year" : 2012
    }, {
      "title" : "A Novel Wound Dressing Based On Ag/Graphene Polymer Hydrogel: Effectively Kill Bacteria And Accelerate Wound Healing",
      "author" : [ "Z. Fan", "B. Liu", "J. Wang", "S. Zhang", "Q. Lin", "P. Gong", "L. Ma", "S. Yang" ],
      "venue" : "Adv. Funct. Mater. 2014,",
      "citeRegEx" : "168",
      "shortCiteRegEx" : "168",
      "year" : 2014
    }, {
      "title" : "Antibacterial Activity Of Graphite, Graphite Oxide, Graphene Oxide, And Reduced Graphene Oxide: Membrane And Oxidative Stress",
      "author" : [ "S. Liu", "T.H. Zeng", "M. Hofmann", "E. Burcombe", "J. Wei", "R. Jiang", "J. Kong", "Y. Chen" ],
      "venue" : "ACS Nano 2011,",
      "citeRegEx" : "169",
      "shortCiteRegEx" : "169",
      "year" : 2011
    }, {
      "title" : "Toxicity Of Graphene And Graphene Oxide Nanowalls Against Bacteria",
      "author" : [ "O. Akhavan", "E. Ghaderi" ],
      "venue" : "ACS Nano 2010,",
      "citeRegEx" : "170",
      "shortCiteRegEx" : "170",
      "year" : 2010
    }, {
      "title" : "Antibacterial Efficiency Of Graphene Nanosheets Against Pathogenic Bacteria Via Lipid Peroxidation",
      "author" : [ "K. Krishnamoorthy", "M. Veerapandian", "L.-H. Zhang", "K. Yun", "S.J. Kim" ],
      "venue" : "J. Phys. Chem. C 2012,",
      "citeRegEx" : "171",
      "shortCiteRegEx" : "171",
      "year" : 2012
    }, {
      "title" : "Destructive Extraction Of Phospholipids From Escherichia Coli Membranes By Graphene Nanosheets",
      "author" : [ "Y. Tu", "M. Lv", "P. Xiu", "T. Huynh", "M. Zhang", "M. Castelli", "Z. Liu", "Q. Huang", "C. Fan", "H. Fang" ],
      "venue" : "Nat. Nanotechnol. 2013,",
      "citeRegEx" : "172",
      "shortCiteRegEx" : "172",
      "year" : 2013
    }, {
      "title" : "Enhancement Of Dendritic Cell Production By Fms-Like Tyrosine Kinase-3 Ligand Increases The Resistance Of Mice To A Burn Wound Infection",
      "author" : [ "T.E. Toliver-Kinsky", "W. Cui", "E.D. Murphey", "C. Lin", "E.R. Sherwood" ],
      "venue" : "Journal Of Immunology 2005,",
      "citeRegEx" : "174",
      "shortCiteRegEx" : "174",
      "year" : 2005
    } ],
    "referenceMentions" : [ {
      "referenceID" : 3,
      "context" : "recovery, overall health, and cost.(4) Chronic wounds do not heal in a predicted time period, are",
      "startOffset" : 35,
      "endOffset" : 38
    }, {
      "referenceID" : 4,
      "context" : "more susceptible to infection, and are considerably more difficult to manage.(5)",
      "startOffset" : 77,
      "endOffset" : 80
    }, {
      "referenceID" : 5,
      "context" : "developing a foot ulcer in a diabetes patient is estimated to be 25%.(6) The most dreaded",
      "startOffset" : 69,
      "endOffset" : 72
    }, {
      "referenceID" : 6,
      "context" : "five years post-amputation according to long-term studies.(7) Therefore, there are multi-faceted",
      "startOffset" : 58,
      "endOffset" : 61
    }, {
      "referenceID" : 28,
      "context" : "nanocomposite, nanoengineered hydrogels and self-assembled nanostructures.(30) These newly",
      "startOffset" : 74,
      "endOffset" : 78
    }, {
      "referenceID" : 29,
      "context" : "wounds.(31) Additionally, exposure of nanoparticles in external wounds is more localized and",
      "startOffset" : 7,
      "endOffset" : 11
    }, {
      "referenceID" : 30,
      "context" : "thereby highly controlled.(32) Undesirable effects, if any, can be easily detected and controlled due",
      "startOffset" : 26,
      "endOffset" : 30
    }, {
      "referenceID" : 3,
      "context" : "2).(4) Pathogenic infection of the wounds can extend the healing process,",
      "startOffset" : 3,
      "endOffset" : 6
    }, {
      "referenceID" : 38,
      "context" : "response rather than a local response to injury.(41)",
      "startOffset" : 48,
      "endOffset" : 52
    }, {
      "referenceID" : 39,
      "context" : "initiate inflammation.(42) Neutrophils are the first to clean up the wound bed from invading",
      "startOffset" : 22,
      "endOffset" : 26
    }, {
      "referenceID" : 40,
      "context" : "microbes and dead cells of the host.(43) Monocytes divide and differentiate into macrophages,",
      "startOffset" : 36,
      "endOffset" : 40
    }, {
      "referenceID" : 41,
      "context" : "with wound closure, which is accomplished via traction forces generated by the fibroblasts.(44)",
      "startOffset" : 91,
      "endOffset" : 95
    }, {
      "referenceID" : 42,
      "context" : "crosslinked during this time.(45) The cells in granulation tissue undergo apoptosis, and the cell-rich",
      "startOffset" : 29,
      "endOffset" : 33
    }, {
      "referenceID" : 43,
      "context" : "granulation tissue results in formation of scar tissue.(46) The density of the blood vessels in the",
      "startOffset" : 55,
      "endOffset" : 59
    }, {
      "referenceID" : 44,
      "context" : "granulation tissue reduces, and the wound becomes pale in color due to reduced blood flow.(47)",
      "startOffset" : 90,
      "endOffset" : 94
    }, {
      "referenceID" : 45,
      "context" : "This results in formation of striated scar tissue consisting of collagen fibers and myofibroblasts.(48)",
      "startOffset" : 99,
      "endOffset" : 103
    }, {
      "referenceID" : 49,
      "context" : "proliferation of progenitor cells are also often defective in chronic wounds.(52) The net result is",
      "startOffset" : 77,
      "endOffset" : 81
    }, {
      "referenceID" : 52,
      "context" : "acetyl-D-glucosamine.(56) The amino groups present on the chitin backbone offer many Page 8 of 65",
      "startOffset" : 21,
      "endOffset" : 25
    }, {
      "referenceID" : 53,
      "context" : "decreases the release rate of entrapped therapeutics from the nanoparticles.(57) Chitosan has been",
      "startOffset" : 76,
      "endOffset" : 80
    }, {
      "referenceID" : 57,
      "context" : "proliferation and nitric oxide production.(61) Nitric oxide is involved in wound healing through",
      "startOffset" : 42,
      "endOffset" : 46
    }, {
      "referenceID" : 57,
      "context" : "production of nitric oxide; this supports the role for chitosan nanoparticles in wound healing.(61)",
      "startOffset" : 95,
      "endOffset" : 99
    }, {
      "referenceID" : 60,
      "context" : "adenosine diphosphate (ADP) or fibrinogen (FN) were explored.(64) ADP binds to the receptors on",
      "startOffset" : 61,
      "endOffset" : 65
    }, {
      "referenceID" : 60,
      "context" : "the most effective molecule.(64) ADP/FN in CS-NPs interacts with blood-derived thrombin and",
      "startOffset" : 28,
      "endOffset" : 32
    }, {
      "referenceID" : 61,
      "context" : "for therapeutic delivery.(65) Administration of CS-TPP nanoparticles encapsulated with",
      "startOffset" : 25,
      "endOffset" : 29
    }, {
      "referenceID" : 61,
      "context" : "ulcerative gastrointestinal lesions in rats.(65) In addition, the free extract was cytotoxic at higher",
      "startOffset" : 44,
      "endOffset" : 48
    }, {
      "referenceID" : 62,
      "context" : "antibacterial and wound healing applications.(66) The CS-FN nanoparticles completely inhibited",
      "startOffset" : 45,
      "endOffset" : 49
    }, {
      "referenceID" : 62,
      "context" : "took significantly more time (22 days) for the saline-treated wounds to heal completely.(66) Page 10 of 65",
      "startOffset" : 88,
      "endOffset" : 92
    }, {
      "referenceID" : 63,
      "context" : "nanoparticles.(67) Gene-loaded CS-NPs were delivered into mice through subcutaneous and",
      "startOffset" : 14,
      "endOffset" : 18
    }, {
      "referenceID" : 64,
      "context" : "electrospinning or self-assembled techniques.(68) Chitosan alone cannot form electrospun",
      "startOffset" : 45,
      "endOffset" : 49
    }, {
      "referenceID" : 52,
      "context" : "can be obtained.(56) The addition of collagen also facilitates proliferation and migration of",
      "startOffset" : 16,
      "endOffset" : 20
    }, {
      "referenceID" : 65,
      "context" : "DD) with and without arginine-modified chitosan (CS-A).(69) Male Wistar rats were wounded and",
      "startOffset" : 55,
      "endOffset" : 59
    }, {
      "referenceID" : 34,
      "context" : "electrospun into CS/PEO nanofibrous scaffolds.(36) Additionally, poly-lactic-co-glycolic acid",
      "startOffset" : 46,
      "endOffset" : 50
    }, {
      "referenceID" : 34,
      "context" : "polystyrene (TCPS) controls.(36) Plates containing CS/PEO scaffolds with PDGF-BB loaded",
      "startOffset" : 28,
      "endOffset" : 32
    }, {
      "referenceID" : 34,
      "context" : "hair coverage due to the faster healing process.(36) This study demonstrates a promising approach",
      "startOffset" : 48,
      "endOffset" : 52
    }, {
      "referenceID" : 66,
      "context" : "13 Fibrin is a biopolymer of fibrinogen, which is formed by the action of thrombin.(70) Fibrin,",
      "startOffset" : 83,
      "endOffset" : 87
    }, {
      "referenceID" : 67,
      "context" : "differentiation, and angiogenesis to promote wound healing.(71) Enzymatically degradable fibrin",
      "startOffset" : 59,
      "endOffset" : 63
    }, {
      "referenceID" : 68,
      "context" : "combined action of VEGF and the fibrin degradation products released within the system.(72)",
      "startOffset" : 87,
      "endOffset" : 91
    }, {
      "referenceID" : 66,
      "context" : "more stable than the free form in simulated wound environments.(70) Incorporation of chitosan",
      "startOffset" : 63,
      "endOffset" : 67
    }, {
      "referenceID" : 66,
      "context" : "matrix was able to retain bioactivity and facilitate proliferation of fibroblast cells in vitro.(70)",
      "startOffset" : 96,
      "endOffset" : 100
    }, {
      "referenceID" : 69,
      "context" : "antimicrobial properties as a drug delivery system for healing infected wounds.(73) Results showed Page 13 of 65",
      "startOffset" : 79,
      "endOffset" : 83
    }, {
      "referenceID" : 69,
      "context" : "highlighted the ability of the nanomaterials system to respond to pH change.(73)",
      "startOffset" : 76,
      "endOffset" : 80
    }, {
      "referenceID" : 70,
      "context" : "3).(74) The CFBs were found to be microporous, flexible, and biodegradable.",
      "startOffset" : 3,
      "endOffset" : 7
    }, {
      "referenceID" : 70,
      "context" : "chitosan matrix, might produce an additive effect on wound healing.(74)",
      "startOffset" : 67,
      "endOffset" : 71
    }, {
      "referenceID" : 74,
      "context" : "blend to prepare a nanocomposite sponge for wound dressing.(78) Hyaluronic acid was included",
      "startOffset" : 59,
      "endOffset" : 63
    }, {
      "referenceID" : 75,
      "context" : "muscular atrophy and improving reperfusion in ischemic hind limb wounds.(79) However, PLGA",
      "startOffset" : 72,
      "endOffset" : 76
    }, {
      "referenceID" : 76,
      "context" : "and tested on the full-thickness diabetic wounds of rats.(80) PLGA nanoparticles facilitated a slow",
      "startOffset" : 57,
      "endOffset" : 61
    }, {
      "referenceID" : 76,
      "context" : "nanoparticles without growth factors or controls.(80)",
      "startOffset" : 49,
      "endOffset" : 53
    }, {
      "referenceID" : 77,
      "context" : "PLGA nanoparticles were fabricated.(81) The PLGA nanoparticles were loaded with VEGF and",
      "startOffset" : 35,
      "endOffset" : 39
    }, {
      "referenceID" : 77,
      "context" : "epithelialization, enhanced granulation tissue formation/maturity, and collagen deposition.(81)",
      "startOffset" : 91,
      "endOffset" : 95
    }, {
      "referenceID" : 78,
      "context" : "was encapsulated in PLGA (PLGA-CC) nanoparticles.(82) The release kinetics showed an initial",
      "startOffset" : 49,
      "endOffset" : 53
    }, {
      "referenceID" : 78,
      "context" : "complete re-epithelialization and significantly increased deposition of connective tissue.(82) This",
      "startOffset" : 90,
      "endOffset" : 94
    }, {
      "referenceID" : 80,
      "context" : "remodeling.(84) However, NO delivery using a conventional delivery platform is challenging due",
      "startOffset" : 11,
      "endOffset" : 15
    }, {
      "referenceID" : 83,
      "context" : "was achieved using PLGA-polyethylenimine (PEI) nanoparticles.(87) PEI/diazenium-diolate",
      "startOffset" : 61,
      "endOffset" : 65
    }, {
      "referenceID" : 83,
      "context" : "thickness wounds in mice were treated with NO-releasing nanoparticles.(87)",
      "startOffset" : 70,
      "endOffset" : 74
    }, {
      "referenceID" : 84,
      "context" : "of colitis.(88) PLGA-PEG-maleimide nanoparticles were decorated with the KLWVLPK peptide of",
      "startOffset" : 11,
      "endOffset" : 15
    }, {
      "referenceID" : 85,
      "context" : "wound repair.(89) In vivo studies in annexin A1 knockout mice showed that a single administration",
      "startOffset" : 13,
      "endOffset" : 17
    }, {
      "referenceID" : 86,
      "context" : "scaffolds conjugated with CD29 antibodies were investigated for wound healing.(90) Full-thickness",
      "startOffset" : 78,
      "endOffset" : 82
    }, {
      "referenceID" : 86,
      "context" : "days for the untreated wounds to close.(90) This study clearly indicates that use of nanofibrous",
      "startOffset" : 39,
      "endOffset" : 43
    }, {
      "referenceID" : 87,
      "context" : "sericin nanofiber blend as the first layer and pure PLLA nanofibers as the second layer.(91) Sericin,",
      "startOffset" : 88,
      "endOffset" : 92
    }, {
      "referenceID" : 87,
      "context" : "loaded dual-layer nanofiber mats, but 84% for the commercial woven dressing.(91)",
      "startOffset" : 76,
      "endOffset" : 80
    }, {
      "referenceID" : 88,
      "context" : "delivery system for wound healing.(92) Indomethacin, an anti-inflammatory drug used for wound",
      "startOffset" : 34,
      "endOffset" : 38
    }, {
      "referenceID" : 90,
      "context" : "20 a ring electrode and a point electrode.(94) Ex vivo grafting of these fibers into a piece of dura with a",
      "startOffset" : 42,
      "endOffset" : 46
    }, {
      "referenceID" : 93,
      "context" : "(PHPMA).(98) Self-assembled copolymers formed gel networks of micelles with bridging chains",
      "startOffset" : 8,
      "endOffset" : 12
    }, {
      "referenceID" : 93,
      "context" : "dressing material loaded with drugs and growth factors.(98)",
      "startOffset" : 55,
      "endOffset" : 59
    }, {
      "referenceID" : 79,
      "context" : "curcumin for improved wound healing.(83) Dermal drug delivery capacity was studied in vitro in",
      "startOffset" : 36,
      "endOffset" : 40
    }, {
      "referenceID" : 79,
      "context" : "epithelialization with multiple layers of thick epidermis.(83) Page 22 of 65",
      "startOffset" : 58,
      "endOffset" : 62
    }, {
      "referenceID" : 30,
      "context" : "against pathogens.(32) Antibacterial activity of AgNPs increased with decreasing size of the",
      "startOffset" : 18,
      "endOffset" : 22
    }, {
      "referenceID" : 97,
      "context" : "nanoparticles.(102) Size-dependent antimicrobial activity of AgNPs was also observed with",
      "startOffset" : 14,
      "endOffset" : 19
    }, {
      "referenceID" : 96,
      "context" : ", and Aspergillus niger.(101) The size-dependent microbial",
      "startOffset" : 24,
      "endOffset" : 29
    }, {
      "referenceID" : 98,
      "context" : "activity of AgNPs was in fact due to the size-dependent release of silver ions.(103)",
      "startOffset" : 79,
      "endOffset" : 84
    }, {
      "referenceID" : 98,
      "context" : "for the antimicrobial action, it is the silver ions that they carry and release.(103) Electrostatic",
      "startOffset" : 80,
      "endOffset" : 85
    }, {
      "referenceID" : 99,
      "context" : "rapid breakdown of proton motive force resulting in cell lysis.(104) In addition, silver ions",
      "startOffset" : 63,
      "endOffset" : 68
    }, {
      "referenceID" : 100,
      "context" : "group, and induce hydroxyl radical formation resulting in bacterial cell death.(105) AgNPs-",
      "startOffset" : 79,
      "endOffset" : 84
    }, {
      "referenceID" : 101,
      "context" : "transduction pathway and in essential enzymes may also inhibit the growth of the organisms.(106)",
      "startOffset" : 91,
      "endOffset" : 96
    }, {
      "referenceID" : 94,
      "context" : "death.(99) It was thought that such a multifaceted mode of action would guard against the",
      "startOffset" : 6,
      "endOffset" : 10
    }, {
      "referenceID" : 102,
      "context" : "developed by de novo mutations in existing genes.(107) These results clearly show that more",
      "startOffset" : 49,
      "endOffset" : 54
    }, {
      "referenceID" : 106,
      "context" : "aeruginosa.(111) Mussel-inspired poly(dopamine methacrylamide-co-methyl",
      "startOffset" : 11,
      "endOffset" : 16
    }, {
      "referenceID" : 103,
      "context" : "4).(108) In this method, AgNPs were coated uniformly without any Page 24 of 65",
      "startOffset" : 3,
      "endOffset" : 8
    }, {
      "referenceID" : 107,
      "context" : "silver sulfadiazine.(112) While treating second-degree, deep-dermal burn wounds in humans,",
      "startOffset" : 20,
      "endOffset" : 25
    }, {
      "referenceID" : 108,
      "context" : "AgNPs showed complete wound healing 10 to 14 days earlier than silver sulfadiazine.(113) Apart",
      "startOffset" : 83,
      "endOffset" : 88
    }, {
      "referenceID" : 105,
      "context" : "hypertrophic scarring and normal hair growth.(110) In acute burn and excision wound models, mice",
      "startOffset" : 45,
      "endOffset" : 50
    }, {
      "referenceID" : 37,
      "context" : "wound dressing material with ionic silver), and silver sulfadiazine.(40) This is a significant",
      "startOffset" : 68,
      "endOffset" : 72
    }, {
      "referenceID" : 107,
      "context" : "AgNPs were combined with chitosan, which ensured a control over its exposure to cells.(112)",
      "startOffset" : 86,
      "endOffset" : 91
    }, {
      "referenceID" : 84,
      "context" : "and infection control.(88) Uniform distribution and pH dependent release was observed when",
      "startOffset" : 22,
      "endOffset" : 26
    }, {
      "referenceID" : 110,
      "context" : "to facilitate healing of cut wounds.(115) Gold nanoshells with peak extinction (matching the near",
      "startOffset" : 36,
      "endOffset" : 41
    }, {
      "referenceID" : 110,
      "context" : "while welding surgically cut wounds.(115) Tensile strength of the welded site was equal to the",
      "startOffset" : 36,
      "endOffset" : 41
    }, {
      "referenceID" : 111,
      "context" : "effectively inhibit the growth of vancomycin-resistant enterococci.(116) AuNPs capped with p-",
      "startOffset" : 67,
      "endOffset" : 72
    }, {
      "referenceID" : 112,
      "context" : "aureus (MSSA) and MRSA.(117) Similarly, inactive amino-substituted",
      "startOffset" : 23,
      "endOffset" : 28
    }, {
      "referenceID" : 115,
      "context" : "were the most effective against Gram-negative and Gram-positive bacteria.(120) These studies",
      "startOffset" : 73,
      "endOffset" : 78
    }, {
      "referenceID" : 116,
      "context" : "with AuNP-Chitosan nanocomposite than pure chitosan.(121)",
      "startOffset" : 52,
      "endOffset" : 57
    }, {
      "referenceID" : 117,
      "context" : "on shape and concentration of the nanomaterial use.(122) The possibility of a novel application for",
      "startOffset" : 51,
      "endOffset" : 56
    }, {
      "referenceID" : 118,
      "context" : "detachment.(123) The age of the cell, intensity and duration of laser power, and AuNP patterning",
      "startOffset" : 11,
      "endOffset" : 16
    }, {
      "referenceID" : 121,
      "context" : "abundant in the wound surface.(126) Liposome encapsulation of the Calendula officinalis extract",
      "startOffset" : 30,
      "endOffset" : 35
    }, {
      "referenceID" : 122,
      "context" : "and physiological stability.(128) The surface of a hydrocolloid membrane coated with AuNPs",
      "startOffset" : 28,
      "endOffset" : 33
    }, {
      "referenceID" : 122,
      "context" : "5).(128) For example, the wound closure rate was significantly enhanced in the treated group",
      "startOffset" : 3,
      "endOffset" : 8
    }, {
      "referenceID" : 36,
      "context" : "500nm nanosilica, forming a gold–silica core–shell structure.(39) The AuNPs were allowed to",
      "startOffset" : 61,
      "endOffset" : 65
    }, {
      "referenceID" : 36,
      "context" : "complete healing, whereas the wounds of the rh-bFGF treatment had not completely healed.(39)",
      "startOffset" : 88,
      "endOffset" : 92
    }, {
      "referenceID" : 125,
      "context" : "of cytoskeletal system shown to be essential for wound healing.(131) Genes of these two proteins",
      "startOffset" : 63,
      "endOffset" : 68
    }, {
      "referenceID" : 126,
      "context" : "mice expressing anti-miR-378a showed enhanced wound healing.(132) Encouraged by these results,",
      "startOffset" : 60,
      "endOffset" : 65
    }, {
      "referenceID" : 127,
      "context" : "mesoporous silica nanoparticles (MSNs) was done by the water-in-oil microemulsion method.(133)",
      "startOffset" : 89,
      "endOffset" : 94
    }, {
      "referenceID" : 128,
      "context" : "tetraethoxysilane or tetramethoxysilane by the sol–gel method.(134) The secondary amino groups Page 30 of 65",
      "startOffset" : 62,
      "endOffset" : 67
    }, {
      "referenceID" : 128,
      "context" : "duration of NO release.(134) Further control over the NO release could be achieved by",
      "startOffset" : 23,
      "endOffset" : 28
    }, {
      "referenceID" : 129,
      "context" : "incorporating the NO-releasing silicate nanoparticles into electrospun polyurethane fibers.(135) In",
      "startOffset" : 91,
      "endOffset" : 96
    }, {
      "referenceID" : 130,
      "context" : "releasing nanocomposites.(136) Heating the nanocomposites facilitated the thermal reduction of",
      "startOffset" : 25,
      "endOffset" : 30
    }, {
      "referenceID" : 131,
      "context" : "comparing the NO-treated group with the untreated group.(137)",
      "startOffset" : 56,
      "endOffset" : 61
    }, {
      "referenceID" : 132,
      "context" : "6).(138) The same group has further refined it",
      "startOffset" : 3,
      "endOffset" : 8
    }, {
      "referenceID" : 133,
      "context" : "wounds made in the skin and liver of rats.(139) In this method, a droplet of nanoparticle solution is",
      "startOffset" : 42,
      "endOffset" : 47
    }, {
      "referenceID" : 133,
      "context" : "hemostasis, biliostasis, and wound closure were achieved without affecting the liver function.(139)",
      "startOffset" : 94,
      "endOffset" : 99
    }, {
      "referenceID" : 134,
      "context" : "nanoparticles before incorporating them in collagen based nanocomposite hydrogel system.(140)",
      "startOffset" : 88,
      "endOffset" : 93
    }, {
      "referenceID" : 135,
      "context" : "and thereby, wound healing.(141) Hydrogel/glass composites were made using",
      "startOffset" : 27,
      "endOffset" : 32
    }, {
      "referenceID" : 35,
      "context" : "functionalized with EGF (MMT-EGF) were evaluated for epithelial wound healing in vitro.(38)",
      "startOffset" : 87,
      "endOffset" : 91
    }, {
      "referenceID" : 35,
      "context" : "cell migration resulting in complete wound closure.(38)",
      "startOffset" : 51,
      "endOffset" : 55
    }, {
      "referenceID" : 138,
      "context" : "promote wound healing.(144) In another study, nanosilicates have used to release growth factor-rich",
      "startOffset" : 22,
      "endOffset" : 27
    }, {
      "referenceID" : 139,
      "context" : "hemostasis.(146) Penetrating injuries results in loss of blood and depending on the body parts",
      "startOffset" : 11,
      "endOffset" : 16
    }, {
      "referenceID" : 139,
      "context" : "times by 77%, and shown to form stable clot-gel systems under in vivo conditions.(146) The",
      "startOffset" : 81,
      "endOffset" : 86
    }, {
      "referenceID" : 140,
      "context" : "property for wound dressings.(147) Physical analysis showed that the interlayer space of MMT was",
      "startOffset" : 29,
      "endOffset" : 34
    }, {
      "referenceID" : 140,
      "context" : "proliferation and cell migration towards the wound area in 24 hours.(147)",
      "startOffset" : 68,
      "endOffset" : 73
    }, {
      "referenceID" : 141,
      "context" : "need further modifications to overcome the problem of burst release and cytotoxicity.(148) The",
      "startOffset" : 85,
      "endOffset" : 90
    }, {
      "referenceID" : 142,
      "context" : "acid (Lap/Glu), leucine (Lap/Leu), and lysine (Lap/Lys) amino acids.(149) Over a period of 24",
      "startOffset" : 68,
      "endOffset" : 73
    }, {
      "referenceID" : 142,
      "context" : "controls.(149) This is in contrast with an earlier report in which Laponite was shown to be non-",
      "startOffset" : 9,
      "endOffset" : 14
    }, {
      "referenceID" : 149,
      "context" : "angiogenic growth factors from human stromal cells and facilitate angiogenesis.(156) The 45S5",
      "startOffset" : 79,
      "endOffset" : 84
    }, {
      "referenceID" : 151,
      "context" : "of the melt-derived bioglass particles.(158) Recent studies have investigated bioglass nanoparticles",
      "startOffset" : 39,
      "endOffset" : 44
    }, {
      "referenceID" : 152,
      "context" : "cells (HUVECs).(159) HUVECs treated with bioglass nanoparticles showed increased expression of",
      "startOffset" : 15,
      "endOffset" : 20
    }, {
      "referenceID" : 152,
      "context" : "proliferation, angiogenic tube formation and wound closure.(159) Recent study have shown",
      "startOffset" : 59,
      "endOffset" : 64
    }, {
      "referenceID" : 154,
      "context" : "Zn ions from ZnO colloidal solution.(161) Based on in vitro and in vivo wound healing and",
      "startOffset" : 36,
      "endOffset" : 41
    }, {
      "referenceID" : 157,
      "context" : "and can be used for wound healing applications.(165) As per the FDA, ZnO is a generally-regarded-",
      "startOffset" : 47,
      "endOffset" : 52
    }, {
      "referenceID" : 161,
      "context" : "reduced graphene oxide, graphite, and graphite oxide.(169) Extremely sharp edges of the graphene",
      "startOffset" : 53,
      "endOffset" : 58
    }, {
      "referenceID" : 162,
      "context" : "comparison with bare stainless steel substrate used as control.(170) It was reported that graphene",
      "startOffset" : 63,
      "endOffset" : 68
    }, {
      "referenceID" : 163,
      "context" : "of ROS.(171) While the zero-dimensional fullerenes and one-dimensional carbon nanotubes enter",
      "startOffset" : 7,
      "endOffset" : 12
    }, {
      "referenceID" : 164,
      "context" : "coli causing lethal damage to cellular integrity.(172) Additional damage is caused",
      "startOffset" : 49,
      "endOffset" : 54
    }, {
      "referenceID" : 165,
      "context" : "wound healing, and increase mortality.(174) Sepsis initiates a complex interplay of host pro-",
      "startOffset" : 38,
      "endOffset" : 43
    }, {
      "referenceID" : 3,
      "context" : "Adapted and reprinted with permission.(4) Copyright",
      "startOffset" : 38,
      "endOffset" : 41
    }, {
      "referenceID" : 70,
      "context" : "Adapted and reprinted with permission.(74) Copyright 2012, Mary Ann Liebert, Inc.",
      "startOffset" : 38,
      "endOffset" : 42
    }, {
      "referenceID" : 103,
      "context" : "Adapted and reproduced with permission.(108) Copyright 2015, American Chemical Society.",
      "startOffset" : 39,
      "endOffset" : 44
    }, {
      "referenceID" : 122,
      "context" : "Adapted and reproduced with permission.(128) Copyright 2015, Royal Society of Chemistry.",
      "startOffset" : 39,
      "endOffset" : 44
    }, {
      "referenceID" : 132,
      "context" : "(a) and (b) adapted and reproduced with permission.(138) Copyright 2014, Macmillan Publishers Limited; and (c) and (d) adapted and reproduced with permission.",
      "startOffset" : 51,
      "endOffset" : 56
    }, {
      "referenceID" : 133,
      "context" : "Copyright 2014, Macmillan Publishers Limited; and (c) and (d) adapted and reproduced with permission.(139) Copyright 2014, Wiley-VCH Verlag GmbH & Co.",
      "startOffset" : 101,
      "endOffset" : 106
    }, {
      "referenceID" : 138,
      "context" : "Adapted and reproduced with permission.(144) Copyright 2011,",
      "startOffset" : 39,
      "endOffset" : 44
    }, {
      "referenceID" : 155,
      "context" : "Adapted and reproduced with permission.(162) Copyright 2012, Royal",
      "startOffset" : 39,
      "endOffset" : 44
    } ],
    "year" : 2016,
    "abstractText" : null,
    "creator" : null
  }
}